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The publication of a draft equine genome sequence and the release by Illumina of a 
50,000 marker single-nucleotide polymorphism (SNP) genotyping chip has provided 
equine researchers with the opportunity to use new approaches to study the 
relationships between genotype and phenotype.  In particular, it is hoped that the use 
of high-density markers applied to population samples will enable progress to be 
made with regard to more complex diseases.  The first objective of this thesis is to 
explore the potential for the equine SNP chip to enable such studies to be performed 
in the horse.  The second objective is to investigate the genetic background of 
osteochondrosis (OC) in the horse.  These objectives have been tackled using 348 
Thoroughbreds from the US, divided into cases and controls, and a further 836 UK 
Thoroughbreds, the majority with no phenotype data.  All horses had been genotyped 
with the Illumina Equine SNP50 BeadChip. 
Linkage disequilibrium (LD) is the non-random association of alleles at 
neighbouring loci.  The reliance of many genomic methodologies on LD between 
neutral markers and causal variants makes it an important characteristic of genome 
structure.  In this thesis, the genomic data has been used to study the extent of LD in 
the Thoroughbred and the results considered in terms of genome coverage.  Results 
suggest that the SNP chip offers good coverage of the genome.  Published theoretical 
relationships between LD and historical effective population size (Ne) were exploited 
to enable accuracy predictions for genome-wide evaluation (GWE) to be made.  A 
subsequent in-depth exploration of this theory cast some doubt on the reliability of 
this approach in the estimation of Ne, but the general conclusion that the 
Thoroughbred population has a small Ne which should enable GWE to be carried out 
efficiently in this population, remains valid. In the course of these studies, possible 
errors embedded within the current sequence assembly were identified using 
empirical approaches. 
Osteochondrosis is a developmental orthopaedic disease which affects the joints of 
young horses.  Osteochondrosis is considered multifactorial in origin with a variety 
of environmental factors and heredity having been implicated.  In this thesis, a 
 
genome-wide association study was carried out to identify quantitative trait loci 
(QTL) associated with OC.  A single SNP was found to be significantly associated 
with OC.  The low heritability of OC combined with the apparent lack of major QTL 
suggests GWE as an alternative approach to tackle this disease.  A GWE analysis 
was carried out on the same dataset but the resulting genomic breeding values had no 
predictive ability for OC status.  This, combined with the small number of significant 
QTL, indicates a lack of power which could be addressed in the future by increasing 
sample size.  An alternative to genotyping more horses for the 50K SNP chip would 
be to use a low-density SNP panel and impute remaining genotypes.  The final 
chapter of this thesis examines the feasibility of this approach in the Thoroughbred.  
Results suggest that genotyping only a subset of samples at high density and the 
remainder at lower density could be an effective strategy to enable greater progress 
to be made in the arena of equine genomics.  Finally, this thesis provides an outlook 
on the future for genomics in the horse. 
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Chapter 1: General introduction 
1.1 From genetics to genomics in the horse 
Genetics is defined as the branch of science that deals with heredity and the variation 
of inherited characteristics in living organisms [1].  Since the first description of the 
action of genes by Crick in 1958 [2], tremendous effort has been devoted to 
improving our understanding of the relationship between genotype and phenotype.  
Genetic mapping in the horse began in the 1970’s with the discovery of the first 
genetically linked markers which consisted of protein polymorphisms and blood 
group systems [3-6].  Figure 1-1 provides a summary of the progress that has 
subsequently been made (for a more detailed review, see Chowdhary & Raudsepp 
(2008) [7]).  As more markers were discovered, their potential utility in parentage 
testing was recognised and probability of exclusion statistics were commonly 
presented [8-10].  During the 1990s, microsatellites were added to parentage testing 
panels for horses [11, 12].  At the same time, reports began accumulating on the 
identification of genes or chromosomal regions that influenced traits of economic 
importance in a range of livestock species such as fecundity in sheep [13, 14] and 
double muscling in cattle [15], and equine geneticists realised the potential utility of 
a genetic map of the horse in tackling common diseases.   
From this enthusiasm was borne the Horse Genome Project (University of Kentucky 
(2012).  Horse Genome Project. [Online] Available from: 
http://www.uky.edu/Ag/Horsemap/abthgp.html), the initial goal of which was to 
identify landmarks on each chromosome that could be used to establish points of 
reference with the human genome sequence, which had already begun to be 
sequenced.  The value of this comparative mapping approach was soon 
demonstrated, with comparative candidate gene studies leading to the development 
of DNA tests for several single-gene disorders affecting particular breeds of horse 
(see Table 1-1).    
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Figure 1-1 A timeline of the main developments in the generation of an equine genetic map and genome sequence.  I = [3]; II = [16]; III = [17]; IV = [18]; V = 
[19]; VI = [20]; VII = [21]; VIII = [22]; IX = [23].  
1970's - First genetically linked markers 
consisting of protein polymorphisms & 
blood group systems are published, e.g. I 
1990 - By this time, 25 genes had been 
assigned to 5 separate autosomal linkage 
groups and the X chromosome 
1992 - First equine microsatellite markers 
published (II) 
1995 - 70 scientists from 20 countries 
meet to make a plan for mapping the horse 
genome and the Horse Genome Project is 
launched 
1998 - Primary male autosomal linkage 
map consisting of 140 markers in 25 
linkage groups, assigned to 18 autosomes 
and covering 679cM, is published (III) 
1999 - Linkage map consisting of 161 
markers in 29 linkage groups, assigned to 
26 autosomes and covering 936cM, is 
published (IV) 
2000 - Linkage map consisting of 359 
markers in 42 linkage groups representing 
all chromosomes (including the X 
chromosome) and covering 1,780cM is 
published (V) 
2003 - Linkage map consisting of 344 
markers in 34 linkage groups representing 
all autosomes and covering 2,262cM, is 
published (VI) 
2005 - Linkage map consisting of 
766 markers, 625 of which are 
linearly ordered, covering 
3,740cM, is published (VII) 
2006 - Sequencing begins and a 
final linkage map with 742 
markers, one linkage group per 
chromosome, covering 2,772cM, is 
published (VIII) 
2007 - A draft sequence of the 
equine genome is completed in 
January and subsequently updated 
to EquCab2 in Sepetember (IX) 
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Adult skeletal muscle sodium 
channel α-subunit – 
responsible for HYPP in 
humans 
Linkage analysis showed 
segregation of the gene with 
HYPP status.  Subsequent 
sequencing of the gene revealed a 










catalytic subunit - responsible 
for SCID in mice 
Sequencing of the gene revealed a 
frame-shift mutation in affected 
horses. 
[26-28] 






Endothelin receptor B - 
responsible for similar 
phenotypes in mice and 
humans 
Sequencing of the gene revealed 
an Ile to Lys substitution in 
affected horses. 
[29] 
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Throughout the 1990’s, linkage mapping played an increasingly important role in the 
generation of genetic maps for a range of species.  Linkage groups identified through 
this approach could be assigned to chromosomes using molecular approaches such as 
Fluorescence In-situ Hybridisation (FISH), allowing the integration of genetical and 
physical data.  In horses, this approach was first demonstrated in 1997 [30], but by 
this time, primary and in some cases second generation linkage maps were already 
available for a number of other domestic species.  The slow progress in the horse has 
been attributed to the high costs and demands of breeding horses and to their 
somewhat unique position between companion animal and livestock [19, 22].  When 
combined with a long gestation period, monoparous births, and a lack of success of 
the super-ovulation techniques practiced in cattle, these factors make it particularly 
challenging to establish the large full sib families required for efficient linkage 
mapping [17].  Researchers were thus forced to rely on existing family material such 
as the large half sib families present for popular stallions.  This approach required 
greater sample numbers and could only produce male linkage maps.  Despite these 
challenges, the horse linkage map continued to be developed alongside synteny and 
radiation hybrid (RH) maps.  A major breakthrough came in 2000 as a result of 
developments in reproductive technologies.  Using embryo splitting, Swinburne et al. 
(2000) [19] produced two 3-generation full-sibling families, crossing four breeds to 
maximise heterozygosity, enabling the generation of a much more comprehensive 
linkage map which for the first time included linkage groups on the X chromosome.  
The final and most comprehensive linkage map for the horse was published in 2006 
and consisted of 742 markers covering 2,772cM [22], this being remarkably close to 
an earlier estimate made from chiasma counts of 2,720cM [31]. 
By 2005, it had become clear that a revision of strategy was necessary.  Research had 
shown that genes, whilst highly conserved across species, typically made up a very 
small proportion of mammalian genomes with only 1-2% of the human genome 
sequence encoding proteins [32].  It became apparent that the remaining 98% of the 
genome was also likely to be important in regulating gene function [32, 33].  
Consequently, members of the Horse Genome Project developed a new goal of 
sequencing the entire horse genome, which given the timing, was very ambitious.  
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The consortium was successful in convincing the National Human Genome Research 
Institute (NHGRI) to prioritise the horse as one of 24 mammals to be sequenced as 
part of their efforts to identify the similarities and differences of the human genome 
compared with those of other mammals (University of Kentucky (2012).  Horse 
Genome Project. [Online] Available from: 
http://www.uky.edu/Ag/Horsemap/abthgp.html). 
The equine genome was sequenced by the Broad Institute at MIT and Harvard in 
conjunction with the Equine Genome Sequencing Consortium.  Sequencing began in 
February 2006 and in January 2007 the first draft of the genome sequence was 
released.  This sequence was subsequently updated in September of the same year 
(EquCab2) [23].  Initial sequencing was based on the DNA of a female 
Thoroughbred, Twilight, chosen for her low heterozygosity rate, which reduces the 
complexity of the task.  A Whole Genome Shotgun (WGS) approach was used to 
produce 6.8X coverage of the genome, similar to that achieved for Bos taurus. 
The equine genome comprises 31 pairs of autosomes and two sex chromosomes 
(2n=64), commonly denoted using the prefix ECA which stands for Equus caballus.  




, with the remainder 
being acrocentric
3
.  The average N50
4
 contig size during assembly was 112.38kb, 
considerably longer than the N50 size reported for B.taurus (48.7kb), with the total 
                                                 
 
1
 Metacentric – having the centromere medially situated so that the two chromosomal arms are of 
roughly equal length (Merriam-Webster (2012).  Dictionary. [Online]  Available from: 
http://www.merriam-webster.com/dictionary). 
2
 Submetacentric – having the centromere situated so that one chromosome arm is somewhat 
shorter than the other (Merriam-Webster (2012).  Dictionary. [Online]  Available from: 
http://www.merriam-webster.com/dictionary).  
3
 Acrocentric – having the centromere situated so that one chromosomal arm is much shorter than 
the other (Merriam-Webster (2012).  Dictionary. [Online]  Available from: http://www.merriam-
webster.com/dictionary). 
4
 N50 - The N50 size is the median sequence length of the contigs. 
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length of the contigs reaching 2.43Gb.  The N50 can be viewed as one measure of 
the quality of the draft.  When the gaps between the contigs in scaffolds were 
included, the total length of the Thoroughbred mare’s genome was 2.68Gb.  
Repetitive sequences, many equine-specific, make up 46% of the genome assembly 
[23].  The current gene set comprises 22,900 genes and 20,646 proteins (National 
Center for Biotechnology Information (2012).  Equus caballus (Horse) [Online].  
Available from: http://www.ncbi.nlm.nih.gov/genome?term=equus%20caballus).  By 
2008, approximately 92% of the sequence had been ordered and oriented on the 
chromosomes using linkage maps, RH maps and FISH mapping data [7].  The draft 
genome sequence is subject to continued efforts by the community to improve its 
veracity both in terms of the sequence assembly and with respect to the associated 
annotation.  With this in mind, in Chapter 6, genotype data is used to identify 
possible sequence errors. 
This process of map development has led equine geneticists into the era of genomics.  
Considerable progress has been made in mapping genomes over the last ten to twelve 
years, but huge challenges remain in understanding how differences in sequence 
relate to the variation that is observed both within and across different species.  The 
focus is now on learning how to utilise what is known about the equine genome to 
tackle disease and, potentially, to improve performance. 
1.2 Genomics, disease and the horse 
Genomics is defined as the scientific study of nucleotide sequencing, gene mapping, 
and the analysis of genome [1] and new tools are constantly being developed and 
made available to advance this field.  In the horse, approximately 1.5 million single-
nucleotide polymorphisms (SNP) were identified during both the assembly of the 
genome and the generation of approximately 100,000 WGS reads from each of seven 
horse breeds, chosen to represent a mixture of ancient and more modern populations.  
These SNP markers were then used to produce a DNA microarray, the Illumina 
Equine SNP50 BeadChip (‘50K SNP chip’), which contains over 50,000 SNPs and 
was released in 2007.  This technology prompted and then enabled the current 
project, although the fact that this chip has since been superseded by a chip with 
74,000 SNPs shows the speed of development in this field. 
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In the late 1990’s, the potential for such dense SNP genotypes to be used in so-called 
genome-wide association studies (GWAS) to identify regions of the genome 
associated with quantitative traits, including disease, was recognised [34].  Today, 
GWAS are widely used to map susceptibility loci, so-called quantitative trait loci 
(QTL), for complex disease, typically using either a population or case-control study 
design.  Population studies involve selecting individuals at random from the 
population and recording details of the trait of interest, the result being a sample in 
which disease occurs at the same rate as in the wider population.  In contrast, in case-
control studies, individuals are selected for the presence or absence of a particular 
condition.  This enables the enrichment of the sample for cases which is particularly 
useful when studying rare diseases.  A basic analysis then involves the comparison of 
allele (or genotype) frequencies between groups of affected (cases) and unaffected 
individuals (controls), under the assumption that the cases will have a higher 
prevalence of susceptibility alleles.  Assuming that causal loci themselves are 
unlikely to be genotyped with currently-available SNP chips, GWAS rely on linkage 
disequilibrium (see below) between causal loci and markers to enable the 
identification of susceptibility through indirect association [35].  The framework for 
statistical inference of QTL mapping is challenging and new statistical approaches to 
infer such relationships are continually being developed, e.g. [36-38].  Assuming an 
associated region has been identified and validated, fine-mapping using additional 
markers and possibly across-population (or breed) analysis, is used to search for the 
causal variant.  The identification of such causal variants can help to improve our 
understanding of the underlying biology, illuminating new biological pathways and 
in turn informing new treatments and management strategies.  In the context of 
domestic animals, QTL can also be utilised in breeding strategies and this is referred 
to as marker assisted selection (MAS). 
Whilst GWAS have led to the discovery of numerous common genetic variants, 
many QTL identified in preliminary analyses have not been validated in subsequent 
analyses [39] and much of the additive genetic variation remains unexplained [40-
42].  This latter issue, coined ‘the missing heritability’ by Maher in 2008 [41], has 
been the feature of many articles since in which researchers attempt to ‘find’ or at 
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least to explain this phenomenon [43-45].  Other potential issues of the GWAS 
methodology which have been identified relate to sample properties, shortcomings in 
statistical inference, and general underlying assumptions of the method [39, 40, 42, 
46-48]; these have been discussed in the literature at length and therefore will not be 
considered in any further detail here, although some of these issues are addressed in 
Chapters 7 and 8.  The lack of QTL of large effect, combined with issues relating to 
implementation, has meant that whilst MAS has been beneficial in the case of 
monogenic diseases [49], there are only a small number of examples of its successful 
implementation with respect to more complex traits [50]. 
In recognition of the limited ability of single QTL to help address more complex 
production and disease traits, an alternative approach to marker based selection was 
suggested [51] and subsequently demonstrated [52].  Genomic or genome-wide 
evaluation (GWE) permits the estimation of the breeding value of animals using 
genotypic information without having to identify individual causal variants, thus 
avoiding the aforementioned issues of statistical inference.  The method involves the 
simultaneous estimation of a large number of marker effects from a limited number 
of phenotypic records, with the expectation that most QTL will be in linkage 
disequilibrium (see below) with at least one marker.  Genomic breeding values 
(GEBV) are generated by first collecting genotype and phenotype data for a so-called 
reference population and estimating allele effects for each marker or haplotype.  
Subsequently, breeding values for selection candidates can be estimated from 
genotypes alone by summing all the allele effects for the individual.  A variety of 
methods have been proposed to estimate the allele effects, which poses a challenge 
due to the fact that there are usually considerably more allelic effects to be estimated 
than there are observations to estimate the effects from. The most commonly used 
methodologies to date are those of BLUP estimation (a ridge regression method), 
where all SNP effects are assumed to follow the same distribution, and Bayesian 
methods which make use of prior knowledge regarding the distribution of QTL 
effects [52].  Alternative non-parametric and semi-parametric methods including the 
use of machine learning algorithms have also been proposed [53-56].  The use of 
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GEBV to select animals for breeding is referred to as genomic selection (GS), and 
has already been applied within the dairy industry with encouraging results [57, 58]. 
Whilst first considered in the context of selection in animal breeding, human 
geneticists have relatively recently recognised the potential of the GWE 
methodology to help to explain the aforementioned ‘missing heritability’ of complex 
traits [59, 60].  Genome-wide evaluation can also be used to derive an individual’s 
genetic predisposition to a particular disease [61].  In this context, the emphasis is on 
identifying high risk individuals (human or animal) so that their environment can be 
managed to reduce the likelihood of them developing the disease.  Furthermore, 
whilst in animal breeding the focus has traditionally been on the additive genetic 
component and the narrow sense heritability, in the context of risk prediction there 
might also be value in estimating the non-additive components that contribute to the 
broad sense heritability, for example, dominance and epistasis.  In this case, the 
nonparametric methods of Gianola et al. (2009) [62] might be beneficial.  This 
ability to generate genetic risk predictions from birth offers great potential to reduce 
the incidence of common diseases that are known to also have a significant 
environmental component. 
The success of these new SNP-based approaches in the horse will depend on how 
well the available markers capture the sequence variation present in the population.  
This in turn depends on the informativeness of the markers and on particular 
structural properties of the equine genome.  Trait-specific properties such as the 
distribution of underlying gene effects, in particular the joint distribution of effect 
size and allele frequency, are also important although generally not known.  
Important SNP statistics when predicting likely success of genomic approaches 
include genotyping rate, the distribution of minor allele frequencies (MAF) and the 
extent of linkage disequilibrium.  Linkage disequilibrium (LD) describes the 
tendency for particular alleles at neighbouring loci to be co-inherited or in a 
statistical sense, is the non-random association of alleles at two (or more) loci [35].  
As previously mentioned, genomic methodologies such as GWAS and GWE are 
dependent on the LD that exists between causal variants and SNP markers; greater 
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LD between SNPs and causal variants increases the power to detect QTL in GWAS 
and increases the accuracy with which GEBV can be estimated in GWE. 
Preliminary work undertaken as part of the equine sequencing project provided some 
insight into these areas.  The characterisation of haplotype structure within and 
across breeds showed that major haplotypes were frequently shared among diverse 
populations [23], increasing the possibility of disease associations being replicated 
across breed groups.  Within-breed LD was found to be moderate with the majority 
of breeds showing a similar level of LD [23].  These early findings allowed some 
comparisons to be made with other species, as well as enabling some power 
predictions to be made regarding the number of SNPs that would be needed for 
future gene mapping studies to be successful.  However, this analysis was not 
comprehensive, involving only 24 samples per breed and SNP genotypes from ten 
2Mb regions, and the results cannot be assumed to be representative of all equine 
populations. 
The equine population investigated in this thesis is the Thoroughbred, an important 
breed both in the UK and across the world.  As well as having a considerable impact 
on the equine industry through horseracing, the Thoroughbred has contributed 
genetically to a wide range of sport horse breeds and continues to be used both in its 
purebred form and as a crossbred in a wide range of disciplines.  A comprehensive 
within-Thoroughbred analysis of marker informativeness and genome structure has 
not previously been done and is presented in Chapter 3.  The extent of LD is at least 
partly dependent on past effective population size and this relationship is explored 
more fully in Chapters 3, 4 and 5. 
At the outset of this PhD, several groups had published preliminary findings of 
GWAS performed using the 50K SNP chip.  Two of these studies focused on 
diseases thought to be simply inherited and monogenic, Lavender Foal Syndrome in 
Arabian horses [63] and dwarfism in Miniature horses [64]. A further study 
addressed a condition with a previously unknown genetic background, Adolescent 
Idiopathic Lordosis in American Saddlebred Horses [65], which has since been 
hypothesised to be caused by a recessive gene [66].  Whilst success has already been 
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seen with respect to Lavender Foal Syndrome, the causal mutation having been 
identified [66, 67], fine-mapping and candidate gene studies are apparently on-going 
in the case of the other diseases.  Somewhat in contrast to these early studies, this 
PhD considers how the 50K SNP chip can be used to investigate more common 
complex diseases, using osteochondrosis in the Thoroughbred as an example of such 
a condition.  This disease is more typical of the multifactorial, lowly heritable 
conditions that GWAS and GWE have been developed to study. 
1.3 Introduction to the disorder osteochondrosis 
1.3.1 Clinical background 
Osteochondrosis (OC) is a disease of the locomotory system which affects many 
animals, but is most frequently observed in pigs, horses and dogs [68].  In horses OC 
is classified as a developmental orthopaedic disease (DOD) and has been defined as a 
disturbance in the physiological process of endochondral ossification that occurs in 
young, growing individuals [69].  The normal process of endochondral ossification 
involves several stages – cartilage formation, hypertrophy, degradation and 
replacement by bone [70], a system which ensures all structures of the skeletal 
system remain functional during growth.  In long bones, there are two regions at 
which endochondral ossification occurs, the growth plate (physis) and the articular-
epiphyseal cartilage complex at the end of the bone.  Osteochondrosis can affect both 
of these areas but in horses the term is most often used with respect to the articular 
form of the disease and this convention is upheld here.  Articulations most 
commonly affected by OC are the joints of the fetlock, hock and stifle, but OC can 
also affect the shoulder and cervical spine [71] (see Figure 1-2).  Specific so-called 
‘predilection sites’ exist within each of these joints [72] and these sites are the focus 
of radiological examinations in clinical investigations of OC. 
In horses with OC, irregular ossification leads to the formation of primary lesions of 
necrotic tissue within the growth cartilage [68, 70].  These lesions may then progress 
into the adjacent structures of the articular cartilage and/or subchondral bone [68, 
70].  In cases where the lesion extends through the articular cartilage to form 
cartilage flaps or loose fragments at the joint surface, the condition is generally 
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referred to as osteochondrosis dissecans [68, 70] or osteochondritis dissecans [72], 
with these terms apparently being used interchangeably and abbreviated to OCD.  
This range in severity of disease leads to considerable variability in clinical 
presentation.  Whilst the primary lesions may be subclinical in nature, as the disease 
progresses clinical signs include synovitis and pain, accompanied by varying degrees 
of lameness [73].  The management of clinical cases of OC depends on the site and 
severity of signs.  Approaches range from conservative measures, such as restricted 
exercise, to surgical intervention in the form of arthroscopy to remove damaged 
cartilage [71]. 
Whilst the underlying cause of OC is not known, it is considered multifactorial in 
origin and factors which have been implicated in the horse include high growth rate, 
nutrition, endocrinological factors, biomechanical factors relating to both 
conformation and exercise, and heredity [71, 74-76].  However, there is much 
conflicting evidence regarding the influence of these factors and based on a review of 
available literature, it has been suggested that hereditary and anatomic factors are the 
most important contributors to the pathogenesis of OC [68]. 
 
Figure 1-2 Joints affected by osteochondrosis in the horse, taken from Jeffcott (1997) [71] 
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1.3.2 Prevalence 
There appears to be considerable variation in the prevalence of OC across breeds.  
Estimates vary from 16.6% in Italian Warmbloods (Maremmano) [77] to 70% in 
Dutch Warmbloods [69] (for a comprehensive list of prevalence estimates, see van 
Grevenhof et al. (2009) [69]).  However, a large proportion of this variation may be 
attributed to differences in the methods used, including different disease definitions 
as discussed in detail below.  Of particular relevance is the fact that OC can be 
subclinical and for a horse to be confidently designated as unaffected, radiographs 
must be taken.  Studies based on clinical instances of OC alone will inevitably record 
lower prevalence rates than those in which all horses have undergone a radiographic 
survey.  However, the radiographs are another source of between-study variability as 
the number and position of the radiographs are likely to influence the number and 
severity of lesions observed, with fewer examined sites potentially resulting in 
missed cases.  Age at examination is also relevant because of the transient nature of 
the disease.  Primary lesions often repair spontaneously in horses under the age of 
five and eight months in the case of the hock and stifle joints, respectively [78], and 
therefore a definitive diagnosis can only be made after this stage.  Regardless of the 
exact prevalence, OC is recognised as a significant problem in horses, especially 
since it has been suggested that the incidence of OC in horses may be increasing [71, 
79]. 
1.3.3 Genetic control 
Observations that the progeny of certain sires suffered more frequently from the 
disease than those descended from other sires [80] provided the initial evidence of an 
additive genetic component to OC.  Subsequent studies have attempted to determine 
the heritability of OC in a number of different populations.  Heritability estimates 
vary widely, with this variation likely to be at least partly attributable to issues 
relating to phenotypic definition which are discussed in more detail below.  
Heritability estimates based on the binary classification and calculated using a linear 
model are expected to be lower than those calculated on the underlying scale, with 
the scaling factor dependent on disease prevalence, such that the rarer the disease, the 
greater the underestimation of heritability under the linear model.  However, the 
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transformation of observed heritabilities according to Dempster & Lerner (1950) 
[81], produces estimates on the liability scale which are expected to be comparable to 
those calculated by fitting a threshold model, for example a logit model, in the first 
instance.  Variability in heritability estimates is also expected because they are by 
definition both population and environment specific.  Table 1-2 presents the results 
of a sample of heritability studies undertaken in a variety of breeds, along with a 
meta-analysis of these studies (see A.i for meta-analysis methodology). 
Large standard errors are fairly characteristic of heritability estimates for OC.  This is 
likely due both to the small sample sizes and the non-ideal family structures typical 
of such studies.  Theory dictates that the optimum half-sib family size for estimating 
genetic parameters is 20-30 or, more precisely in cases where the heritability is 
known,  
  
⁄  [82].  Assuming heritability for OC of 0.10, this represents 40 offspring 
per sire, a figure that is not typically achieved in horse samples.  A high variation in 
the number of offspring, with typical pedigrees containing a small number of sires 
with a relatively large number of offspring, and a large number of sires with a small 
number of offspring, is also expected to increase the variance of the estimate [83].  
The results of simulation work done by Stock et al. (2007) [84, 85], designed to 
explore the power of typical horse samples, support these theoretical predictions.  In 
this thesis, a genomic approach to heritability estimation is presented in Chapters 7 
and 8. 
Despite these issues, there is strong evidence to suggest a genetic component to OC 
and meta-analysis results in Table 1-2 indicate heritabilities which are significantly 
different from zero.  Therefore, implementation of selection strategies should, in 
principle, help to reduce the incidence of OC in equine populations.  Simulations 
based on a heritability for OC of 0.14, which appears reasonable given the meta-
analysis results in Table 1-2, and five generations of active selection on males and 
females, demonstrated the potential to reduce the incidence of OCD in Maremmano 
horses from its current level (16.6%) to a level of around 1.8% [77].    
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Table 1-2 Summary of pedigree based heritability studies of OC.  The result of a meta-analysis 
of the heritability estimates on an underlying scale and for each phenotype is presented. 




All joints OC/OCD Meta-analysis 0.21 (0.08)  
n=350 Maremmano Italian WB LAM 0.14 (0.23)
 I
 [77] 
n=167 SGC LAM 0.17 (0.19)
 I
 [86] 
n=811 Dutch WB LAM 0.23 (0.09)
 II
 [87] 
Fetlock joint OC/OCD Meta-analysis 0.12 (0.06)  
n=167 SGC (OC) LAM 0.16 (0.16)
 I
 [86] 
n=167 SGC (OCD) LAM 0.08 (0.09)
 I
 [86] 
n=811 Dutch WB LAM 0.14 (0.08)
 II
 [87] 
Hock joint OC/OCD Meta-analysis 0.20 (0.09)  
n=325 Danish Trotters SM 0.26 (0.14)
 III
 [80] 
n=793 Swedish SB Trotters LSM 0.24 (0.19)
 I
 [88] 
n=167 SGC (OC) LAM 0.04 (0.07)
 I
 [86] 
n=811 Dutch WB LAM 0.36 (0.11)
 II
 [87] 
Stifle joint OC/OCD Meta-analysis 0.05 (0.05)  
n=350 Maremmano Italian WB LAM 0.09 (0.24)
IV
 [77] 
n=811 Dutch WB LAM 0.05 (0.05)
 II
 [87] 
SB = Standardbred; SGC = South German Coldblood; WB = Warmblood; OC = 
osteochondrosis; OCD = osteochondrosis dissecans; LAM = linear animal model; SM = sire 
model; LSM = linear sire model.  
I
Heritability estimates using a linear model then transformed 
following Dempster & Lerner (1950) [81]; 
II
Heritability estimates after prior transformation to 
a continuous liability scale; 
III
Heritability estimates using a threshold model; 
IV
Heritability 
estimate taken from Table 1 in van Grevenhof et al. (2009) [87]. 
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1.3.4 The phenotype 
A key area of concern when conducting genetic studies is the phenotypic definition 
used.  Optimal phenotypic definitions are those with strict inclusion criteria, ideally 
in the form of a clinical diagnostic test.  In the case of OC, the phenotypic definition 
is far from standardised, making results from both epidemiological and genetic 
studies difficult to interpret.  There are a large number of radiographic findings that 
have been associated with OC over the last 20 to 30 years, some of which have 
subsequently been attributed to other causes such as trauma, for example, plantar 
osteochondral fragments (POFs) found in the fetlock.  This has led to some 
confusion amongst practitioners and in some cases, whether a horse is diagnosed 
with OC or not will depend on the training, experience and perspective of the 
veterinarian.  The exact location of the lesions and/or fragments within joints is 
generally considered to be an important factor in distinguishing between horses with 
OC and horses suffering from an injury of a traumatic nature.  However, OC derived 
fragments are often studied alongside more generally described ‘osteochondral 
fragments’ which occur in regions not generally associated with OC, for example, 
the aforementioned POFs, and this has increased the confusion.  For example, in a 
review of heritability estimates for OC/OCD, van Grevenhof et al. (2009) [87] 
present results from Stock et al. (2005) [89] and Stock et al. (2006) [90], neither of 
which restricted cases to OC.  Rather these were studies of osseous fragments, not 
restricted by joint location or cause, and their interpretation as OC/OCD is despite 
Stock et al. (2005) [89] stating that ‘osseous fragments as analysed in the present 
study cannot generally be attributed to the OC syndrome.’  This confusion around 
disease diagnosis has led to authors defining their own, study-specific criteria for OC 
case inclusion.  However, further issues surround the way in which OC cases are 
then considered in the analysis itself.  Two principal areas of conflict between studies 
are: (i) the appropriateness of the binary classification for OC; and (ii) the treatment 
of OC in different joints as separate traits. These issues are discussed in more detail 
below.   
The variability in the severity and manifestation of the disease from primary lesions 
that are barely visible, through loose bodies associated with OCD to subchondral 
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fractures, makes recording phenotypic descriptions within studies challenging, and 
across studies even more so.  This has led to some debate as to whether OC should 
be described as a categorical trait that reflects severity or a simple binary 
classification based on presence or absence of disease.  The system of grading cases 
according to severity has its origins in a clinical setting, where it can be used to help 
determine the best treatment option.  However, its relative usefulness when 
compared with a binary classification in the genetic context remains unclear.  Whilst 
it is assumed that there is an underlying disease liability, it is currently unknown 
what the relationship is between an individual’s genetic liability for OC and the 
severity of the phenotype displayed.  For example, does an increase in the number of 
susceptibility alleles in an individual cause lesions to become bigger or does it cause 
them to become more numerous?  This ambiguity makes the alignment of severity 
and liability scales questionable, and undermines a standard assumption that a more 
quantitative trait is preferable.  Furthermore, the severity of disease is likely to be 
more strongly confounded with environmental factors, such as the age of the horse at 
examination and its management up to that point.  In a study of environmental risk 
factors of DOD (including OC), Lepeule et al. (2011) [91] demonstrated that risk 
factors are different for the presence and for the extent of disease.  Whilst such 
factors may need to be present in models used to evaluate the genetic variance on any 
scale, the interpretation of a categorical scoring system may depend more heavily on 
the correct environmental model. 
The empirical evidence in favour of using a categorical definition for OC in genetics 
studies remains limited.  The recommendations of van Grevenhof et al. (2009) [87] 
that OC should be scored in more than two categories were based on results that 
showed higher heritability estimates could be obtained when using such an approach.  
These results are largely in line with genetics theory which predicts that the 
estimation of heritability using a logistic model and binary classification will be 
lower than that estimated using a threshold model and do not indicate any increase in 
genetic variance per se.  However, the decrease in the standard error of the estimates 
based on the categorical definition demonstrates an increase in power which, 
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provided the aforementioned problem relating to the alignment of severity and 
liability scales could be overcome, would also be beneficial in QTL mapping studies.   
The occurrence of OC in different joints and at different sites within joints further 
complicates the phenotypic definition.  The degree of lameness can vary by joint 
affected and is therefore clinically relevant [92].  Literature from the 1990s, tends to 
refer to OC as a generalised condition but following a review of possible models of 
pathogenesis, Ytrehus et al. (2007) [68] concluded that the focal nature of OC 
lesions, which most likely originate due to ischemia, mean that studies should focus 
on site-specific traits.  However, generalised factors were also acknowledged as 
being potentially influential, with the lesions then being secondary to the generalised 
condition.  In a diagram of causal factors of OC, Ytrehus  et al. 2007 [68] 
acknowledged a role for heredity only at the site-specific level, for example, relating 
to an anatomical predisposition to the disease.  However, it seems equally plausible 
that genetic factors could also be involved at the generalised level.  For example, if 
heritable generalised factors predispose a horse to OC, then further heritable 
anatomical characteristics could determine in which joint lesions will appear.  The 
heritability estimates in Table 1-2, which indicate a genetic component to OC both at 
the generalised level and at the joint level, appear to lend credence to this argument.  
Therefore, there is no biological consensus on whether cases should be divided by 
joint affected in genetic studies. 
Several studies have attempted to address the question of whether OC in different 
joints should be treated as different traits by calculating genetic correlations of OC in 
different joints [79, 86, 87, 93].  However, at least one of these studies, a study of 
South German Coldblood horses by Wittwer et al. (2007) [86], had an insufficient 
number of samples to allow any valid conclusions to be made.  As predicted by 
theory [82, 83, 94], the dataset of 167 horses from 30 half-sib families, giving a mean 
number of offspring of 5.6 per sire (range 1 to 28), resulted in such large standard 
errors that it was impossible to exclude genetic correlations of 0 or 1 or -1.  
Furthermore, theory and simulation work by Stock et al. (2007) [84, 85] suggest the 
sample sizes of <500 horses used by Lykkjen et al. (2012) [79], may also be 
underpowered to detect significant genetic correlations.  Whilst van Grevenhof  et al. 
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(2009) [87] had only a moderate sample of 811 Dutch Warmbloods from 32 sires, 
with a greater mean number of offspring per sire (25.3) it benefitted from a much 
lower variance in family size (22 to 28 offspring per sire).  Despite this more 
powerful study design, the standard errors of the genetic correlations were still 
relatively large, such that a correlation of zero could not be excluded in two out of 
three cases.  Similar studies in pigs also appear to show conflicting results, with both 
positive and zero correlations having been recorded between OC in different joint 
locations, despite sample sizes being typically much larger.  For example, in a study 
of around four thousand pigs from two different breeds Jørgensen & Andersen 
(2000) [95] recorded both positive and negative correlations between OC in a range 
of joints and there was little correspondence in estimates between the two breeds. 
Interestingly, both Jørgensen & Andersen (2000) [95] and van Grevenhof et al. 
(2009) [87] conclude from their results that OC should not be considered a 
generalised disease and that OC in different joints should be considered as different 
traits.  Indeed, the combination of low and non-significant correlations observed to 
date has led to this being the general consensus of researchers at the current time.  
However, it would seem that the tendency of these authors and others to err on the 
side of caution and make recommendations such that OC in different joints should be 
considered as different traits, is due to the way in which the hypotheses tests are 
formulated.  By setting the null hypothesis (H0) equal to there being no correlation 
between traits, if a significant correlation is not found the conclusion must be that the 
traits are separate.  However, if what we are really looking for is evidence that OC in 
different joints is not the same disease, this hypothesis seems incorrect.  Combining 
the three genetic correlations from Table 3 in van Wittwer et al. (2007) [86] and the 
two from Table 4 in van Grevenhof et al. (2009) [87] by meta-analysis (see A.i), 
gives an estimated genetic correlation of 0.32 (0.20).  Although the validity of this 
approach (combining correlation estimates across traits) is questionable, there does 
not seem to be sufficient evidence to reject the idea that there is shared genetic 
variance across the disease in different joints.  Therefore, in my opinion, the question 
of whether or not OC in different joints represents genetically distinct diseases 
remains unanswered.              
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In conclusion, there remains a great deal of uncertainty surrounding the issue of 
optimal phenotypic definition.  Unfortunately, the issues raised above in the context 
of prevalence and heritability studies are now impacting on genomic analyses. 
1.3.5 Quantitative trait loci mapping 
The search for QTL associated with OC in horses began with family-based linkage 
analyses using genome-wide microsatellite markers.  The first such study was carried 
out on a sample of 123 Hanoverian Warmbloods (HWB) in 2003 [96].  Two further 
studies involving a larger HWB cohort and a sample of South German Coldblood 
(SGC) horses were conducted in 2007 [97, 98].  Following the release of the 50K 
SNP chip, GWAS have been performed in three different horse breeds to date:  HWB 
[99, 100], French Trotters [101] and Norwegian Standardbreds [102].  These studies 
have led to a large number of putative QTL being identified although no validated 
markers for OC have yet been published.  In many cases, authors have gone on to 
discuss the relative merit of nearby genes as candidate genes for OC.  However, the 
point made by Cardon & Bell (2001) [103] that, due to a lack of understanding of the 
mechanisms of action of complex trait loci, a plausible argument can be made for 
most associated alleles, most likely still holds true.  Furthermore, the results of these 
mapping studies are once again strongly influenced by study design and phenotypic 
definition. 
Presumably due to the uncertainty surrounding the optimal definition for OC, all but 
one of the aforementioned QTL mapping studies have analysed multiple disease 
phenotypes.  Studies conducted on the HWB and SGC cohorts involved the analysis 
of up to six phenotypes, representing two different manifestations – OC and OCD, 
and three different locations – hock, fetlock and hock and fetlock combined.  A 
similar approach was taken by Teyssèdre et al. (2011) [101] who analysed hock, 
fetlock and other cases separately and as a combined trait which also accounted for 
the number and severity of the lesions.  This repeated testing using different clinical 
phenotypes was recognised by Cardon & Bell (2001) [103] as a common error in 
association studies because it leads to subgroups that are small, providing less robust 
results and creating a substantial risk of false positives.  This could well explain the 
variable correspondence between QTL locations for the different phenotypes tested 
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in these studies.  An alternative approach to this retrospective subdivision of cases is 
to collect more uniform cases in the first instance.  For example, Lykkjen et al. 
(2010) [102] preferentially chose cases with OCD just at the intermediate ridge of the 
distal tibia (part of the hock joint).  When compared to the testing of multiple 
phenotypes within a dataset, this approach is instinctively more statistically robust, 
leaving readers with little doubt as to the researcher’s intentions at the outset of the 
study.   
It is also common for researchers to use multiple significance thresholds and several 
different statistical approaches to analyse the data. For example, Lykkjen et al. 
(2010) [102] presented results for a chi-square-test, a logistic regression, a Cochran-
Mantel-Haenszel (CMH) test and a mixed-model analysis on the same dataset.  
Whilst these kinds of approaches might be considered thorough, as in the case of 
testing multiple phenotypes, they also cast doubt on the statistical validity of what 
has been done and make interpretation of the results more challenging.  Whilst these 
issues are not specific to studies of OC in the horse, they do seem to be exacerbated 
by small sample sizes, the tendency for related horses to be used, and by the 
aforementioned issues surrounding phenotypic definition.  In Chapter 7, whilst 
mindful of these issues, a GWAS for OCD is performed.   
The large numbers of different results that are published as a result of these 
uncertainties make comparing results across studies extremely challenging.  Three 
instances of potential QTL correspondence have so far been reported by the authors.  
These are for:  
 A QTL for hock OCD observed by Lykkjen et al. (2010) [102] at 77.4Mb on 
ECA5 and corresponding QTL for fetlock OCD observed by Lampe et al. (2009) 
[104] at 78.0-90.2Mb on ECA5. 
 A QTL for hock OC observed by Teyssèdre et al. (2011) [101] at 100.4-107.9Mb 
on ECA3 and corresponding QTL for hock OCD observed by Lykkjen et al. 
(2010) [102] at 113.5Mb on ECA3. 
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  A QTL for fetlock OC observed by Teyssèdre et al. (2011) [101] at 6.9-12.9Mb 
on ECA13 and corresponding QTL for fetlock OCD observed by Lampe (2009) 
[99] at 15.3Mb on ECA13. 
Whether these are viewed as true validations depends not only on an apparently 
subjective interpretation of statistical significance and phenotype equivalence, but 
also on the maximum distance at which QTL are considered to overlap.  A more 
direct assessment of QTL correspondence is conducted in Chapter 7.  
In summary, several genetic analyses and QTL mapping studies for OC have been 
published.  However, due to differences in populations, trait definitions and 
methodologies, it is very difficult to get an overview of the results and make general 
conclusions.  The evidence for a genetic component of OC is compelling, providing 
justification for conducting genomic analyses, but how a genetic susceptibility for 
OC translates into the phenotype we observe is not clear.  The lack of a standardised 
phenotype for OC, combined with the wider issues associated with the 
implementation of QTL mapping studies, has resulted in a largely incoherent body of 
literature on the topic of the genetic background of OC.   
1.4 Thesis outline 
The main objective of this thesis is to investigate the potential for new genotyping 
technologies to enhance our understanding of the genetic component of complex 
diseases in the horse.  As well as exploring the properties of the 50K SNP chip with 
respect to the Thoroughbred horse genome, osteochondrosis is used as an exemplar 
for the application of the 50K SNP chip to a complex disease in the horse. 
Chapter 2 describes the datasets used throughout this thesis. 
Chapter 3 summarises the extent and decline of LD in two Thoroughbred 
populations, considering the results in the context of the genome coverage provided 
by the Illumina Equine SNP50 BeadChip.  The theoretical relationship between LD 
and Ne is used to predict the Ne of the two Thoroughbred populations when Ne is 
assumed to be constant a priori and when it is not.  The results are considered in the 
context of the efficacy of genomic methodologies such as GWAS and GWE.   
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Chapter 4 evaluates the reliability of the methods used in Chapter 3 to predict Ne 
from molecular data.  A thorough review of the theory that describes the relationship 
between the rate of decline of LD, the distance between markers and the Ne is 
presented.  The impact of several developments on the estimation of Ne using both 
simulated and equine SNP data, when Ne is assumed to be constant a priori and when 
it is not, are considered.   
Chapter 5 considers an alternative approach to that used in Chapters 3 and 4 for 
predicting Ne of a population using marker data.  Preliminary findings only are 
presented since this approach was not progressed. 
Chapter 6 uses LD to identify SNP on the Illumina Equine SNP50 BeadChip which 
may be incorrectly positioned on the genome map.  Linkage disequilibrium was 
evaluated in a pair-wise fashion between all autosomal SNPs, both within and across 
chromosomes.  Filters were then applied to the data firstly, to identify SNPs which 
may have been mapped to the wrong chromosome and secondly, to identify SNPs 
which may have been incorrectly positioned within chromosomes.  The likely impact 
of the findings on a range of commonly used genomic approaches is discussed.   
Chapter 7 details a GWAS for QTL associated with OCD in the Thoroughbred.    A 
secondary objective was to test the effect of previously identified QTL in the current 
population.  Genotype data for 348 horses which had been classified as cases or 
controls according to clinical findings was used.   The effects of 24 SNPs, 
representing QTL previously identified in a sample of Hanoverian Warmblood 
horses, were tested directly using the data.    
Chapter 8 evaluates the potential utility of GWE in tackling common complex 
diseases in the horse.  Genotype data is analysed using both true OCD phenotypes 
and using a simulated binary trait intended to resemble OCD.  Two methodologies 
are used to predict GEBV and the predictive ability of the models assessed.    
Chapter 9 evaluates the potential for low-density genotyping panels to be used to 
reduce genotyping costs in the future.  Three different approaches are used to select 
SNPs for panels of varying density and their efficacy judged according to the 
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accuracy with which missing genotypes could be imputed.  The results are 
considered with respect to both the cost of each of the panels and the intended use of 
the imputed genotypes.   
Chapter 10 features a final summary of the research undertaken in this thesis.  A 
critical review of the results is conducted and the limitations of what has been done 
are considered. Considerations regarding the future for genomics research and its 
application to the horse are then presented.    
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Chapter 2: Description of dataset 
2.1 Data source 
Genotypic and phenotypic data were provided by the Animal Health Trust (AHT) as 
part of the Equine Genetics Research (EGR) programme, a joint initiative between 
the AHT and the British Horseracing Board (now the British Horseracing Authority).  
The aim of this wider project was to identify genomic regions contributing to 
complex musculo-skeletal disease in the Thoroughbred, specifically focusing on 
osteochondrosis (OC), recurrent exertional rhabdomyolysis and the risk of fracture as 
phenotypes.  Samples for the project were collected from affected and unaffected 
Thoroughbred horses from the United Kingdom (UK) and in the case of OC, 
additionally from the United States (US). Collections took place over several years 
from 2006 onwards and involved a number of people
5
.  Samples collected in the UK 
came from horses from both National Hunt and flat racing stables in the UK.  As 
such, these samples are expected to comprise primarily of relatively unrelated horses 
originating from a wide geographical area.  Samples collected in the US came from 
flat racehorses admitted to the Rood and Riddle Equine Hospital (RREH) (further 
details below).  Genotyping was funded by the Horserace Betting Levy Board 
(HBLB) and the Thoroughbred Breeders’ Association. 
2.2 Genotyping 
Blood samples were collected in ethylene-diamine-tetra-acetic (EDTA), and 
deoxyribonucleic acid (DNA) extracted either by Tepnel 
(http://www.tepnel.com/dna-extraction-service.asp) or at the AHT using Nucleon 
BACC DNA extraction kits (http://www.tepnel.com/dna-extraction-kits-blood-and-
cell-culture.asp).  A small dilution of each sample was prepared at 70ng/ul and 
submitted for genotyping to Cambridge Genomic Services 
                                                 
 
5
 Sarah C. Blott (SCB), June E. Swinburne (JES), Charlene Sibbons (CS), Laura Y. Fox-Clipsham 
(LYFC), Maud Helwegen (MH), J. Richard Newton (JRN) and Mark Vaudin (MV) of the AHT, Tim 
D. H. Parkin (TDHP) of the University of Glasgow, Lawrence R. Bramlage (LRB) of RREH, and C. 
Wayne McIlwraith (CWM) of Colorado State University. 
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(http://www.cgs.path.cam.ac.uk/services/snp-genotyping/services.html). The 
Illumina Equine SNP50 Genotyping BeadChip 
(www.illumina.com/documents/products/datasheets/datasheet_equine_snp50.pdf) 
was used to genotype all samples.  This BeadChip comprises 54,602 single 
nucleotide polymorphisms (SNP) located across all autosomes and the X 
chromosome.  These were selected from the database of over one million SNP 
(http://www.broadinstitute.org/ftp/distribution/horse_snp_release/v2/) generated 
during the sequencing of the horse genome 
(http://www.broadinstitute.org/mammals/horse).  Genotyping data was analysed at 
the AHT using the Illumina GenomeStudio genotyping module and a series of 
quality control metrics were used to identify poorly performing SNPs.  Quality 
control (QC) at this stage led to the removal of 7.1% (n=3,895) of SNPs from the 
analysis due to poor genotyping quality and these SNPs were subsequently set to 
missing in all samples (see Table 2-1).      
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Table 2-1 Quality control criteria implemented on genotype data and the number of SNPs 
discarded at each step 
Metric Examined 
Purpose of metric 
applied 
Threshold applied 
No. of SNP 





Removal of SNPs 
with inadequately 
defined clusters 
<0.25 discarded 1319 
Call frequency 
Removal of SNPs 
which were not called 
in a minimum number 
of samples 






Removal of SNPs 
with low intensity 
data 




Removal of SNPs 
where the 
heterozygote cluster 
is not well separated 
from the homozygote 
clusters 















Removal of X 
chromosome markers 








Measures the separation between the three genotype clusters and varies from 0 to 1 
II
Mean normalized intensity of the heterozygote cluster, with values increasing from 0 
III
Mean of the normalized theta values of the heterozygote cluster, with values ranging from 0-1.  
Values of <0.2 and >0.8 indicate the heterozygote cluster has shifted toward the homozygotes. 
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2.3 Preliminary data cleansing  
The output from the initial screening carried out by the AHT and described above 
provided the starting dataset for this PhD and consisted of 1,235 horses genotyped 
for up to 50,707 SNPs.  Samples had been anonymised, each being given a unique 
individual identification number (IID) and no pedigree data was available.  Of the 
1,235 samples, 399 had associated phenotypic data which reflected the horse’s 
osteochondrosis (OC) status, either case or control, which were mostly collected 
from the US and will be referred to as the OC dataset.  The remainder, having been 
collected for the other disease studies to be carried out at the AHT, had no associated 
OC status, were collected from the UK, and will be referred to as the population 
control dataset.  A limited number of individuals had also been assigned a sex.   
The preliminary exploration of the dataset involved the investigation of SNP quality 
through calculation of:  genotyping rate, defined as, the number of missing 
genotypes, both by SNP and by sample; Hardy-Weinberg equilibria; and the 
distribution of minor allele frequencies (MAF).  In addition, genotype data was used 
to estimate genome-wide identity by descent (IBD) sharing coefficients between all 
pairs of samples.  This was done using a technique within Plink whereby the prior 
probability of identity by state (IBS) sharing is first expressed in terms of the allele 
frequency and then a global IBD estimate is calculated for that pair by the method of 
moments [105, 106].  This analysis revealed 17 pairs of individuals who had IBD 
coefficients of one, indicating that they had all genotypes in common.  This result is 
indicative of sample duplication, such that 17 horses had been sampled twice and 
given two different IIDs.  In some cases, the phenotype for the two samples making 
up the pair differed and, therefore, a conservative approach was taken and all 34 
samples involved were excluded from future analyses.  Consequently, 15 individuals 
were removed from the OC dataset and 19 from the population control dataset, 
leaving 384 samples (190 cases and 194 controls) in the former and 817 in the latter.  
Of the remaining samples, 417 had sex assigned.  Sex determination, based upon 
detecting heterozygosity of X-chromosome SNPs [105, 106], revealed 29 instances 
of mismatched sex.  Seventeen of these represented instances whereby homozygosity 
levels (F) fell in the range between the default thresholds used to define males and 
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females (0.2<F<0.8).  In the remainder (n=12), the sex associated with the sample in 
the data file contrasted with that indicated by the X chromosome SNP data; these 
were all samples from the population control dataset.  Since these samples did not 
have associated phenotypic data, there would be no impact of incorrect sex 
assignment or sample misidentification on the results of the intended analyses and 
therefore these samples were not excluded.  The previous investigation of SNP 
quality described above was then repeated on this reduced dataset.  Whilst some 
preliminary analyses of the OC dataset were carried out at this stage, further 
phenotypic information was desirable prior to carrying out the final analyses.    
2.4 Phenotypic enrichment of the osteochondrosis 
dataset 
The OC dataset consisted primarily of samples collected by LRB at RREH in 
Lexington, Kentucky, in the first quarters of 2007 and 2008.  Initially, a simple 
case/control categorisation was provided for samples in the dataset which did not 
allow consideration of any additional phenotypic criteria such as joint affected or 
severity (see 1.3.4 for further details).  Furthermore, whilst it was known that the 
horses sampled for the OC study originated from several different horse farms in the 
vicinity of RREH, the initial dataset did not include the farm of origin.  Farm of 
origin was relevant since environmental factors would most likely vary by farm.    
To help address the data gaps, more data was provided from RREH and AHT with 
additional details about the samples in the OC dataset.  The following details were 
provided:  country of origin – indicating that 36 of the OC dataset samples were 
collected from Thoroughbreds in the UK with the remainder having come from 
RREH; phenotype details – including, for the US samples, a list of conditions each 
horse was treated for and the joint affected; sex; farm – for the US samples, farm of 
origin was indicated using an anonymous coding system.   
The new information highlighted two potential areas of concern.  Firstly, there were 
ambiguities in the OC status of samples between the original dataset and the updated 
version; 85 horses had opposing OC status across the two datasets.  This finding 
suggested some mis-labelling of samples which needed to be resolved before any 
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further phenotypic analysis could be carried out.  Secondly, it became clear from the 
phenotypic details provided that both cases and controls suffered from a range of 
orthopaedic conditions other than OC (see below for further details) which would 
need to be considered in any future analysis of OC using this dataset.  These issues 
could not be simply resolved and therefore, a visit was made to RREH in order to 
examine the raw data collection forms for the 348 samples that originated from the 
US. 
Discussions with LRB established that OC case samples consisted of horses, aged 
between nine and twelve months, which were diagnosed as having OC in at least one 
joint from radiographic surveys performed by referring veterinarians (see Table 2-2).  
Such surveys of youngstock are often carried out in the first few months of the year 
in preparation for the yearling sales.  The diagnosis was then confirmed through 
repeat radiography of suspected OC affected regions on the admission of the horses 
to RREH and where necessary, arthroscopic surgery was performed by LRB.   A 
typical arthroscopic surgery involves the removal of all fragments and the 
debridement of any separated articular cartilage and defective bone from the joint 
[107].  Therefore, to qualify for surgery and subsequent sampling, cartilage and/or 
bone fragments separated from the articular surface would have to be present. 
Consequently, according to the definition of Ytrehus et al. (2007) [68], the cases can 
be considered as suffering specifically from osteochondritis dissecans (OCD) (see 
1.3.1 for further details) and represent a subset of OC affected horses suffering from 
a specific manifestation of the disease.  This reduction in the phenotypic 
heterogeneity addresses some of the concerns discussed in 1.3.4 regarding 
phenotypic definition.  Further details that were also recorded include: sex of the 
horse; the code for farm of origin; the number of OCD lesions observed; the specific 
location of the OCD lesions observed; the approximate size of the OCD lesions 
observed (where recorded); and details of the non-OC conditions for which horses 
were operated on.  Of the 348 US horses, 169 had OCD (cases) and 179 were 
negative for OCD (controls).  
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Table 2-2 Radiographic surveys: 32 radiograph views as recommended by Keeneland 
Thoroughbred Racing and Sales, Lexington, and based on guidelines provided by the American 
Association of Equine Practitioners (AAEP).  Description taken from Preston et al. (2010) [108].  
Right and left metacarpophalangeal (fetlock) joints 
Dorsoproximal-palmarodistal oblique (15° proximal to the supporting surface)  
Dorsomedial-palmarolateral oblique (30° medial to the dorsopalmar line) 
Dorsolateral-palmaromedial oblique (30° lateral to the dorsopalmar line) 
Lateromedial (obtained with the joint flexed) 
Right and left metatarsophalangeal (fetlock) joints 
Dorsoproximal-plantarodistal oblique (15° proximal to the supporting surface) 
Dorsoproximomedial-plantarodistolateral oblique (15° proximal to the 
supporting surface and 30° medial to the dorsoplantar line)  
Dorsoproximolateral-plantarodistomedial oblique (15° proximal to the 
supporting surface and 30° lateral to the dorsoplantar line) 
Lateromedial (obtained with the horse standing) 
Right and left carpal joints 
Dorsolateral-palmaromedial oblique (30° lateral to the dorsopalmar line) 
Dorsolateral-plantaromedial oblique (30° medial to the dorsopalmar line) 
Lateromedial (obtained with the joint flexed) 
Right and left tarsal (hock) joints 
Dorsomedial-plantarolateral oblique (65° medial to the dorsoplantar line)* 
Dorsolateral-plantaromedial oblique (10° lateral to the dorsoplantar line) 
Lateromedial 
Right and left stifle joints 
Lateromedial 
Caudolateral-craniomedial oblique (20° lateral to the craniocaudal line; must 
include medial femoral condyle in its entirety) 
 
*Alternatively, the plantarolateral-dorsomedial oblique view (25° lateral to the 
dorsoplantar line) may be used.  
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2.5 Phenotypic Summary 
Using the newly enriched OC dataset, a more detailed phenotypic summary based on 
the US samples in this set was carried out.  There was a slight difference in the 
proportion of cases and controls per sex (Figure 2-1).  Furthermore, having sex 
assigned to all samples meant that sex checking against X chromosome genotype 
data could be used during subsequent QC.  Horses originated from one of 19 
surrounding horse farms.  The number of horses per farm ranged from two to 89, 
with approximately equal numbers of cases and controls sourced from each farm (see 
Figure 2-2).  Although the anonymity of samples prevented pedigree details from 
being known, it is hypothesised that the dataset consists of a mixture of half-sibs and 
less related horses.  This hypothesis is based on the results of molecular analyses 
whereby relationships between pairs of individuals were predicted based on genomic 
data.  The common practice in horse breeding of using a single stallion on several 
mares both within and across farms, and of using the same mares within farms to 
produce foals in subsequent years, adds further credence to this hypothesis.  
Cases could now be categorised according to the joint(s) affected by OCD (see 
Figure 2-3).  The most commonly affected joint was the hock, with over half of cases 
suffering from this particular form of OCD.  The next most commonly affected joint 
was the stifle, followed closely by the fetlock.  Only one horse suffered from OCD in 
the shoulder.  The severity of the disease, as demonstrated by the number and size of 
lesions present, could now be assessed (Figure 2-4 and Figure 2-5), enabling further 
characterisation of cases and comparisons with other studies.  However, for the 
reasons outlined in 1.3.4, notably the ambiguity surrounding the alignment of 
severity and liability scales, this information was not used directly in subsequent 
analyses.    
Horses were categorised according to the non-OC conditions which they were treated 
for (Figure 2-6).  The most commonly occurring conditions were angular limb 
deformities (ALD), osteochondral fractures of the proximal (first) phalanx in the 
fetlock joint (fetlock chips) and sesamoid fractures (see Figure 2-7).  Angular limb 
deformities (ALD) involve deviations in a limb when  viewed from the front or back, 
such that deviation is excessive from side to side [109].  The condition is the result of 
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one side of the physis growing faster than the other [110] and can be treated with 
transphyseal bridging to stop growth on one side of the plate [109].  Osteochondral 
fractures of the proximal (first) phalanx in the fetlock joint (fetlock chips) although 
previously associated with OC have since been shown not to be part of the OC 
complex [111, 112] (L. R. Bramlage 2010, Pers. Comm.), but instead to have 
traumatic origins [107, 113].  Concussion and overextension of the joint have been 
identified as the most likely reasons for bone fracture [114].  Sesamoid fractures are 
also believed to have traumatic origins with excessive fetlock extension due to 
muscle fatigue resulting in the overloading of the sesamoid bones at the back of the 
fetlock which then fail [114, 115].  The uneven distribution of these conditions 
between cases and controls (see Figure 2-6) means that the presence/absence of at 
least the three most common non-OC conditions should be accounted for in future 
analyses.  
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Figure 2-1 Number of cases and controls by sex (n=348) 
 
Figure 2-2 Distribution of cases and controls by farm of origin (n=348) 
 
Figure 2-3 Percentage of case horses affected by OCD in the fetlock, hock, 
shoulder and stifle (n=169) 
 
Figure 2-4 Number of joints affected by OCD in case horses (n=169) 
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Figure 2-5 Number of OCD lesions in case horses (n=169) 
 
 
Figure 2-6 Percentage of case and control horses affected by non-OC conditions (n=348).  
Condition: 1 – angular limb deformity (ALD); 2 – fetlock chip(s); 3 – other chip(s); 4 – sesamoid 
fracture; 5 – other bone related conditions; 6 – other (non-bone related) conditions. 
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Figure 2-7 Non-OC conditions 
a) Angular limb deformity: Drawing of a foal with a valgus deformity in the distal radius region 
(left) and a foal with a varus deformity of the same location (right).  Taken from Bramlage & 
Auer (2006) [116]; b) Fetlock chip: A comminuted first phalanx fracture.  Taken from 
Vanderperren & Saunders (2009) [117]; c) Sesamoid fracture: a lateral apical sesamoid fracture 
in a yearling.  Taken from Schnabel et al. (2007) [118]. 
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The additional data concerning, for example, sex of the horses, farm of origin and the 
presence of non-OC conditions made it possible to reduce potential confounding in 
subsequent analyses.  However, since horses were pre-selected for their case/control 
status with an unspecified degree of matching, as opposed to being sampled at 
random from the population, no conclusions can be drawn with respect to the effect 
of these factors on the incidence of OC.  The final phenotypically enriched dataset 
consisted of 384 samples with associated OC status, 348 from the US and 36 from 
the UK, and 817 samples with no OC status from the UK, giving a total of 1,201 
samples.  Whilst the original data collection of the population dataset samples 
required horses to be categorised as cases or controls for the diseases of interest, for 
all analyses in this thesis, the horses were treated as a single population sample.   
Table 2-3 provides details of which subsets of data have been used in the following 
chapters. 
 
Table 2-3 A description of data used in subsequent chapters 
Chapter Subset used, no. of samples & their origin 
3 
Population control dataset – 817 UK samples 
OC dataset – 348 US samples 
4 Population control dataset – 817 UK samples 
5 Simulated data only 
6 All 1,201 samples 
7 OC dataset – 348 US samples 
8 OC dataset – 348 US samples 
9 All 1,201 samples, categorised by country of origin 
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Chapter 3: Linkage disequilibrium and effective 
population size in the Thoroughbred horse 
3.1 Introduction 
Linkage disequilibrium (LD) describes the non-random association of alleles at 
different loci and can result from processes such as migration, selection and genetic 
drift in finite populations [119].  The efficacy of genomic techniques such as 
genome-wide association studies (GWAS), marker assisted selection (MAS) and 
genome-wide evaluation (GWE) is dependent on the extent of LD and its rate of 
decline with distance between loci within the population under study.  The recent 
release of the Illumina Equine SNP50 Genotyping BeadChip has increased the 
potential for such techniques to be applied to the horse.  Researchers have already 
begun to make use of the single-nucleotide polymorphism (SNP) chip in GWAS 
[120-122] and the opportunity exists to use validated loci for MAS in the future as 
some success has already been seen in the localisation of QTL for simple diseases 
[63, 64, 123].  As has been shown in human studies, when applied to complex 
diseases the outcomes of GWAS are generally less successful [45] and therefore, the 
GWE techniques of Meuwissen et al. (2001) [52] may become more attractive.  The 
opportunities will depend on the extent of LD and therefore the characterisation of 
LD exhibited with the current SNP50 BeadChip will assist in planning future studies 
of complex traits and in the development of genomic tools.   
Linkage disequilibrium structure can also provide insights into the evolutionary 
history of a population.  The strength of LD at different genetic distances between 
loci can be used to infer ancestral effective population size (Ne), where Ne is the 
number of individuals in an idealised population that would give rise to the same rate 
of inbreeding as observed in the actual breeding population [124].  Deterministic 
equations derived by Daetwyler et al. (2008) [61] show that, once the Ne for a 
population is known, the accuracy of GWE for a range of scenarios can be 
calculated.  The pattern of historical Ne in domestic livestock populations can also 
help us to understand the impact of selective breeding strategies on the genetic 
variation present in populations and can provide an insight into the level of 
inbreeding in populations for which pedigrees are incomplete or unavailable. 
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The pattern of LD in the Thoroughbred and indeed the horse more generally, has yet 
to be comprehensively characterised and predictions of Ne are limited to those 
inferred from pedigree data which itself may be inaccurate [125].  An early study by 
Tozaki et al. (2005) [126] based on 300 horses, concluded that useful LD in the 
Thoroughbred extends up to 7cM, but this study covered only one small region of the 
genome.  More recently, Wade et al. (2009) [23] investigated LD across ten 2Mb 
regions in a number of different horse breeds, using sample sizes of 24 horses per 
breed.  In contrast, genome-wide LD in livestock populations has been the focus of 
numerous studies [127-129].  Studies have also been done to evaluate the historical 
Ne of a variety of cattle breeds, all of which suggest a continuous decrease in Ne since 
the time of domestication [130-132]. 
The objective of this study was to characterise LD in two geographically distinct 
samples of Thoroughbred horses using data generated from the Illumina Equine 
SNP50 BeadChip and to consider the results in the context of genomic 
methodologies.  The decline of LD over distance is used to predict the Ne both 
assuming a constant population size and assuming linear growth.  These results are 
considered in the context of current knowledge of the establishment of the 
Thoroughbred breed. 
3.2 Materials and methods 
3.2.1 Genotypic data 
The data for this study comprised the population control dataset sourced in the UK 
(n=817) and the OC dataset samples that were sourced in the US (n=348), genotyped 
at the 50,707 SNPs that passed preliminary quality control (QC).  Further QC carried 
out as part of this study led to the removal of additional SNPs on the basis of poor 
genotyping quality, deviations from Hardy-Weinberg equilibrium (HWE) and 
monomorphism; these exclusions are detailed in Table 3-1.  The genotyping rate 
once these exclusions had been made was greater than 99%, with no individuals 
having more than 10% SNPs missing.  Previous studies have demonstrated that 
including markers with low minor allele frequencies (MAF) can bias LD estimates 
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[131, 133, 134], therefore a MAF threshold of 0.10 was also imposed on the data (see 
Table 3-1).  This study used only autosomal markers. 
Table 3-1 SNP exclusions made during quality control 
 




 UK US 
>5% missing genotypes 21 8 




Monomorphic in sample 4,086 4,778 
Minor allele frequency <0.10 9,286 9,361 
I
Quality control was carried out in Plink [105, 106]  
II
Since case/control groups were unknown, HWE was tested using all samples 
III
HWE tested in control samples 
 
3.2.2 Linkage disequilibrium 
The measurement of LD used throughout this study is the squared correlation 






2  , 
where, BAAB pppD   and pA, pa, pB and pb, are the frequencies of alleles A, a, B, 
and b, respectively.  An EM algorithm [136], written by Dr. Ricardo Pong-Wong, 
was implemented to estimate haplotype frequencies.  r² was calculated (to four 
decimal places) for all syntenic marker pairs.  Individuals with a missing genotype 
for a given marker were excluded when calculating LD for that marker.  Details of 
the physical position of the markers can be found in Illumina product literature 
(http://www.illumina.com/documents/products/marker_lists/marker_list_equineSNP
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50.xls).  In order to accommodate the large range of marker distances observed and 
to enable clear presentation of results showing LD in relation to physical distance 
between markers, SNP pairs were divided into three distance classes and 
subsequently put into 87 distance bins, with bin ranges dependent on the class (see 
Table 3-2).  The mean r² for each of the distance bins was then plotted against the 
median of the distance bin range (Mb).  This analysis was carried out on a 
chromosome by chromosome basis; the pooled results are presented here.  r² was 
also calculated for a random selection of non-syntenic SNPs.  Thirty SNPs per 
autosome were randomly selected and r² values calculated for all non-syntenic 
markers, resulting in a total of 418,500 pairwise comparisons.   







Within class bin 
distance range (Mb) 
No. of Bins 
1 0 0.5 0.01 50 
2 0.5 20.5 1 20 
3 20.5 190 10 17 
 
3.2.3 Modelling decline of linkage disequilibrium with 
distance 
Under the assumption of an isolated population with random mating, Sved (1971) 
[137] derived an approximate expression for the expectation of r², such that: 
Equation 3-2   12 41)(  cNrE e , 
where, Ne is effective population size and c is the recombination frequency.  In this 
paper, as in previous studies [92, 130-132, 138, 139], c is replaced by map distance 
in Morgans.  The validity of this replacement is explored in Chapter 4.  Based on this 
formula, a non-linear least squares approach to statistically model the observed r² 
was implemented within R [140] using the following model: 
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Equation 3-3   iii ebday  41 , 
where, yi is the value of r² for SNP pair i, at linkage distance di in Morgans.  
Parameters a and b were estimated iteratively using least squares.  Chromosome-
specific megabase to centiMorgan conversion rates were calculated based on total 
physical chromosome length, as stated on the NCBI website (National Center for 
Biotechnology Information (2009).  Map View [Online].  Available from: 
http://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9796), and total 
chromosome genetic length inferred from the equine linkage map [22] (see Table 
3-3).  Marker pairs with less than 100bp between them were excluded from this 
analysis, as it has been suggested that Sved’s (1971) model is not appropriate for 
very small values of c [130, 141] and at small distances gene conversion contributes 
to the breakdown of LD [35, 139, 142].  The minimum MAF threshold of 0.10 was 
also applied here as Equation 3-2 may be a poor approximation when allele 
frequencies are close to zero [141, 143].  This model was applied to data for each 
autosome in turn and parameter estimates combined by meta-analysis in R [140] 
using an inverse variance method for pooling and a random effects model based on 
the DerSimonian-Laird method [144] (see A.i for further details). 
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Table 3-3 Chromosome specific megabase to centiMorgan conversion 
ratios 
Chromosome Length (Mb) Length (cM) cM/Mb Ratio 
ECA1 186 194 1.04 
ECA2 121 129 1.07 
ECA3 119 120 1.01 
ECA4 109 123 1.13 
ECA5 100 100 1.00 
ECA6 85 127 1.49 
ECA7 99 102 1.03 
ECA8 94 109 1.16 
ECA9 84 105 1.25 
ECA10 84 106 1.26 
ECA11 61 65 1.07 
ECA12 33 58 1.76 
ECA13 43 58 1.35 
ECA14 94 153 1.63 
ECA15 92 97 1.05 
ECA16 87 111 1.28 
ECA17 81 71 0.88 
ECA18 82 88 1.07 
ECA19 60 56 0.93 
ECA20 64 81 1.27 
ECA21 58 76 1.31 
ECA22 50 80 1.60 
ECA23 56 56 1.00 
ECA24 47 47 1.00 
ECA25 40 49 1.23 
ECA26 42 24 0.57 
ECA27 40 93 2.33 
ECA28 46 63 1.37 
ECA29 34 75 2.21 
ECA30 30 50 1.67 
ECA31 25 41 1.64 
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3.2.4 Ancestral effective population size estimation 
Rearrangement of Equation 3-2 allows the prediction of effective population at a 
given point in time, expressed as generations in the past [130, 138, 141]: 
Equation 3-4     14)( 121   cT rctN , 
where, NT is the effective population size t generations ago, c is the distance between 
markers in Morgans, 
2
cr  is the mean value of r² for markers c Morgans apart and 
  12  tc , assuming linear growth [138].  As previously, marker pairs with less than 
100bp between them and SNPs with MAF less than 0.10 were excluded from this 
analysis.  To compute NT, the number of prior generations was selected and a suitable 
range for c was calculated (see Table 3-4).  The binning process was designed to 
ensure sufficient SNP pair comparisons within each bin to get a representative 
estimate of r².  The mean r² between marker pairs in each bin was then computed.  
This process was carried out for each chromosome in turn and also for markers 
pooled across chromosomes, as suggested by Hayes et al. (2003) [138] to reduce the 
variability of estimates of NT caused by finite population size.   
3.2.5 Sample size comparison 
Sample size has been shown to bias LD estimates to varying degrees, depending on 
the distance between markers [128].  Whilst this relationship is explored more fully 
in Chapter 4, here, in order to differentiate between an effect of sample size versus a 
true difference between the UK and US population samples, a random sample of 348 
horses was drawn from the UK dataset.  The analyses described above were then 
repeated on this subset for ECA1 markers and the results compared to corresponding 
results from the full UK dataset and the US dataset. 
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Table 3-4 Description of generation binning process 
Generation range 
applied to 
No. of generations 
represented by 
each bin 
Example for first bin 
Generation Generation range 
Corresponding distance range 
(Morgans) 
1 - 10 1 1 0.5 to 1.5 0.33 to 1.0 [6.7 x 10
-1
] 
20 - 100 10 20 15 to 25 0.02 to 0.033 [1.3 x 10
-2
] 
200 - 1,000 100 200 150 to 250 0.002 to 0.0033 [1.3 x 10
-3
] 
2,000 - 10,000 1,000 2,000 1,500 to 2,500 0.0002 to 0.00033 [1.3 x 10
-4
] 
20,000 - 100,000 10,000 20,000 15,000 to 25,000 0.00002 to 0.000033 [1.3 x 10
-5
] 
200,000 - 500,000 100,000 200,000 150,000 to 250,000 0.000002 to 0.0000033 [1.3 x 10
-6
] 
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3.3 Results 
3.3.1 Genotypic data 
Of the 52,063 autosomal SNPs on the 50K SNP chip, 34,848 (66.9%) and 34,221 
(65.7%) remained after filtering in the UK and US datasets, respectively.  This 
resulted in more than 20 million pairwise comparisons being made per dataset.  The 
number of SNPs per autosome remaining after exclusions ranged from 414 to 2,760 
and was closely related to chromosome length, as shown in Figure 3-1.  The average 
distance between adjacent markers (±SD) was 64.05±86.84kb in the UK dataset and 
65.24±86.76kb in the US dataset, with the distance between adjacent SNPs ranging 
from 1bp to 2849kb.  In both sample groups, the MAF of remaining SNPs followed a 
uniform distribution and averaged (±SD) 0.30±0.12.  
 
 
Figure 3-1 Chromosome length and the number of SNPs per chromosome (average of UK and 
US) 
 
3.3.2 Linkage disequilibrium 
Linkage disequilibrium declined with increasing distance between SNP pairs, as 
shown in Figure 3-2.  The most rapid decline was seen over the first 0.2Mb with the 
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mean r² decreasing by more than half over this period.  The mean r² then decreased 
more slowly with increasing distance, and the decline in LD was almost linear with 
log-transformed distance (Figure 3-3).  Linkage disequilibrium values were slightly 
higher in the US dataset across the full range of marker pair distances, with the 
relative difference increasing with increasing distance between markers.  The 
coefficient of variation of r², as calculated in the UK dataset, increased from 0.6 at 
5kb to a maximum of 2.2 at 15Mb, subsequently decreasing and remaining below 1.5 
for distances greater than 50Mb.  A total of 10,130 and 14,191 SNP pairs were in 
complete LD (r²=1) in the UK and US datasets, respectively, and of these, 5,139 and 
6,146 were adjacent pairs.  The mean (±SD) r² between adjacent SNP markers was 
0.46±0.36 and 0.47±0.37 in the UK and US datasets, respectively.  Slightly more 
than half the adjacent SNP marker pairs exhibited r²≥0.3.  The mean (±SD) r² 
between random non-syntenic markers in the UK dataset was 0.0018±(2.49 x 10
-3
), 
with the equivalent measure in the US dataset being slightly higher at 
0.0044±(6.20x10
-3
).  In both cases, the value was similar to that observed between 
syntenic markers at distances greater than 100Mb (Figure 3-2). 
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Figure 3-2 Average LD measured by r
2
, pooled over autosomes and plotted against the median 
of the distance bin range 
a) Distance range from 0 to 0.5Mb, in bins of 0.01Mb 
b) Distance range from 0.5 to 20.5Mb, in bins of 1.0Mb 
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3.3.3 Modelling of decline of linkage disequilibrium with 
distance 
The non-linear regression modelling of the decline of LD with distance resulted in 
both a and b being significantly different from zero.  The mean estimate and 95% 
confidence interval by meta-analysis across autosomes for a was 2.25 [2.18; 2.33] 
and for b was 103.1 [95.8; 110.3] for the UK dataset.  For the US dataset, 
corresponding estimates were 2.31 [2.23; 2.40] and 84.4 [78.8; 89.9].  The line of 
predicted r² from the non-linear regression equation only approximately follows that 
of the mean observed r², with the greatest discrepancy occurring at distances less 
than 0.03Mb, as shown in Figure 3-3.  Parameter b showed greater variability 
between chromosomes than parameter a; although estimates for both parameters 
showed an approximately symmetrical distribution about the median.  A significant 
negative correlation (p<0.01) was observed between chromosome length and 
estimates of b, but there was no such relationship with estimates of a (Figure 3-4).  
The interpretation of b as an estimate of effective population size is considered in the 
discussion.  
3.3.4 Ancestral effective population size 
An initial pattern of decreasing Ne, with values of over 3,000 estimated in the distant 
past and values closer to 100 estimated at 20 generations ago was observed (Figure 
3-5).  The results suggest that an increase in Ne has occurred over the past ten 
generations.  This increase appears much greater in the UK population which reaches 
a maximum of approximately 190 two generations ago, compared to an estimate of 
just 90 in the US population.  Variation in predicted Ne across chromosomes was 
greatest for estimates corresponding to the most recent ten generations and those 
corresponding to the most distant generations (over 800 generations ago) (Figure 
3-6).  
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Figure 3-3 Predicted r
2
 versus observed r
2
 against mean distance between markers (on a log 
scale).  Predicted r
2





Figure 3-4 Parameter estimates from the modelling of Equation 3-3 by chromosome, plotted 
against chromosome length according to the equine linkage map of Swinburne et al. (2006) [22] 
a) Estimates of a; b) Estimates of b   
a 
b 
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Figure 3-5 Average TN̂  plotted against generations in the past 
a) Generations 1 to 10,000 on a log scale 
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Figure 3-6 Boxplot representing TN̂  plotted against generations in the past (on a non-linear 
scale), truncated at 1,000 generations.  Variation at each time point reflects variability in 
estimates within generation bins between the 31 autosomes (results for the UK dataset). 
 
3.3.5 Sample size comparison 
As shown in Figure 3-2, LD values were consistently higher in the US dataset 
compared to the UK sample.  In the subsequent subset analysis, the level of LD in 
the subset of UK data closely followed that of the full UK dataset for marker pairs up 
to around 20Mb apart (Figure 3-7).  However, at distances greater than this, LD 
levels in the subset were approximately midway between the full UK dataset and the 
US dataset (Figure 3-7).     
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The results of the non-linear regression modelling of the decline of LD are shown in 
Table 3-5.  Estimates of a were relatively consistent across the three datasets, whilst 
estimates of b differed the most between the UK datasets and the US dataset.  
Estimates of ancestral effective population size for the UK subset tracked that of the 
full UK dataset until around generation seven (data not shown), at which point 
estimates for the UK subset fell between that of the full UK sample and the US 
sample (Figure 3-8).      
Table 3-5 Parameter estimates from non-linear regression modelling of ECA1 data 
 Estimate (SE) 
Parameter UK UK Subset US 
a 2.09 (2.13 x 10
-3
) 2.11 (2.13 x 10
-3
) 2.08 (2.22 x 10
-3
) 
b 75.2 (0.08) 73.2 (0.08) 58.0 (0.07) 
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Figure 3-7 Average LD on ECA1 measured by r
2
 and plotted against the median of the distance 
bin range 
a) Distance range from 0 to 0.5Mb, in bins of 0.01Mb 
b) Distance range from 0.5 to 20.5Mb, in bins of 1.0Mb 
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Figure 3-8 Average TN̂ plotted against generations in the past, truncated at 20 generations 
 
3.4 Discussion 
This study provides an overview of LD in the Thoroughbred using a high density 
SNP panel.  Validation work by Khatkar et al. (2008) [128] on their cattle data 
suggests that my minimum sample size of 348 horses, is more than sufficient to 
obtain an unbiased picture of LD.  The pattern of decline of LD with distance in 
these populations is consistent with that reported by Wade et al. (2009) [23] in a 
sample of 24 Thoroughbreds, with both data sets exhibiting a decrease in r² from 
around 0.6 to 0.2 when the distance between markers is increased to 0.5Mb.  The LD 
observed is higher at short distances and more extensive than that observed in human 
populations [145].  Linkage disequilibrium declines more slowly in the 
Thoroughbred populations studied here than in the range of cattle populations studied 
by de Roos et al. (2008) [130], with average r² remaining above 0.3 for distances up 
to 185kb compared with a maximum distance of 35kb in the cattle data.   
The mean value of r² between non-syntenic SNPs was 0.0018 and 0.0044 in the UK 
and US datasets, respectively, and this provides an approximation of the LD that can 
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be expected by chance, assuming that the markers used have not undergone 
simultaneous selection.  The values observed here are of a similar magnitude to that 
observed by Khatkar et al. (2008) [128] in a sample of over 1,500 cattle (0.0032).  
The mean non-syntenic r² value reflects both sampling of animals and genetic 
sampling (drift) and hence may be expected to decrease with increases in both 
sample size and Ne.  Therefore, whilst the larger non-syntenic LD value in the US 
sample here is likely to be due to a smaller sample size, in the Australian Holstein-
Friesian cattle sample (n=1,546) of Khatkar et al. (2008) [128], it may reflect a lower 
Ne in this cattle population.  The low LD seen between non-syntenic SNPs in both of 
the Thoroughbred populations suggests that the LD created by admixture during 
breed formation [125], has declined to negligible levels for these markers.  A similar 
decline of LD between non-syntenic markers was observed in Coopworth sheep 
approximately ten generations after the foundation of the breed through crossing 
[129].  At distances greater than 100Mb, average r² between syntenic SNPs is 
reduced to non-syntenic or background levels, and is no longer a function of 
distance.  This is expected, as the recombination rate at such distances approaches 
0.5.      
The LD observed in the US sample was slightly higher than that seen in the UK 
sample.  The results of the sample size comparison suggest that, at distances <20Mb, 
the lower number of samples does not explain this difference.  At long distances 
(>20Mb) and for the non-syntenic case, sample size appears to have some effect on 
estimates of LD but still does not fully account for the difference in LD between the 
UK and US samples.  Whilst the remaining differences may be due to differences in 
demographic history, for example, greater inbreeding in the US Thoroughbred 
population, it is also possible that the results of the US analysis are biased by the 
presence of more half-sibs and other close relatives, with the average relationship of 
the US horses being greater than that of the UK.  For this reason, the remainder of 
the discussion will focus on the results from the UK dataset which is likely more 
broadly representative of the wider Thoroughbred population.  
By using Sved's (1971) [137] formula for the expectation of r², a non-linear 
regression model was fitted to the data in order to describe the relationship between 
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linkage distance and LD.  Without making any assumptions about the value of r² at 
the intercept, estimates of a and b, as predicted using Equation 3-3 and averaged over 
all autosomes, were 2.25 and 103, respectively.  Parameter a determines the value of 
expected r² when the line crosses the y-axis (i.e. when the distance between markers 
is effectively zero).  The estimate of a calculated here supports an alternative version 
of Sved’s (1971) [137] equation, derived by Tenesa et al. (2007) [139], which takes 
into account mutation and puts a equal to two, whilst at the same time raising the 
question of whether fixing a to unity in the model as Abasht et al. (2009) [146], 
Toosi  et al. (2010) [134] and Zhao et al. (2005) [147] is appropriate.  The impact of 
such model assumptions are explored in Chapter 4.  The heterogeneity of variance 
associated with the observed r², such that the variance of r² declined with increasing 
distance between markers, may also have impacted on the results.  A significant 
negative relationship between chromosome length (cM) and estimates of b from the 
non-linear model was observed, suggesting LD is higher in longer chromosomes.  
This contrasts with the findings of Tenesa et al. (2007) [139] who observed a 
positive relationship, but is in keeping with the observations in domestic livestock 
species of Khatkar et al. (2008) [128] and Muir et al. (2008) [148]. 
Our estimate of b (103), is an estimate of Ne assuming constant population size.  
However, this assumption is difficult to sustain and therefore b more likely 
represents a conceptual average Ne over the period inferred from the marker distance 
range, for example, see Toosi et al. (2010) [134].  As an alternative, Figure 3-5 
shows the results following the approach of Hayes et al. (2003) [138], that is, of 
calculating historical Ne, assuming linear population growth.  The pattern observed 
shows a decrease in Ne up until around 20 generations ago, followed by an increase 
until one generation ago.  The interpretation of such trends is difficult, with the dip in 
Ne observed potentially representing any one of a number of scenarios including a 
founder event, an immigration event, a hybridisation event or any combination of 
these [119].  Therefore, it is useful to consider the results in the context of what is 
known about the Thoroughbred’s demographic history. 
Documentary evidence suggests that the Thoroughbred was derived from a cross 
between sires originating from the Mediterranean Middle East and British native 
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breeds, and the breed was established during the seventeenth century [125].  It is not 
clear from published literature what effects an admixture like this would have on 
patterns of estimated Ne prior to the crossing event although clues may be observed 
in Toosi et al. (2010) [134].  However, what may be predicted is that such a crossing 
event would appear as a bottleneck in the population, creating an initially high level 
of LD in the beginning.  Therefore, one might infer from results here that the lowest 
point of the curve reflects the point at which the breed was formed; this 
approximately coincides with the findings of Mahon & Cunningham 1982 [149], that 
Thoroughbreds born in the 1960s were separated from seventeenth century founders 
by an average of 21.5 generations.  Cunningham et al. (2001) [150] also found 
evidence for a population bottleneck at the time of breed formation.   
The reliability of this method depends on the technical implementation (see Chapter 
4) and, as discussed above, on the demographic history of the breed.  Some 
calibration of the accuracy of the Ne profile presented can be obtained by comparison 
with values obtained from pedigree analyses.  For example, Cunningham et al. 
(2001) [150] calculate the effective number of studbook founders of the 
Thoroughbred to be 28.2.  Since this relies on calculating the long term contributions 
of the founders, quantitative genetic theory suggests that the Ne for this generation is 
twice this value if in HWE [151], providing an estimate of 56 soon after breed 
formation.  This may be compared with the minimum Ne of 88 obtained in this 
analysis, which gives fair agreement.  A further estimate of reliability can be 
obtained by comparing the mean inbreeding of 0.125 (SE 0.005) obtained by Mahon 
& Cunningham (1982) [149] for the 21.5 generations from breed foundation to 1964, 
with the accumulated inbreeding for generations four to 25 (assuming four 












, with Ne estimated from Figure 
3-5.  The value obtained of 0.112 is remarkably close.  Therefore, the minimum of 
Ne≈90 is of the correct magnitude, and the increase in Ne over the last ten generations 
may be explained by an increase in actual population size.  In Thoroughbreds, with 
low reproductive rate of the mare and the ban upon use of artificial insemination, 
there is a greater likelihood that increases in census size will be translated into an 
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increase in Ne.  However, the results of Binns et al. (2012) [152], published after this 
work had been completed, suggest an increase in inbreeding in the Thoroughbred 
since 1960.  This apparent contradiction may be due to sample differences or, more 
likely, due to the technical limitations of the methods.  The limitations of the 
methods used in this chapter are explored more fully in the next chapter.   
3.4.1 Implications for genome-wide association studies, 
marker assisted selection and genome-wide evaluation  
The extent of LD in a population can be used to estimate the SNP density required 
for GWAS studies to be effective, as well as giving some indication as to the likely 
precision with which the QTL region will be located.  The required sample size has 
been shown to be inflated by 1/r² when it is necessary to rely on marker-QTL LD, 
rather than on the QTL itself [153] and this has prompted authors to propose 
thresholds for useful LD.  The term ‘useful LD’ has been described as the proportion 
of QTL variance explained by a marker [130] and the consensus is that an average 
r²>0.3 will permit reasonable sample sizes to be employed for GWAS [35, 128, 153].  
In this dataset, markers 185kb apart achieve an average LD of r²=0.3 and this 
corresponds to approximately 14,500 evenly spaced markers across the genome.  
However, because markers with r²=1 will likely be excluded in GWE and given the 
high variability of r² values at small distances, this is an underestimation of the actual 
number of SNPs needed.  Indeed, in this study of 34,848 SNPs, just over half (54%) 
the adjacent SNP pairs exhibited r
2
 values of at least 0.3 and this fell to 46% when 
SNP pairs with r
2
=1 were excluded.  In reality, because a causal mutation would be 
in LD with a marker on each side, this represents a good, though variable, level of 
coverage of the genome.  With MAS also relying on close and consistent linkage 
between markers and QTL, the high LD observed here is promising.  Genome-wide 
evaluation appears to be effective at lower average r² than that required for GWAS, 
with simulation results demonstrating accuracies of up to 0.65 with an average r² 
between adjacent SNPs as low as 0.2 and a trait heritability of 0.1 [154].  
Deterministic equations derived by Daetwyler et al. (2008) [61] demonstrate that the 
accuracy of GS can be expressed as a function of the effective number of loci (Me) in 
a population.  Me relates to the number of independent chromosome segments and, 
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given the current Ne estimate of ~180 (Figure 3-5) and assuming a random mating 
population, the Me for the UK Thoroughbred population is ~1,500 [155].   Thus, the 
potential accuracy of GS in this population for a range of scenarios can now be 
predicted (see Table 3-6).   
Table 3-6 Predictions of accuracy for genome-wide evaluation.  Based on Daetwyler et al. (2008) 
[61] and assuming a disease prevalence of 25%. 
 Sample Size 
Ne Heritability 300 600 1200 
100 
0.1 0.15 0.21 0.29 
0.2 0.21 0.29 0.39 
150 
0.1 0.13 0.18 0.25 
0.2 0.18 0.25 0.34 
200 
0.1 0.11 0.16 0.22 
0.2 0.16 0.22 0.30 
 
In summary, dense SNP genotype data was used to characterise LD and make 
inferences regarding ancestral Ne for two samples of Thoroughbred horses.  In the 
population studied, LD extended for long distances, reaching base line levels at 
around 50Mb.  From the decay in LD with distance, ancestral Ne was inferred and a 
decrease in Ne since the distant past reaching a minimum of ~90 20 generations ago, 
followed by an increase until the present time was observed.  Such an approach could 
be used to investigate the demographic histories and rates of inbreeding of horse 
breeds with less extensive pedigree records than the Thoroughbred.  A more detailed 
exploration of this approach is presented in the next chapter.  The results from this 
chapter indicate that genomic methodologies which are reliant on LD between 
markers and QTL have the potential to perform well within Thoroughbred 
populations genotyped for the 50K SNP chip.     
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Chapter 4: The estimation of effective 
population size using linkage disequilibria: A 
methodological review 
4.1 Introduction 
Effective population size (Ne), which is defined as the number of individuals in a 
population with random selection and perfect random mating that would give rise to 
the same rate of inbreeding as observed in the actual breeding population [124], is an 
important parameter in a wide variety of biological fields.  Whilst Ne in livestock 
populations can be estimated from pedigree information, or by using formulae which 
relate demographic parameters such as sex ratio and variance of reproductive success 
to Ne [124, 156], or predicted through expected long term genetic contributions 
[151], such approaches may not be appropriate in practice and cannot be applied in 
the case of natural populations where parameterisation is lacking.   
In finite populations, genetic drift plays a crucial role in determining the amount and 
distribution of genetic variation within a population and through this process Ne 
influences genome structure.  It is therefore possible that Ne for a population may be 
predicted from the genome structure using neutral and selection-free genetic markers 
in a random sample of the population.  A range of summary statistics are available 
that enable such predictions to be made, for example, measures of heterozygosity, 
temporal changes in allele frequencies and measures of linkage disequilibrium (LD).  
Methodologies using these statistics have been reviewed by Wang (2005) [119].  
This study focuses on a method by which Ne can be estimated from the LD between 
syntenic markers in the genome. Linkage disequilibrium describes the non-random 
association of alleles at different loci resulting from processes such as migration, 
selection and genetic drift in finite populations [119].  Whilst there are a number of 
measures of LD, the measure used extensively in this paper is r² [135]. 
Genetic models describing the relationship between Ne and LD appear in the 
literature from the 1960’s onwards [135, 137, 141, 157-161].  In particular, Sved 
(1971) [137] and Sved & Feldman (1973) [161] derived a formula for the expectation 
of r² (E[r²]) between a pair of markers as a function of Ne and recombination 
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frequency (c), validated by simulation for distances up to 10cM.  Such work implied 
that the measurement of LD might provide information about Ne.  However, Weir & 
Hill (1980) [162] showed that methods relating E[r²] to Ne will also depend on 
sample size (n).   Hill (1981) [141] explored the use of such equations in inferring Ne 
from LD, suggesting that LD at closely linked markers would reflect ancient 
population history, whilst LD between markers further apart would reflect more 
recent events.  Hayes et al. (2003) [138] built on this idea by deriving a relationship 
between the lengths of homozygous segments (CSH) and generations in the past, 
under the assumption of constant linear growth.  
In terms of empirical application and validation, feasibility was considered to be the 
limiting factor in early work [141].  However, this conclusion was made based on 
only 18 pairs of loci being available; subsequent developments in genotyping 
technology, such as dense single-nucleotide polymorphism (SNP) chips, have 
substantially increased marker density, and some of the limitations can now be 
overcome.  Along with this new opportunity to exploit historical formulae has come 
the challenge of validating the theories, derived under a variety of assumptions, with 
empirically derived data. Since 2003, Hayes’ formula [138], combined with Sved’s 
(1971) [137] original formula for E[r²] (together referred to here as the variable Ne 
method), has become an increasingly popular way of estimating past and present Ne 
in human and more often, in livestock populations [130-132, 139, 163, 164].  Due to 
concerns relating to accuracy and underlying assumptions, these authors and others 
investigating non-syntenic LD [165, 166], have implemented various changes to the 
formula for E[r²] presented by Sved (1971) [137] in order to take account of, for 
example, sampling (as mentioned above) [132, 163] and mutation [131, 139, 164].  
However, despite a continual effort being made to improve the fit of the model to 
empirically derived data, few studies have explored, in a comparative fashion, the 
importance of these modifications.  Furthermore, the issue of the assumptions 
underlying these techniques has been raised [167].     
This paper considers the wide range of approaches which previous authors have 
taken to estimate Ne from LD data and the impact the assumptions have on the 
estimates.  The theoretical basis of each of the approaches is considered; these are 
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then tested firstly on simulated data and secondly on the sample of 817 UK 
Thoroughbreds sourced in the UK and genotyped for the Illumina Equine SNP50 
Genotyping BeadChip. The approaches examined include methods for both variable 
and constant Ne.  The results are considered in terms of potential applications of the 
general method. 
4.2 Materials and methods 
I will address the theoretical basis for the various models tested, and then describe 
their validation in simulated datasets and their application to Equine SNP50 genotype 
data.  Models are tested first under the assumption of constant Ne by non-linear 
regression (constant Ne method) and subsequently under the assumption of linear 
growth in Ne as in Hayes et al. (2003) [138] (variable Ne method).  Throughout this 
paper, c represents recombination frequency or fraction (no units) and d refers to 
linkage distance (in Morgans).  In the case of the equine dataset, linkage distance 
between markers was calculated under the assumption of a genome-wide linear 
relationship such that 1cM≈1Mb.   
4.2.1 Theory for constant effective population size 
4.2.1.1 An expression for E[r²] and its interpretation 
Hill & Robertson (1968) [135] introduced r
2
, a squared correlation coefficient, as a 
normalised measure for the amount of disequilibrium between two loci where 
     122 11  BBAA ppppDr , BAAB pppD  , and pA and pB are the 
frequencies of alleles A and B.  They recognised that the value of r² is almost 
entirely determined by the product of effective population size, Ne, recombination 
frequency, c, and generations since mutation, measured proportional to Ne. For loci 
initially in perfect disequilibrium, the limiting value of E[r²] over time approaches 
(4Nec)
-1
 for large Nec, and 1 for Nec tending to 0.  This led to an approximation of the 
form: 
The application of genomic technologies to the horse 
Chapter 4 The estimation of effective population size using linkage disequilibria: A 
methodological review 
64 
Equation 4-1      12 41  cfNrE e   [137]  
In Hill & Robertson (1968) [135] and Sved (1971) [137], f(c) = c, with c assumed to 
be small.  Sved (1971) [137] used simulation to show that Equation 4-1 holds with 
‘reasonable accuracy’ assuming no selection or mutation. 
However, this construction does not account for mutation.  In the presence of 
mutation, only some of the loci will have reached such an asymptotic state at any 
given time, with the remainder having lower values of r², and therefore at c=0, 
E[r²]<1.  With mutations occurring at different time points on the same chromosome, 
the expected association between polymorphisms is incomplete even with physical 
linkage.  With the same infinite sites model as used by Hill & Robertson (1968) 
[135], Ohta & Kimura (1969) [158, 159] used diffusion equations to calculate 
      BBAAd ppppEDE  1122 ; whilst the ratio of expectations is not the same 
as the expectation of the ratio, they showed that   22 drE  .  Using this 
approximation, Ohta & Kimura (1971) [160] obtained an equilibrium expression for 
2
d ; in this formulation 115
2 d  when Nec=0 (a value derived subsequently by 
Hill (1975) [157]), rather than 1, as implied in Equation 4-1.  This expression may 
also be derived using coalescence theory [168].  The natural extension in Equation 
4-1 is then: 
Equation 4-2      12 4  cfNarE e , 
where, a=11/5=2.2 so that mutation is accounted for.  In this context, Tenesa et al. 
(2007) [139] proposed a=2. 
An important assumption in the derivation of Equation 4-1 was that c, was ‘small’.  
However, the length of chromosomes covered by SNP markers often exceeds 
100Mb, equivalent to c~0.43, assuming 1Mb≈1cM with Haldane’s mapping 
function.  Since such distances cannot be considered ‘small’, it may be more 
appropriate to return to the version of Equation 4-1 which was presented by Sved & 
Feldman (1973) [161].  Here, the inclusion of second order terms in Ne
-1
 and c, led to 
The application of genomic technologies to the horse 
Chapter 4 The estimation of effective population size using linkage disequilibria: A 
methodological review 
65 
   
2
1 cccf   and Ne being replaced by (Ne – ½).  A common interpretation is that 
f(c)=d in Equation 4-1, where d is measured in Morgans and this may be 
questionable.  The relationship of d with c can be described using Haldane’s 






 .  From Taylor’s approximation, for 
small c, d ≈ c, but the second order approximation is d ≈ c(1+c), and it can be seen 
that the result of Sved & Feldman (1973) [161] is not a second order approximation 
to d and therefore provides no justification for setting f(c)=d.  The frequent need to 
infer the linkage map distance between markers from their physical locations with 
only limited direct information on recombination rates, represents a further 
compromise in the determination of c for input to Equation 4-1.  It has become 
common with cattle and human genomes to assume , where  is the 
distance in base pairs; this approximation can also be used in the case of the equine 
genome (27.7M versus 2.68Gb).    
4.2.1.2 Sampling effects 
Up until this point it has been assumed that D is known exactly for any pair of loci.  
However, in reality D is estimated from a limited sample of individuals from the 
population.  This additional sampling event can be expected to contribute to the LD 
observed and therefore any equation for E[r²]  should consist two components; the 
first being a function of Ne and c as in Equation 4-1 and Equation 4-2, and the second 
being a function of n, the number of diploid individuals sampled.  From the work of 
Weir & Hill (1980) [162], it can be hypothesised that the necessary modification to 
formulae for E[r²] depends on the approach taken to estimate r².  In instances where 
the haplotypes of diploid individuals are known without error, the minimum term of 
adjustment, (2n)
-1
, should be applied, where n is the number of individuals sampled.  
Alternatively, if coupling and repulsion double heterozygotes cannot be 
distinguished and r² is estimated using a composite coefficient, e.g. Burrows [169], 
the maximum term of adjustment, n
-1
, is more appropriate.  However, as analytical 
methods progress, we are presented with an ever increasing range of methods to 
predict r² from unphased genotype data, e.g. EM algorithms and phasing algorithms 
using multiple loci, and there has been no work done to determine the appropriate 
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.  Here, observed r² values are adjusted by subtracting (2n)
-1
 since 
in the case of the simulated data at least, haplotypes are known, and dense SNP 
typing is allowing progress towards this state.  The extension to Equation 4-2 is thus: 
Equation 4-3      12 4  cfNarE eadj , 
   where,   122 2  nrradj   
4.2.2 Extension to variable effective population size 
The rearrangement of Equation 4-1 to solve for Ne, allows the prediction of Ne from 
LD data.  This concept provides the basis of derivation of a formula by Hayes et al. 
(2003) [138] relating LD, or in their case CSH, to the Ne that existed t generations in 
the past, i.e. a function NT(t) to be estimated.  This mapping from c to t was of the 
form , therefore: 
Equation 4-4        acrEcftN tadjtT   121 |4 , 
where, NT is the effective population size t generations ago, and the expectation is 
conditional on the markers being the appropriate distance apart given t and the 
mapping function f(c).  A key assumption stated by Hayes et al. (2003) [138] is 
constant linear growth of Ne with t.  
Equation 4-1 to Equation 4-4 allow both current and historical Ne to be estimated 
from dense marker data.  Further, they provide an opportunity to assess the impact of 
simplifying assumptions made by various authors.  I do this through analyses of 
simulated and real data. 
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4.2.3 Data sets investigated  
4.2.3.1 Simulated data 
SNP marker data was generated by forward simulation
6
 of a population of random 
mating individuals with Ne=200, and the number of male and female parents each 
generation being ½Ne.  In each generation, each individual was generated from a 
male and a female parent selected at random and with replacement, and the gametes 
were generated via independent recombination events.  At generation 0, all 
individuals had identical genotypes; mutations were introduced at a rate of 10
-8
 
(equivalent to 1 mutation per Morgan per generation).  Recombination was modelled 
according to a Poisson distribution with a mean of 1 recombination per Morgan per 
generation.  Haldane’s mapping function (i.e. no interference) is implicit in the 
simulation.  In generation 3,001 (by which time mutation-drift equilibrium had been 
established for >5Ne generations), a set of 750 individuals was generated by random 
mating as described above and subsequently subdivided into four sets of sample size 
(n) 50, 100, 200 and 400 individuals, representing 25%, 50%, 100% and 200% of the 
simulated Ne.  Thirty chromosomes of one Morgan (1M) each were simulated using 
independent runs of the simulation program and these are treated as replicates.  The 
number of segregating sites observed closely followed the theoretical expectation 
[170], with a mean percentage deviation across the four sample sizes of 1.3%.  The 
expected heterozygosity over all loci was 0.149 and the mean heterozygosity 
observed when averaged over all loci for the 750 sampled individuals was 0.144.  
Further details of the simulation validation process can be found in A.ii. 
For n=200, the following MAF thresholds were applied: 0.15, 0.10, 0.05 and 0.01, 
with SNPs below the threshold being excluded.  Due to there being a greater number 
of SNPs for MAF thresholds of 0.05 and 0.01, a random subset was chosen in these 
cases to give similar numbers of SNPs for all MAF thresholds.  For the remaining 
sample sizes, a MAF threshold of 0.10 was used.  This resulted in, for example for 
                                                 
 
6
 Simulation program written by Ariel Liu and John Woolliams (both of The Roslin Institute). 
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n=50, an average of 1796 segregating sites remaining per chromosome.  This is 
similar to the number of SNPs observed on equine chromosome 5 (which is 1M in 
length) at the same MAF threshold when a random sample of size 50 was drawn 
from the equine data set described below.        
4.2.3.2 Equine data 
The empirical dataset for this study comprised the population control dataset (n=817 
Thoroughbreds from the UK) genotyped at the 50,707 SNPs that passed preliminary 
quality control (QC).  Prior to analysis, SNPs genotyped in less than 95% of samples 
(21) and those that deviated significantly from Hardy-Weinberg equilibrium 
(p<0.0001) (173) were excluded [105, 106].  A further 13,372 SNPs were excluded 
based on a MAF threshold of 0.10.  The decision to exclude these markers was made 
based on evidence that markers with low minor allele frequencies (MAF) can bias 
LD estimates [131, 133, 134] and that as a result of this Equation 4-1 may be a poor 
approximation when allele frequencies are close to zero [141, 143].  This study used 
only autosomal markers and of the 52,063 autosomal SNPs genotyped, 34,848 
(66.9%) remained after filtering.  A multi-dimensional scaling analysis showed no 
evidence of underlying population structure [105, 106].  The average distance 
between adjacent markers (±SD) was 64.05±86.84kb, with the distance between 
adjacent SNPs ranging from 1bp to 2849kb.  Here, d was estimated by   
and c was estimated from d according to Haldane’s mapping function.   
4.2.4 Data analysis 
A number of analyses, based on the range of model interpretations described above, 
were carried out.  Where appropriate, model combinations were chosen to reflect 
those most frequently used in existing literature. 
4.2.4.1 Estimating linkage disequilibrium 
The measurement of LD used throughout this study was the squared correlation 
coefficient between SNP pairs (r²) [135]. In the case of the equine dataset, an EM 
algorithm [136] , written by Dr. Ricardo Pong-Wong, was implemented to estimate 
haplotype frequencies and r² was calculated (to four decimal places) for all syntenic 
marker pairs resulting in more than 20 million syntenic estimates.  Individuals with a 
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missing genotype for a given marker were excluded when calculating LD for that 
marker. In the analysis of the equine dataset, marker pairs with less than 100bp 
between them were excluded in order to avoid gene conversion contributing to the 
breakdown of LD [35, 139, 142].  In the case of the simulated data, haplotypes were 
known and therefore r² values were calculated directly for marker pairs.   
4.2.4.2 Estimating constant effective population size 
Based on the range of model interpretations described above, a non-linear least 
squares approach to modelling was implemented within R [140].  The statistical 
model corresponding to Equation 4-1 was of the form: 
   iii ecbfay 
1
4 , 
where, yi is the value of r² (or adjusted r²) for SNP pair i, separated by f(ci), ei 
represents the residual and, as appropriate, parameters a and b are estimated 
iteratively using least squares.  Here b represents
eN̂  when the models tested were 
f(c) = c or f(c) = d, or 
2
1ˆ eN  when f(c) =  21 cc  .   
In the case of the equine dataset, models were applied to data for each autosome in 
turn and parameter estimates combined by meta-analysis in R [140] using a 
weighting method of DerSimonian & Laird (1986) [144] to account for potential 
variance between chromosomes (see A.i for further details).  For the simulated 
datasets, models were applied to each chromosome and results were averaged, as 
systematic variation between replicates was not present.  Model fit was explored by 
comparing plots of predicted r² with plots of observed values and by inspection of 
residual plots.  
4.2.4.3 Estimating variable effective population size 
To compute NT, for the different models listed in Table 4-1, the number of prior 
generations, t, was nominated and a range for f(c) appropriate to t was calculated as 
in Chapter 3 (see Table 3-4).  This binning process was designed to ensure sufficient 
SNP pair comparisons within each bin to get an estimate of r² with acceptable 
precision.  The mean distance and the mean r² between marker pairs in each bin were 
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then computed for insertion into the relevant equation from Table 4-1.  This process 
was carried out for each chromosome in turn and also for markers pooled across 
chromosomes simultaneously, as suggested by Hayes et al. (2003) [138] to reduce 
the variability of estimates of NT caused by finite population size. 
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I      14)( 121   rcftNT  c 
II      14)( 121   adjT rcftN  c 
III      14)( 121   rcftNT  d 
IV      14)( 121   adjT rcftN  d 
V      2.24)( 121   adjT rcftN  d 
VI      2.24)( 121   adjT rcftN  c 




adjT rcftN   21 cc   
 
I
NT(t) is the effective population size t generations ago and 




4.3.1 Simulated data 
4.3.1.1 Impact of minor allele frequency threshold 
Changes to the MAF threshold had a considerable impact on parameter estimates 
under the constant Ne scenario (shown in Table 4-2).  For n=200, increasing the 
MAF threshold led to a decrease in the estimate of parameter a from more than 6 
with a threshold of 0.01, down to 1.5 with a threshold of 0.15.  Assuming a 
monotonic relationship between the threshold and a would result in values of 2.2 or 
2.0 being obtained with a threshold between 0.05 and 0.10.  Similarly, increasing the 
MAF threshold led to a decrease in eN̂ .  In nearly all cases, the MAF threshold 
which led to eN̂  closest to the simulated value was 0.05.  With variable Ne models, 
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changes to the MAF threshold had the greatest impact on distant TN̂ , i.e. small c 
(results not shown) since parameter a is a more dominant term when the Ne-
dependent term is small.  
4.3.1.2 Impact of adjustment for sample size 
The bias in 
eN̂  due to sample size is demonstrated by the mean parameter estimates 
of b in Table 4-3.  When calculated r² values were not adjusted for sampling effects, 
increasing the sample size resulted in an increase in 
eN̂  and, in nearly all cases, 
estimates closer to the simulated value of 200; this reflects the reduction in sampling 
error with increasing n.  However, when adjustment was made, estimates of Ne were 
more stable and robust to changes in n.  Assuming a variable Ne, the adjustment for 
finite sample size had the greatest impact on recent TN̂ , i.e. for large c, where r
2
 is 
smallest (Figure 4-1).  Without adjustment, the values of r
2
 are biased upward, 
resulting in a downward bias in TN̂ , since TN̂  is related to the reciprocal. After 
subtraction of the error term the bias is reduced, but variation across estimates is 
increased (Figure 4-2); both effects are a result of the reciprocal transformation. 
Nevertheless, the adjustment reduces the predicted mean square error (MSE) at 
recent generations, at least when f(c)=d.  When f(c)=c or  
2
1 cc  , recent TN̂  
appears more sensitive to sample size than when f(c)=d.  This causes recent TN̂  to 
become increasingly close to the simulated value with increasing n, but also to an 
overestimate of TN̂  whenever r² is adjusted (Figure 4-1). 
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Table 4-2 Estimates resulting from the non-linear least squares modelling of the simulated dataset.  The estimates shown are in quadruplets arising from the 
different MAF thresholds used for inclusion of markers. Means and standard errors (SE) are calculated from 30 replicates and ‘NA’ denotes where a was 
fixed.  The reciprocal of a is the value of r² at the intercept of the x-axis, that is the expectation of r² under complete linkage (c=0).  Parameter b can be 
interpreted as an estimate of Ne assuming a constant population size over time, except for the case where 
   
2
1 cccf 




Parameter Estimates (MAF threshold
I






SE Mean SE 
 f(c)=c 1.51; 1.89; 2.80; 6.69 0.01; 0.02; 0.03; 0.14 155.5; 170.0; 191.7; 251.2 2.0; 2.1; 2.5; 2.9 
 f(c)=d 1.53; 1.91; 2.85; 6.87 0.01; 0.02; 0.03; 0.15 150.7; 164.2; 184.1; 238.1 2.1; 2.1; 2.5; 3.1 
 f(c)=d, 2adjr  1.51; 1.88; 2.77; 6.30 0.01; 0.02; 0.03; 0.13 158.7; 175.5; 203.4; 300.9 2.2; 2.3; 2.8; 3.6 
 f(c)=d, a=1 NA 199.3; 262.3; 448.2; 2308.8 2.6; 3.1; 8.5; 105.3 
 f(c)=d, a=2.2 NA 126.5; 152.4; 217.4; 645.7 1.6; 1.8; 3.2; 15.8 
   
2
1 cccf   1.50; 1.87; 2.77; 6.58 0.01; 0.02; 0.03; 0.14 158.4; 173.3; 196.2; 259.5 2.0; 2.1; 2.5; 2.9 
I
SNPs with a MAF below the threshold were excluded from the analyses. 
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Table 4-3 Estimates resulting from the non-linear least squares modelling of the simulated 
dataset.  A model and sample size comparison (MAF threshold of 0.10).  The reciprocal of a is 
the value of r² at the intercept of the x-axis, that is the expectation of r² under complete linkage 
(c=0). Parameter b can be interpreted as an estimate of Ne assuming a constant population size 
over time, except for the case where 
   
2
1 cccf 









Model n= 50 100 200 400 50 100 200 400 [MSE
IV
] 
 f(c)=c 2.11 1.95 1.89 1.86 136.7 160.6 170.0 176.2 [719] 
f(c)=d 2.13 1.97 1.91 1.88 133.5 155.8 164.2 170.0 [1056] 
f(c)=d, 
2
adjr  1.96 1.90 1.88 1.87 178.2 178.5 175.5 175.6 [758] 
f(c)=d, a=1 NA 241.4 257.7 262.3 266.8 [4825] 
f(c)=d, a=2.2 NA 130.9 146.4 152.4 156.7 [1988] 
f(c)=d, a=2.2, 
2
adjr  NA 167.8 165.5 161.9 161.5 [1604] 
   
2
1 cccf   2.10 1.93 1.87 1.84 139.0 163.5 173.3 179.7 [540] 
   
2
1 cccf  ,
2
adjr  
1.91 1.86 1.84 1.82 189.2 189.2 186.1 186.2 [339] 
   
2




NA 177.3 174.9 171.3 171.0 [940] 
I




SE: 1.8-3.0, with the exception of when a=1, where SE: 3.1-3.9. 
IV












, where i represents replicate number.  
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Figure 4-1 Simulated data: Average TN̂  (truncated at NT=500) plotted against average 
generations in the past (on a logarithmic scale) truncated at 1,000.  A comparison of sample size 
using models I, II, III and IV (MAF threshold of 0.10) (see Table 4-1 for specification of models).  
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Figure 4-2 Simulated data: Boxplots of TN̂  plotted against generations in the past (on a non-
linear scale), truncated at 500 generations (f(c)=d, MAF threshold of 0.10, n=50).  Variation at 
each time point reflects variability across estimates within generation bins and across the 30 
replicates.  The dashed line represents the simulated Ne. 
a) No adjustment of r
2
 for sampling effects (Model III) 
b) Adjustment of r
2
 for sampling effects (Model IV) 
a 
b 
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4.3.1.3 Impact of form of f(c) and value of a 
Restricting attention in Table 4-3 to the models with adjusted r², estimating a in the 
non-linear regression model resulted in the smallest MSE for Ne, and the use of 
   
2
1 cccf   had consistently smaller MSE than f(c)=d.  Altering the definition 
of f(c) in the constant Ne model had relatively little impact on parameter estimates of 
a and b.  When assuming a variable Ne, altering the value of a had the greatest 
impact on distant TN̂  which were subject to a continually increasing upward bias as 
t increased when a=1.  This trend was reversed by setting a=2.2 (Figure 4-3), with, 
ultimately, negative values being obtained.  The source of this discrepancy can be 
seen in Figure 4-5, which shows that neither model fitted the observed data 
convincingly.  No value of a gave the most accurate TN̂ , as judged by MSE, across 
all generations, but a=1 had the lowest MSE over generations 10 to 200.  The form 
of f(c) had little effect, except at the most recent generations (Figure 4-4).    
4.3.1.4 Summary of models fitted to simulated data 
Unless the finite sample size is accounted for the methods underestimate Ne, and 
when Ne is assumed to be variable, the underestimation is most severe for estimates 
of recent NT.  Changing the value of a to reflect mutation is also important as 
assuming a=1 results in overestimates of Ne which, in the case of the variable Ne 
model, are particularly severe for large t.  When assuming a variable Ne, setting 
a=2.2 can lead to negative TN̂  at distant generations.  When assuming a constant Ne, 
the problems with a can be avoided by estimating a.  For constant Ne models, the 
lowest MSE was achieved using  
2
1)( cccf  , whereas in contrast, for variable 
Ne, the combination which gave TN̂ closest to the simulation data, i.e. a growth rate 
of zero with Ne=200, across the widest range of generations and sample sizes, was 
f(c)=d and a=2.2 with r² adjusted for sampling effects (Model V).  Although this 
equation gave the most accurate TN̂ , estimates were still below the true value (200) 
across all time points and for all sample sizes.  Estimates of NT were very sensitive to 
the model form for generations <7.      
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Figure 4-3 Simulated data: Average TN̂  plotted against average generations in the past (on a 
logarithmic scale) truncated at 1,000, with corresponding predicted mean square error (MSE).  
A comparison of models IV and V (MAF threshold of 0.10 and n=200) (see Table 4-1 for 
specification of models) 
 
 
Figure 4-4 Simulated data: Average TN̂  plotted against average generations in the past (on a 
logarithmic scale), truncated at 1,000 generations.  A comparison of models V, VI and VII 
(MAF threshold of 0.10 and n=200) (see Table 4-1 for specification of models). 
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Figure 4-5 Predicted and observed r
2
 plotted against mean marker distance (on a logarithmic 
scale). 
a) Simulated data: Predicted r
2
 was calculated using the true value of b (200) with a set to 1 or 
2.2.  Observed r
2
 was calculated in the n=200 sample, with a MAF threshold of 0.10. 
b) Equine data: Predicted r² was calculated using parameter estimates of b from models with a 
set to 1 or 2.2 and with f(c)=d (MAF threshold 0.10).  For parameter estimates see Table 4-4.       
a 
b 
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4.3.2 Equine data 
As shown in Table 4-4, the effect of changing the model underlying the constant Ne 
approach had relatively little impact on the parameter estimates, except for the case 
where a=1.  Estimates for parameter a were in the range 2.17 to 2.25, whilst 
estimates of b (
eN̂ ) ranged from 130 to 250.  Figure 4-5 shows the fit of the non-
linear regression model by comparison of the observed r² and the expected value 
based on estimated model parameters.  Fixing a=1 as in Equation 4-1 provided a 
poor fit to the data, with observed r² being much less than expected at short distances 
and greater than expected at long distances.  Fixing a=2.2 as in Equation 4-2 
improved the fit to observed r² but led to a slight underestimation of r² at small 
distances.  The pattern of ranking between the observed and the two models indicate 
that changing a alone will not provide a satisfactory fit.  Using the best model from 
the simulated data (  
2
1)( cccf  , 2adjr  and estimated a) resulted in 142
ˆ eN . 
Analysis under the variable Ne scenario showed a similar pattern, irrespective of the 
estimation method, up to about 30 generations ago.  The trend was for a decrease in 
TN̂ from a maximum (which varied with estimation method) at generations 1-2, to a 
minimum of 100ˆ TN  at generation 20-30.  This was followed by a continual 
increase in TN̂  with increasing generations into the past, reaching values of over 
2,000 in the distant past, except where mutation was included in the model (a=2.2) in 
which case TN̂  declined after 1,000 generations, eventually becoming negative 
(Figure 4-6).  The impact of alterations to the equation for NT were consistent with 
those seen using the simulated data.  The negative TN̂  indicate a problem with the 
model such that 2.2 is not the best estimate for a, i.e. Ohta & Kimura (1969) [158, 
159] does not apply, and to address the theoretical issues discussed below, I used the 
average r² value for marker pairs less than 0.01Mb apart (r²=0.64) to provide an 
empirical value of a (when c=0,  
a
rE 12  ) which was calculated as 1.56, and 
replaced 2.2 in Model V (Figure 4-6).      
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Table 4-4 Estimates resulting from the non-linear least squares modelling of the equine 
dataset.A model comparison (MAF threshold of 0.10).  The reciprocal of a is the value of r² at 
the intercept of the x-axis, that is the expectation of r² under complete linkage (c=0). Parameter 
b can be interpreted as an estimate of Ne assuming a constant population size over time, except 
for the case where 
   
2
1 cccf 








 95% C.I. Mean
I
 95% C.I. 
f(c)=c 2.20 [2.12,2.28] 134.9 [126.7,143.1] 
f(c)=d 2.25 [2.18,2.33] 127.7 [119.6,135.9] 
f(c)=d, 2adjr  2.25 [2.17,2.32] 129.8 [121.5,138.1] 
f(c)=d, a=1 NA 249.7 [230.1,269.4] 
f(c)=d, a=2.2 NA 129.7 [120.6,138.9] 
f(c)=d, a=2.2, 2adjr  NA 131.5 [122.2,140.8] 
   
2
1 cccf   2.17 [2.10,2.25] 138.7 [130.5,147.0] 
   
2
1 cccf  , 2adjr  2.17 [2.09,2.24] 141.0 [132.6,149.4] 
   
2
1 cccf  , a=2.2, 2adjr  NA 140.4 [131.1,149.6] 
I
Mean across autosomes, as calculated by meta-analysis. 
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Figure 4-6 Equine data: Average TN̂  plotted against average generations in the past.  A 
comparison of models III, V and V with a=1.56 (MAF threshold of 0.10) (see Table 4-1 for 
specification of models). 
a) Generations in the past truncated at 4,000 generations 
b) Generations in the past (on a logarithmic scale) truncated at 1,000 generations and TN̂  
truncated at 500 
a 
b 
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In this study the impact of a range of interpretations of Sved’s (1971) [137] formula 
on estimated Ne have been investigated using simulated data and SNP50 genotype 
data of 817 UK Thoroughbred horses.  The most accurate estimates of Ne, assuming 
it a constant, arose from adjusting the values of r² for finite sample size (assumed 
here as (-2n)
-1
) and with a estimated from the data.  Although the average estimates 
themselves were relatively robust to the form of f(c) used,    
2
1 cccf   yielded 
superior results and an increase in accuracy, as assessed by MSE.  With a MAF 
threshold of between 0.05 and 0.10, the estimated value of a was closer to the 
theoretical value of 2.2 [160] than 1 [137], however, there was considerable 
sensitivity to the threshold used.  When fitting models assuming variable Ne, the 
most robust models accounted for finite sample size and generally arose from using 
values of a that accounted for mutation, although between generations 10 to 200, 
values from using a=1 had lower MSE.  Ignoring the effect of n had increasing effect 
as historical time decreased, whilst ignoring mutation had increasing effect as 
historical time increased.  Similarly to the constant Ne model, TN̂  for middle and 
distant historical time were robust to the form of f(c), however, the most recent TN̂  
were increasingly sensitive to f(c).  
For both the constant and dynamic Ne models, the value of a
-1





for two SNPs within the set of markers, and critically the value obtained varied with 
the cut-off applied to MAF for the markers.  It is plausible that this sensitivity will 
also be displayed with other criteria used to select the SNPs.  With MAF≥0.10, 
estimates of a from the equine dataset appeared close to 2.2, as derived by Ohta & 
Kimura (1971) [160], and in the simulated dataset, close to the value of 2 chosen 
empirically by Tenesa et al.(2007) [139].  As the MAF threshold increases, variation 
in allele frequency is reduced and constraints on E[r
2
] due to the impact of frequency 
differences on r
2
 are eased [171], so increasing E[r
2
] and so decreasing a.  The 
impact of different MAF thresholds using actual SNP data from existing chips would 
likely be less, since the distribution of MAF is already biased upwards, resulting in 
proportionately less exclusions at a given MAF threshold.  The practice of excluding 
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loci with extreme allele frequencies results in the preferential exclusion of the most 
recent mutations [172], and this is another form of ascertainment bias.  Obtaining 
~2.2 for the equine data (with MAF≥0.10) cannot be viewed as validation of theory 
since an historical bottleneck in the Thoroughbred is well documented [125, 150].  
Critically, there is no clear asymptote such that by choosing particularly high MAF 
thresholds, an asymptotic value for a may be anticipated.  More markers with lower 
MAF gave much greater values of a than expected from neutral theory, therefore the 
deviation from the theory and its associated assumptions will not be resolved by 
obtaining sequence data.  Such a hypothesis can soon be tested, although inclusion of 
such loci will require large datasets.  Using coalescence, McVean (2002) [168] 
obtains only approximate correspondence between   22 drE   when c=0 and with a 
MAF threshold of 0.10.  Therefore, whilst Hudson (1985) [143] previously observed 




 with mutation [160] are sensitive to MAF thresholds, my 
results suggest ensuring MAF≥0.10 is too simplistic a solution for reconciling results 
with mutation models based on Sved (1971) [137].  Further, any change in the value 
of a or imposing an ad hoc MAF threshold to improve correspondence as c tends to 
0, must also ensure that the equilibrium expression (Equation 4-2) is not 
compromised across the wider range.  Table 4-2 shows that, of the MAF frequencies 
tested, whilst a was closest to theory when MAF≥0.10, Ne was closest to its true 
value when MAF≥0.05. 
The original development of the theory for variable Ne (Hayes et al.(2003) [138] in 
Equation 4-4) was based on chromosomal segment homozygosity (CSH) and this 
was extended by Tenesa et al. (2007) [139] to cover E[r²] since they have the same 
limiting forms, assuming constant Ne and no mutation [138, 139].  The acceptance of 
Equation 4-4 depends on a number of conceptual approximations.  The first is that 
changes in Ne are linear with time, since this provides the theoretical underpinning of 
the mapping from time (measured in prior generations) to recombination fraction.  
The second is that the incorporation of mutation will alter the limiting forms of both 
CSH and E[r²], and to similar degrees; whilst the former is based upon contiguous 
runs, the latter is a pairwise measure.  Finally, is an assumption in implementations 
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including in Chapter 3, that c can be substituted by d or, more generally,   12  ct  
by    12  cft . 





 since it can be estimated, and this provided the best results.  However, 
the theory of variable Ne, which does require a value of a, cannot be disassociated 
from constant Ne since, at its heart, the development of the former relies on 
properties of the latter.  This use of a pre-determined value a is problematical as 
there appears to be no uniformly best model over time.  For example, the use of a = 1 
fitted well from generations 10 to 100 but deviated more and more dramatically from 
the true Ne as historical time increased, whilst negative values were eventually 
obtained with a=2.2 (or 2).  It is possible to use some external information upon 
which to calibrate the model; for example an estimate of recent Ne from demographic 
data.  However, this option places an emphasis for calibration upon pairs of loci with 
large c, beyond the point where approximations in the derivations can be expected to 
hold.  Alternatively, the data associated with very small values of c may be used to 




, and hence a, as demonstrated in Figure 4-6.  
In principle, subject to sampling error, such an approach should avoid the appearance 
of negative estimates of Ne.  Sacrificing Ne estimates beyond ~1,000-2,000 
generations ago, corresponding to c<0.0005 – 0.00025, is unlikely to be a serious 
issue in the case of livestock or companion animals, as it is almost impossible to 
assign such estimates to a single specific population in any case.  However, this 
approach distances procedure from theory. 
The principle of sacrificing extreme historical Ne is further justified since the period 
over which Ne estimates are consistent with true values may be Ne dependent.  For 
example, coalescence theory predicts the expected time for coalescence of a sample 
of gametes is less than 4Ne generations.  Clearly a mutation cannot be older than the 
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coalescence time of the tree, and simulation of coalescent trees
7
 (not shown) 
demonstrates that the probability of mutations older than 2Ne generations will be 
very small, and the probability of a pair of randomly sampled mutations older than 
2Ne will be even smaller.  Therefore, estimates of Ne more than ~4Ne generations into 
the past must be questionable, corresponding to 800 generations in the simulations 
performed here.  This horizon will be population dependent so, with simulations of 
human populations (Ne=10,000), McEvoy et al. (2011) [173] calculated 
representative Ne estimates for 200 to 5,000 generations in the past. 
When fitting the model assuming constant Ne, the lowest mean square error was 
found with    
2
1 cccf  , not with f(c)=d, although d was found to be more robust 
with the variable Ne model.  The former is a concave function of c whereas the latter 
is convex, thus the common practice of f(c)=d is a modification to Sved (1971) [137] 
that moves contrary to theory and observation.  This lack of consistency in results 
undermines the coherence of the variable Ne approach since it is derived from the 
constant model.  An additional potential source of error when using f(c)=d is the 
widely used assumption of a genome-wide linear relationship between genetic and 
physical distance; this has been shown to have an impact on more distant Ne 
estimates [131, 163].  
More generally, the number of individuals required to obtain reliable estimates of r² 
and therefore of Ne, is a key issue.  In most cases, increasing the sample size caused 
an increase in the accuracy of Ne estimates, with Ne being underestimated when the 
sample size was low.  In the variable Ne case, sampling effects were most serious at 
recent generations, demonstrating the relative importance of sampling correction 
when estimating r² at relatively unlinked loci.  Adjustment of observed values of r² to 
take account of sampling effects, led to constant Ne estimates being largely protected 
against the effects of n, although Ne estimates remained below the true Ne, supporting 
                                                 
 
7
 Simulations by John Woolliams (The Roslin Institute). 
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suggestions that the adjustment is inadequate [174].  This trend was also observed in 
the variable Ne case when f(c)=d.  Somewhat unexpected was the failure of a sample 
size equal to or twice the true Ne to overcome the downward bias under the constant 
Ne method.  This result is particularly surprising in light of the work of Waples 
(2006) [166], which showed that when using estimates of non-syntenic LD to 
calculate so-called ‘contemporary’ Ne estimates, sample sizes in excess of the true Ne 
led to its overestimation.   
Despite the apparent inability of large sample sizes to completely ameliorate the 
downward bias in Ne estimates, increasing sample size did improve precision.  The 
increase in precision with increasing sample size is not only intuitive but is predicted 
by Hill (1981) [141] in a formula for the coefficient of variation of 
eN̂ .  This 
equation also predicts a decrease in precision of TN̂  at recent generations, again 
leading myself and others [141] to question Ne estimates for the most recent 
generations.  Whilst the massive increase in markers now available should 
theoretically improve accuracy across all time points, patterns of between-replicate 
variation do largely reflect concerns about recent TN̂ , since estimates of Ne based on 
small sample sizes suffer from considerable between-replicate variation.  The 
pooling of marker pairs across chromosomes is an important step in reducing the 
impact of this variation on final estimates.  It is likely that the method of binning 
SNP pairs will also affect the relative precision of estimates at different time points.  
Here, marker pairs are binned by generation and as such, the number of marker pairs 
per bin and the variation in r² will be different from studies where marker pairs have 
been put in equally sized (by distance) bins.  The optimal binning process is far from 
obvious and, although not examined here, may benefit from standardisation.    
Whilst the constant Ne method has the potential to offer clues about a population’s 
historical Ne, the frequent violation of the assumption of constant Ne in real 
populations limits its use as a predictor.   Nevertheless, this study has demonstrated, 
through multiple comparisons, the potential impact of alternative expressions for 
E[r²] on estimates of Ne.  I have also explored the effect of MAF thresholds and 
sample size on predicted Ne.  In the case of the constant Ne method, a MAF threshold 
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between 0.05 and 0.10 seems preferable to impose on data prior to analysis.  
Furthermore, estimates of r² should be adjusted for sampling effects and f(c) set 
equal to  
2
1 cc   with a estimated.    
With respect to the variable Ne method implemented here, there is empirical evidence 
from the literature of approximate agreement between molecular and pedigree based 
estimates: I have previously compared my results to those from typical pedigree 
inbreeding coefficients (Chapter 3) and Uimari et al. (2011) [175] to actual pedigree; 
furthermore, analysis of human sequence data [176] confirmed results of Tenesa et 
al. (2007) [139].  However, the issues raised here cast doubt on the estimation of 
variable Ne, particularly for recent generations (T<10), even when corrected for finite 
sampling.  Problems with T<10 should be anticipated since they rely on large c, 
whilst the theoretical development by Hayes et al. (2003) [138] relating CSH to Ne 
make use of approximations that become reasonable as c decreases towards 0.05 and 
T increases to 10.  Further, the methodology is highly sensitive to the value of a, and 
in turn any MAF threshold used for screening, which will have considerable impact 
on distant past.  To some extent this sensitivity can be overcome since the estimation 
of Ne can only be expected to be valid for <4Ne generations, and this gives the 
opportunity for an estimate of a to be obtained.  An approximation to the true shape 
over an intermediate period may be obtained, for example, preserving the local 
maxima or minima (although the assumption of linear Ne with time implies there are 
no such change points) and it appears that over middle ranges of historical time the 
methodology can give estimates of Ne that are within a factor of two; this in itself can 
be informative, for example, when comparing populations.  Nevertheless, the 
theoretical basis for models of variable Ne based on E[r
2
] is unclear and has not been 
soundly established, especially in the form currently applied, e.g. f(c)=d, making 
outcomes unreliable.  Further, this conclusion is based on simulations where Ne was 
held constant with random selection, random mating and discrete generations, and 
will strengthen with more complex population structure.  Whilst the theoretical 
development here does not encompass such structure, the results of Toosi et al. 
(2010) [134] give some indication of what can be expected when Equation 4-1 is 
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used to estimate constant Ne in populations with a history of crossbreeding and 
admixture. 
In summary, decision-making based on estimates of Ne calculated by the methods 
presented here, for example to inform conservation, should only be done with 
extreme caution.  Alternative methodologies to predict Ne from SNP marker data 
have been developed and one of these is investigated in the next chapter of this 
thesis.   
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Chapter 5: The estimation of historical effective 
population size using a composite-likelihood 
methodology  
5.1 Introduction 
Linkage disequilibrium (LD) describes the non-random association of alleles at 
different loci and represents an important feature of genomes from many 
perspectives.  The concept of using patterns of LD to provide insights into the 
evolutionary history of populations has already been introduced in Chapters 3 and 4.  
In these chapters, estimates of effective population size (Ne) were derived using 





]), distance between markers and Ne.  A potential disadvantage of this approach 
is its reliance on what is essentially a summary statistic (r
2
) as this means that it is 
not using all of the available information from the data.  Furthermore, r
2
 is 
influenced by allele frequencies at the loci, being limited by both the minor allele 
frequencies (MAF) and the absolute difference in allele frequencies at the two loci 
[131, 153] [177].  In particular, it is clear that the full range of r² (0 to 1) can only be 
realised when the allele frequencies are the same at both loci.  In order to address 
these limitations, an alternative approach based on estimating likelihoods under 
simple neutral models has been suggested [178-181].  This methodology involves the 
comparison of observed sample configurations to sampling distributions generated 
under a simple neutral model in order to infer properties of the population, such as 
the recombination parameter, ρ=4Nec (where c is the recombination rate and is 
referred to as r in Hudson (2001) [181]).  The applicability of this approach was 
initially limited due to the intense computation required to generate both the sample 
probabilities and the maximum likelihood estimates of the parameter [181].  
However, advances in computing and the ability to make sampling distributions 
available led Hudson (2001) [181] to re-visit this empirical approach.                   
The so-called composite-likelihood estimator (CLE) introduced by Hudson (2001) 
[181] is an ad hoc method for estimating the population recombination rate, ρ, on the 
basis of combining coalescent likelihoods over all pairwise comparisons of 
segregating sites.  This approach uses two-locus sample distributions, generated by a 
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random-genealogies Monte Carlo method, to produce likelihoods for the estimation 
of ρ (and Ne if c is known).  The correlation between markers on a chromosome 
assayed in a single sample, caused by linkage, means that marker pairs are not 
independent and therefore that the resulting expression is not a true likelihood, hence 
it is instead referred to as a composite likelihood [181].  There have been studies that 
demonstrate the potential utility of this and similar approaches, in some cases 
applying extensions to the methodology, for example, to incorporate variable 
recombination rates across the genome and to include gene conversion [142, 182-
184].  However, these studies have focused primarily on the analysis of markers that 
are relatively close together, for example, those contained within a gene.  Therefore, 
the methodology has only been tested for a limited range of ρ, typically up to around 
ρ=50.    
One hypothesis is that, by taking into account both allele frequencies and sample size 
in generating sample probabilities, the CLE approach should be subject to less error 
than the approach used in Chapters 3 and 4 (referred to here as the syntenic LD 
method) when estimating Ne.  In order to test this hypothesis, data simulated by the 
coalescent approach has been analysed using both deterministic expressions for E[r²] 
as in Chapters 3 and 4, and by the CLE approach using sampling probabilities to 
estimate Ne.  Data was simulated in order to represent typical sample genotype data 
for a livestock population.  Additionally, the sensitivity of the CLE approach to the 
distance between markers is investigated.   
5.2 Materials and methods 
5.2.1 Data simulation 
Single-nucleotide polymorphism (SNP) marker data was simulated using the ms 
program which assumes the standard coalescent approximation to the Wright-Fisher 
model [185].  The size of the simulated segment was equivalent to one Morgan (1M), 
achieved by setting the number of sites between which recombination can occur to 
1,000,001 (equivalent to the number of base pairs in the locus) and the probability of 
crossing-over per generation between the ends of the locus to 1x10
-6
 (assuming a 
finite-sites uniform recombination model).  An infinite-sites model of mutation is 
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assumed with the number of segregating sites set to 1,500 which represents a similar 
SNP density as is achieved with the 50K SNP chip in the horse.  In instances where 
more than one marker was given the same location (due to rounding in ms), only the 
first marker was retained in the analysis.  Simulations were run assuming a constant 
diploid population size of Ne=200 and Ne=1,000.  Thirty independent samples of 50 
haplotypes (T=50) (equivalent to 25 diploid individuals) were generated in each case. 
5.2.2 Data analysis 
5.2.2.1 Composite-likelihood estimator (CLE)  
5.2.2.1.1 Derivation of sample probabilities 
Analysis of the simulated data followed Hudson (2001) [181] and was based on a 
table of sample probabilities for all possible sample configurations for a pair of 
biallelic markers given 50 sampled haplotypes and for a set of ρ values ranging from 
0 to 120.  This table and similar tables for a range of sample sizes are available to 
download from http://home.uchicago.edu/~rhudson1; these probabilities were 
obtained empirically by generating a large number of independent two-locus 
genealogies using standard coalescent machinery [143, 181, 186]. 
Considering a pair of biallelic polymorphic sites, there are four possible haplotypes.  
The sample configuration can be denoted  11100100 ,,, nnnnn , where ijn  is the 
number of sampled gametes that carry the allele iA  at locus A and jB  at locus B.  
The probability of a particular configuration,  i,j,k,ln  can be denoted 
  ,;,,, lkjiq  where  eN4 , assumed small, and cNe4 .  Hudson’s tables 
are generated assuming that the ancestral allele is known, hence the total possible 
number of marginal allele frequencies (see Figure 5-1) for T=50 is 1,225, i.e. 
(49x50)/2.  However, in this case it is assumed that the ancestral allele is unknown 
(referred to as ‘a-d unspecified’ by Hudson (2001) [181]), in which case the number 
of marginal allele frequencies possible is reduced to 325, i.e. (25x26)/2 because of 
equivalencies.  New sample probabilities were calculated under this assumption by 
summing probabilities for equivalent sample configurations; for an example, see 
Figure 5-1.  These probabilities were then used to calculate sample configuration 
probabilities conditional on marginal allele frequencies observed, i.e. 
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where the summation is over all possible sample configurations, m, for a given 
marginal allele frequency, i.e. over the range of minor allele/minor allele haplotypes 
possible.  For the case ρ=∞, i.e. independent loci, conditional probabilities were 
calculated according to the hypergeometric distribution, such that: 
Equation 5-2  









The logarithm of an approximation to the gamma function, based on the Lanczos 
approximation [187], was used to calculate these probabilities [188]. 
For each possible sample configuration, LD measured as the squared correlation 







r  , 
where, 
0000 BABA
pppD   and    ,    ,     and    , are the frequencies of alleles 
A0, A1, B0, and B1, respectively, was calculated.  Subsequently, values of r², 
conditional on marginal allele frequency, were calculated for each ρ value in the set 
by multiplying the calculated r² by the conditional probability of the sample 
configuration.  Finally, the expected r
2
 conditional on the configuration (Ec[r²]), was 
calculated by summing the conditional r² across all possible configurations for each 
given marginal allele frequency and for each ρ value in the set. 
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Figure 5-1 Sample configurations and marginal allele frequencies 
5.2.2.1.2 Summary of linkage disequilibrium 
To evaluate LD in the simulated data, r² was calculated for each pair of loci.  First, 
the map distance between each pair of loci, di, was calculated as the product of the 
base pair distance and the recombination rate per base pair (10
-6
) assuming a linear 
relationship such that 1Mb=1M.  Pairs of loci were then pooled across the thirty 
replicates according to their marginal allele frequencies and the distance between loci 
in 0.001M intervals.  The mean r² within each bin was then calculated.  Pooling 
across repeats was necessary to ensure that sufficient numbers of comparisons were 
placed in each bin to get reliable estimates of r².  Results are presented for pairs of 
loci with the following marginal allele frequencies (A0,B0):  (5, 5), (5, 15), (5, 25), 
(15, 15), (15, 25) and (25, 25).  The observed r² across the range of distances for each 
of the marginal allele frequencies was then compared to its expected value, Ec[r
2
], 
given different values of         .     
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5.2.2.1.3 Estimation of effective population size 
An estimate of Ne was generated for each of the 30 replicates in turn.  For a range of 
Ne values (from 0 to 10,000, with intervals of 10), ρ was calculated as        
    and the value transformed by  (   )⁄ .  Transformation was necessary in order 
that interpolation was always done between two finite values; the set of ρ values in 
the table of conditional probabilities were similarly transformed.  Sample 
configurations for each pair of loci were determined (described with reference to the 
minor allele and assuming the ancestral allele is unknown).  The likelihood of 
observing the sample configuration in question, given the distance between the 
markers and therefore given ρ, was then calculated by linear interpolation from the 
table of conditional probabilities.  Finally, an estimate of Ne for the entire sequence 
was obtained by combining the likelihoods from all pairwise comparisons: 
Equation 5-4    
k
i
ice qNL ;; ik21 nn,......,n,n  
A global estimate of Ne was taken as the value which had the highest composite log 
likelihood.  This estimation procedure was then repeated for marker pairs binned by 
distance between them (in 0.02M intervals), with an Ne estimate generated for each 
bin. 
5.2.2.2 Syntenic linkage disequilibrium (SLD) 
5.2.2.2.1 Summary of linkage disequilibrium  
Taking r² values previously calculated for all marker pairs, a MAF threshold of 0.05 
was applied to the SNPs.  Single-nucleotide polymorphism pairs were again binned 
according to the distance between loci (0.001M intervals), and the mean r² for each 
bin calculated.  This observed r² was compared to its expectation under Equation 5-5 
below, given Ne=200 or Ne=1,000, and a=1 or 2. 
5.2.2.2.2 Estimation of effective population size 
Ne estimates were derived in a deterministic manner from LD (r²) using the approach 
described in Chapters 3 and 4, that is, based on the theoretical relationship between 
LD, distance between markers and Ne [137], such that: 
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Equation 5-5     12 4  dNarE eadj , 
where, the reciprocal of a is the value of 2
adjr  at the intercept of the x-axis, d is the 
distance in Morgans between the SNPs, and   122  Trradj , where T is the number 
of haplotypes sampled (see Chapter 4).  Estimates assuming, a priori, constant Ne 
were derived using the non-linear least squares approach to modelling described in 
4.2.4.2.  The statistical model took the form:   iii ebday 
1
4 , where yi is the 
value of adjusted r² for SNP pair i separated by di Morgans, ei represents the residual, 
a was set to 1 or 2 or estimated iteratively alongside parameter b using least squares.  
The analyses were carried out firstly with a MAF threshold of 0.05 and then with a 
threshold of 0.10 applied to markers prior to analysis (see Chapter 4 for justification). 
Marker pairs were then binned by distance between them (in 0.02M intervals).  For 
each of the bins, the average 2adjr  and average distance, di, between segregating sites 
were calculated.  Ne was then calculated according to Equation 4-4 in Chapter 4, such 
that:       adrEdtN tadjtT   121 |4 , where NT is the effective population size t 
generations ago,   (   )
   [138], dt is the distance between SNPs in Morgans and 
a was set to 1 or 2 (only results for a=2 are presented).        
5.3 Results 
5.3.1 Linkage disequilibrium 
The observed decline of r² with increasing distance between markers was compared 
with the expectation both under Equation 5-5 and using sampling distributions for a 
selection of marginal allele frequencies (Figure 5-2).  The curves of Ec[r²] vary with 
marginal allele frequencies and when marker pairs were partitioned according to 
their marginal allele frequencies the mean observed r² values approximately matched 
the expectation.  The curves of observed r
2
 were smoother when Ne=1,000, than 
when Ne=200.  The curve of mean observed r² values calculated from all marker 
pairs simultaneously did not closely follow the curve of expectation based on 
Equation 5-5 with a=1.  The E(r²) based on Equation 5-5 with a=2 provided a better 
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fit to the observed data.  This data is not shown here but resembled that shown in 
Figure 4-5, in Chapter 4. 
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Figure 5-2 Observed r
2
 (pooled across 30 replicates) (O) and Ec[r
2
] (E) for marker pairs with different marginal allele frequencies. 
a) Ne=1,000; b) Ne=200 
a 
b 
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5.3.2 Composite-likelihood estimator (CLE) 
Ne estimates calculated by the CLE method are shown in Table 5-1 and Figure 5-3.  
The mean (±SD) Ne estimate for the case where the true Ne=1,000 was 977 (±151) 
and for the case where the true Ne=200 was 206 (±39).  The maximum likelihood 
surfaces are shown in Figure 5-4 and curves were found to be distinctly asymmetric.  
A more peaked log likelihood curve was observed when true Ne=200 than when true 
Ne=1,000, indicating a narrower confidence interval. 
When marker pairs were put into 0.02M bins according to the distance between 
them, the most accurate estimates of Ne were calculated from the closest markers.  As 
the distance between markers increased, accuracy decreased and a positive bias was 
observed and this occurred at a faster rate when the true value of Ne=1,000 compared 
to when Ne=200 (Figure 5-5).  The number of marker pairs per bin was similar across 
replicates but decreased linearly with increasing distance, making it a confounding 
factor in the relationship between accuracy of Ne estimates and the distance between 
marker pairs.  Mean Ne estimates remained within 50% of the true value for markers 
up to 0.13M apart when true Ne=1,000 and for markers up to 0.23M apart when true 
Ne=200.  The maximum Ne for which likelihoods were calculated was 10,000 and 
therefore, estimates of 10,000 would have been returned in all instances when the 
most likely Ne was ≥10,000.  Using the harmonic mean eliminated the upward bias 
observed when using the arithmetic mean and the distance between markers was 
large, but did result in a slight underestimation of Ne in the case of the most distant 
markers (Figure 5-6).  
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Table 5-1 Ne estimates by CLE and SLD under various models 
 Ne = 200 Ne = 1,000 
Method Mean [min, max] MSE Mean [min, max] MSE 
CLE 206 [140, 330] 1530 977 [620, 1250] 22567 
SLD: a estimated 
& MAF 0.05 
204 [157, 282] 593 1001 [759, 1187] 7204 
SLD: a estimated 
& MAF 0.10 
152 [134, 236] 2287 876 [696, 991] 20534 
SLD: a = 2 & 
MAF 0.05 
264 [225, 339] 5045 1286 [1124, 1394] 87536 
SLD: a = 2 & 
MAF 0.10 
179 [147, 228] 790 905 [811, 1012] 11979 
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Figure 5-3 Histogram showing the distribution of Ne estimates by the CLE and SLD methods 
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Figure 5-4 Composite log likelihood curves for replicates 1 to 30, scaled such that the maximum 
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Figure 5-5 Estimates of Ne by CLE from marker pairs binned by distance.  Variation at each 
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Figure 5-6 Mean and standard deviation of estimates of Ne by CLE from marker pairs binned 
by distance 
a) Ne=1,000 
b) Ne=200 (truncated at Ne=4,000)  
a 
b 
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5.3.3 Syntenic linkage disequilibrium (SLD) 
Ne estimates calculated by SLD are shown in Table 5-1 and Figure 5-3.  Regardless 
of the actual Ne, the best estimates of Ne, as judged by the smallest MSE, were 
obtained by estimating a and using a MAF threshold of 0.05.  The best Ne estimate 
(±SD) for the case where the true Ne=1,000 was 1,001 (±86) and for the case where 
the true Ne=200 was 204 (±24).  There was a moderate positive correlation between 
Ne estimates by CLE and SLD (r=0.5 for Ne=200; r=0.6 for Ne=1,000, p<0.01), as 
illustrated in Figure 5-7. 
When marker pairs were put into 0.02M bins according to the distance between them 
(Figure 5-8), the most precise estimates of Ne were generally calculated from the 
closest markers, but for both Ne=1,000 and Ne=200, mean estimates were closest to 
the true Ne for markers in bin 1.4-1.6x10
5
, with closer markers yielding 
underestimates.  As the distance between markers increased, accuracy decreased with 
some large positive and negative estimates of Ne being observed.  Mean Ne estimates 
remained within 50% of the true value for markers up to 0.21M apart when true 
Ne=1,000 and for markers up to 0.25M apart when true Ne=200.  By replacing the 
negative Ne estimates with estimates of infinity and averaging across replicates using 
the harmonic mean, more consistent Ne estimates were generated over a longer 
distance (Figure 5-9).    
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Figure 5-7 Relationship between estimates of Ne by CLE and SLD (MAF threshold of 0.05) 
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Figure 5-8 Estimates of Ne by SLD from marker pairs binned by distance.  Variation at each 
distance reflects variability in estimates within distance bins and across the 30 replicates. 
a) Ne=1,000 
b) Ne=200  
a 
b 
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Figure 5-9 Mean and standard deviation of estimates of Ne by SLD from marker pairs binned 
by distance.  For calculation of the harmonic mean, negative Ne estimates were replaced with 
estimates of infinity. 
a) Ne=1,000 
b) Ne=200  
a 
b 
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To the author’s knowledge, this is the first time the CLE method has been applied to 
markers on a chromosome-wide scale.  Using data from all marker pairs, the CLE 
method produced two good mean Ne estimates.  Asymmetric composite likelihood 
curves suggest that the method is less able to discriminate between large and very 
large Ne, than between small and very small Ne.  Furthermore, the method appeared 
to more confidently estimate Ne when the true Ne was 200 than when it was 1,000, as 
evidenced by the more peaked likelihoods in Figure 5-4.  Confidence intervals were 
not estimated because it has been suggested that the non-independence introduced 
into the calculation of coalescent likelihoods means that standard likelihood theory 
cannot be used to estimate uncertainty about point estimates [142, 182].  When CLE 
and SLD estimates are compared, while the mean estimates are similar, in two out of 
four of the scenarios tested, the SLD method was superior when judged according to 
the MSE of the estimates.  This result is somewhat unexpected because according to 
Hudson (2001) [181], maximum likelihood methods should allow the most powerful 
analyses to be carried out on samples with multiple linked sites.  Possible 
explanations for this finding are discussed below.  A moderate positive correlation 
between Ne estimates by the CLE and SLD methods, indicates that they exploit some 
of the same information from the data.   
Both the CLE and SLD methods showed considerable sensitivity to the distance 
between markers.  When SNP pairs were binned according to the distance between 
them, SLD estimates remained within ±50% of the true value for slightly longer than 
CLE estimates.  In the case of the CLE method, Ne estimates became increasingly 
upwardly biased and increasingly variable as the distance between the SNP pairs 
increased and this appears to be due to an increasing number of Ne estimates of 
10,000.  This is the maximum Ne that was tested and therefore these estimates could 
result from monotonically increasing likelihood curves, as described by Hudson 
(2001) [181], or may correspond to Ne estimates of greater than 10,000.  Somewhat 
in contrast, SLD methods simply become extremely variable with increasing distance 
between SNPs and are in some cases negative because the mean r
2
 value for the bin 
is less than the term of adjustment (   1T ).  The rate at which the accuracy of Ne 
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estimates declines over distance depends on the actual Ne of the sample, such that 
when Ne = 200, estimates remain within ±50% for longer.  Therefore, there appears 
to be less information contained in marker pairs that are further apart and in samples 
with a larger Ne.  The number of marker pairs per bin acts as a confounding factor 
because of the linear relationship between distance and number of marker pairs in the 
bin.  Further work that could be done to resolve this issue include: (i) fixing the 
number of marker pairs across the different distance classes; and (ii) investigating the 
impact of the number of marker pairs for a given distance between markers.  
However, for reasons discussed below, this method was not progressed further and 
therefore this was not done. 
Using the harmonic mean to summarise estimates across replicates resulted in mean 
estimates closer to the simulated value in the case of both the CLE and SLD 
estimates.  This approach resulted in Ne estimates becoming increasingly 
downwardly biased with increasing distance between marker pairs.  The combination 
of Ne estimates by the harmonic mean has been used previously by Waples (2005) 
[189] when combining estimates from temporal samples and in reference to this 
work, Russell & Fewster (2009) [190] suggested that the reciprocal property (1/Ne), 
i.e. inbreeding rate, is a more direct driver of evolutionary processes than Ne itself.  
That said, the real problem is to understand on which scale different samples are 
additive, and therefore when it is natural to average.        
The work presented here is a preliminary analysis and as such there are several areas 
within the methodology that would require further consideration should any further 
work be carried out.  The CLE methodology described by Hudson (2001) [181] and 
followed here appears to implicitly assume small c and therefore, there are several 
issues which arise as a result of its application to long chromosome segments in this 
study.  Using the genetic map distance, di, calculated as the product of the base pair 
distance and the recombination rate per base pair, in the calculation of ρ assumes an 
equivalence of map distance and recombination distance which is only valid for 
small c.  Given the use here of marker pairs up to 1M apart, the transformation of di 
according to Haldane’s mapping function before calculating ρ would seem more 
appropriate.  The failure to do this here would be expected to result in the 
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underestimation of Ne when using markers that are far apart.  An additional issue 
relating to the application of the method to long segments relates to the use of the 
downloaded tables of sample probabilities.  These tables contain sample probabilities 
for ρ values ranging from 0 to 120.  In this study, ρ values of up to 40,000 were used 
in calculating the CLE, placing considerable reliance on probabilities calculated via 
interpolation between probabilities for ρ=120 and ρ=∞.  Because this was considered 
to be largely unsatisfactory, considerable time was spent by John Woolliams on 
generating sample probabilities for 120<ρ<∞, following Hudson (1983 & 1985) 
[143, 186].  However, this process revealed potential issues relating to the 
application of the coalescent theory itself.             
Coalescent theory relies on the assumption that n<<Ne [143] and therefore, the 
minimum sample size to Ne ratio of 1:4 used here may not be appropriate.  
Interestingly, having used Hudson’s ms program to simulate a sample where n>Ne, 
Uleberg et al. (2011) [191] stated that they ‘expected the genealogies to still 
resemble those in QTL mapping experiments involving unrelated individuals.’  
However, a more thorough evaluation of the properties of the sample would be 
needed to confirm the suitability of the ms program for simulating large samples 
from populations with small Ne.  In addition, coalescent theory assumes small c [143] 
and so presumably cannot be expected to extend over a chromosome of 1M as 
simulated here; this may have contributed to the bias in Ne estimates observed at long 
distances.  These issues have the potential to affect both the validity of my simulated 
data and the applicability of the sampled probabilities to my data.  Further discussion 
around this point can be found in Woolliams & Corbin (2012) [192], but the 
fundamental question remains, can coalescent theory be used in the current context? 
As pointed out above, the result that greater variation was seen in Ne estimates when 
the CLE method was used was unexpected.  One potential explanation for this was 
that low MAF alleles added noise to the data because of their low information 
content.  However, when a MAF threshold of 0.05 was implemented (as applied in 
the SLD method) and the analysis repeated, no gain in precision was seen (data not 
shown).   This coincides with the results of McVean (2002) [183] who also found 
that the removal of rare variants had little effect on estimates of ρ.  It is also possible 
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that there was either an undetected bug in the computational code, or an error in the 
interpretation of the procedure described by Hudson (2001) [181] to estimate Ne.  
The description of the CLE method provided by Hudson (2001) [181] is somewhat 
complex and therefore the implementation of the method was challenging.  
Considerable effort was put into generating the sample probabilities independently
8
 
in order to check the interpretation of Hudson’s procedure, revealing several 
anomalies in Hudson’s original work.  For example, the method used here to 
calculate the ‘a-d unspecified’ sample probabilities did not include the adjustment by 
π, as described in Hudson’s equation (6), because it was not clear what π represented.     
In conclusion, using Hudson’s CLE method in this case did not lead to a substantial 
increase in accuracy of Ne estimates over the non-linear regression based SLD 
method.  Both methods suffered from a lack of power when linkage between markers 
was relatively loose, that is when the distance between markers was high.  It seems 
likely that the CLE method as described by Hudson (2001) [181] can only usefully 
be applied over short distances.  This, combined with the relative complexity of the 
CLE method when compared to the SLD method, meant that this approach was not 
pursued further in this thesis.      
                                                 
 
8
 Simulation program written by John Woolliams (The Roslin Institute). 
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Chapter 6: The identification of SNPs on the 
Equine SNP50 BeadChip with indeterminate 
positions 
6.1 Introduction 
During The Broad Institute’s Equine Genome Sequencing Project, DNA from a 
single inbred Thoroughbred mare (Twilight) was sequenced to 6.8X coverage, 
producing a high quality draft assembly (for a full description of the assembly 
process see Wade et al. (2009) [23]).  The sequence was generated using a whole 
genome shotgun (WGS) approach which involves the sequencing of many short 
fragments followed by their assembly, first into small groups or contigs, and then 
into larger sections known as supercontigs or scaffolds.  The sequencing of the 
equine genome followed that of the human, mouse and dog and as such benefited 
from lessons learned.  The assembly of the equine genome was done primarily using 
an enhanced version of the ARACHNE software algorithm [193] to align the many 
sequence reads, alongside molecular tools such as Fluorescence In-situ Hybridisation 
(FISH) which were used to assign remaining pieces of sequence [23].  Advantages of 
the WGS approach include its simplicity and ability to produce rapid early coverage 
[194].  In the case of simple genomes with few repeats WGS sequencing produces 
extremely high quality sequences.  However, in the case of more complex genomes 
which contain numerous repeat sequences, the process of contig aggregation is much 
more difficult and therefore assembly errors are more common.  Mammalian 
genomes show this complexity, with 46% of the assembled equine genome sequence 
identified as being repetitive [23].  It was estimated that chromosomal misassignment 
and local mis-ordering affected <0.3% of the initial assembly of the mouse genome 
sequence [194].  The equine genome is similarly complex and a similar proportion of 
errors would translate into 8Mb of incorrect sequence.  Therefore, despite being 
sequenced to relatively high depth (6.8X), the sequence remains a draft and will 
likely continue to be updated for some time as these errors are identified.  In the 
meantime, it serves as an invaluable resource for genomics studies.  
A single-nucleotide polymorphism (SNP) library was compiled during the 
sequencing project.  Whole genome shotgun sequencing is a particularly effective 
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method for detecting sequence variation in tandem with whole-genome assembly 
[195] and SNPs were identified both during the primary sequencing and 
subsequently through the re-sequencing of a number of horses selected on the basis 
of breed diversity.  The correct positioning of these SNPs is dependent on the correct 
assembly of the contigs on which they reside and any assembly errors will be 
reflected in the positioning of these markers.  The content of the Illumina Equine 
SNP50 BeadChip (“SNP chip”) was derived from the resulting EquCab2.0 SNP 
collection and has proved to be a useful tool for equine geneticists worldwide.   
The most common use of the SNP chip to date has been in the hunt for genes 
underlying both simple and complex diseases.  The increased marker density offered 
has enabled both genome-wide association studies (GWAS) with combined linkage 
analyses and simple GWAS to be carried out with some success [65, 66, 196-198].  
In such analyses whilst correct positioning of SNPs is clearly desirable, subsequent 
fine-mapping and re-sequencing work will likely bring to light any issues relating to 
SNP position.  However, other genomic methodologies are much more sensitive to 
SNP order.  The first of these, homozygosity mapping, can be particularly useful 
when attempting to find the gene variants responsible for rare recessive diseases for 
which there is often a paucity of samples available for analysis.  The aim of this 
technique is to identify long stretches of homozygosity present only in the cases 
which may contain the causal mutation, the assumption being that this segment is 
inherited identical-by-descent from a common ancestor carrying the mutation.  In 
this instance, incorrectly positioned SNPs may disrupt runs of homozygosity leading 
to a failure in their identification by algorithms designed to pick up runs of unusual 
length.   Whilst single misplacements may be dealt with by allowing for some errors, 
when lengths of sequence contain more than one misplaced SNP, it becomes 
impossible to differentiate such errors from normal variation.  A second technique 
which is heavily dependent on SNP order is haplotype and phase assignment.  
Increasingly, investigators are expecting genetically derived algorithms to assign 
phase to population data, allowing individuals in the population to be assigned 
haplotypes in place of the diplotypes which are returned from the SNP genotyping 
process.   These haplotypes can then be used both in future analyses, such as 
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haplotype association tests, and in order to impute from low-density SNP panels 
containing so-called tag SNPs to higher densities.  It has been suggested that 
incorrect SNP order could compromise the accuracy of haplotype analysis [199], 
specifically causing the inaccurate estimation of haplotype block size in the region 
with errors [200].       
Whilst there are many molecular methods available to help refine genome sequence 
assemblies, it has been suggested that linkage disequilibrium (LD) analyses may be a 
useful addition to our armoury in resolving SNP order [201, 202].  Khatkar et al. 
(2010) [201] developed a locus ordering procedure based on LD (LODE) in order to 
position unassigned SNPs and scaffolds on the Bos taurus genome, with validation 
work showing that 96.7% of SNPs with a minor allele frequency (MAF) greater than 
0.05 could be positioned with an accuracy of 99.9% and an average precision of 
~1Mb; the same procedure was then used to check existing genome assembly.  
Bohmanova et al. (2010) [202] compared observed LD patterns to expectations 
under genetics’ theory in order both to identify misplaced SNPs and to re-position 
them.    
Previous studies of LD in the horse have shown LD to be moderate within-breed and 
to be particularly high in Thoroughbreds, being maintained above non-syntenic 
levels for up to 20Mb (Chapter 3 and [23]).  In this chapter, LD is used to check 
genome assembly in preparation for work to identify QTL associated with OCD 
(Chapter 7) and work to select SNPs for low-density panels (Chapter 9).  An 
outcome of this chapter is to identify regions of the genome which may benefit from 
further re-sequencing.   
6.2 Materials and methods 
The data for this study comprised all 1,201 available samples (n=853 Thoroughbreds 
from the UK and n=348 Thoroughbreds from the US), genotyped at the 50,707 SNPs 
that passed preliminary quality control (QC).  PLINK [105, 106] was used to 
calculate the squared correlation based on genotypic allele counts; this is identical to 
the r
2
 measure of LD when mating is at random, i.e. assuming genotypic frequencies 
are in Hardy-Weinberg equilibrium (HWE).  However, to denote the distinction in 
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 will be used. Values of rg
2
 were calculated in a pair-wise 
fashion between all SNPs with a MAF≥0.01 (9,997 exclusions made), including 
those on different chromosomes.  The average MAF of the remaining SNPs was 0.26 
(±0.14 SD).  Autosomal SNP pairs with rg
2
>0.25 were retained for further analysis. 
A filter was applied to non-syntenic marker pairs in order to identify all such pairs 
with rg
2
>0.25.  A filter was also applied to syntenic marker pairs, this time to identify 
all SNPs for which the maximum recorded rg
2
 value was with another SNP that was 
>10Mb away in at least one direction.  Previous work has shown that less than 0.5% 
of SNP pairs separated by 10Mb can be expected to exhibit r²>0.25 (Chapter 3).  
This initial analysis uses subjectively chosen thresholds to identify SNPs whose 
location may be incorrect whilst minimising false positives and is consistent with 
Bohmanova et al. (2010) [202].  A second step was taken to validate the regions 
identified through the visualisation of LD structure in Haploview [203] and through 
the examination of comparative maps of Equus caballus chromosomes (ECA) 
against Homo sapiens chromosomes (HSA) using the synteny option in ensemble 
(Ensembl (2012).  Equus caballus. [Online] Available from: 
http://www.ensembl.org/Equus_caballus). 
6.3 Results 
6.3.1 SNPs assigned to the wrong chromosome 
The test for non-syntenic rg
2
>0.25 identified two potential discrepancies.  The first 
involved a single SNP, BIEC2-723147, whose position is given as 232,540 on 
ECA28 but which showed considerable LD with a group of SNPs on ECA10.  This 
SNP had rg
2
>0.25 with a total of 63 SNPs on ECA10 (located between 19,507,420 
and 33,005,513), and was in complete LD with two of these SNPs (BIEC2-111876 
and BIEC2-111538).  Further analysis in Haploview [203] revealed BIEC2-723147 
had rg
2
≤0.002 with its current neighbours on ECA28 up to 1.1Mb away (Figure 6-1) 
and was in greater LD with SNPs in the region identified on ECA10.  BIEC2-723147 
is the second SNP on ECA28 on the SNP chip but in this analysis the first SNP was 
excluded due to monomorphism.  No unusual pattern of synteny was revealed in the 
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region during comparative work; up to 30.6Mb on ECA28 corresponds to HSA12 
and the remainder to HSA22.   
The second discrepancy involved a cluster of SNPs mapped to ECA5 (14,185,421 – 
15,408,157) which showed unusually high LD with many SNPs on ECA19 (6,860 – 
4,114,838).  Further analysis in Haploview [203] showed that the cluster of SNPs 
identified in the primary analysis in fact extended to a SNP at 15,914,852.  White 
regions in the Haploview plot in Figure 6-2a, which are indicative of extremely low 
LD, clearly delineate these SNPs on ECA5 from the rest of the chromosome.  This 
unusual LD structure led me to hypothesise that this group of SNPs currently mapped 
to ECA5 do not belong on this chromosome and may in fact belong on ECA19.  The 
comparative analysis of this region offers further support for this hypothesis.  Figure 
6-2b shows the synteny between horse and human for ECA5.  The centre 
chromosome represents ECA5, and the smaller chromosomes show syntenic regions 
with human sequence (in this case HSA1, 3 and 7).  Blocks are coloured according to 
the human chromosome number and are connected with lines to indicate syntenic 
blocks with either the same orientation (black lines) or with the opposite orientation 
(brown lines).  Figure 6-2b shows that, whilst the majority of ECA5 maps to HSA1, 
the genomic region identified in this analysis corresponds to HSA3.  There is also a 
small section of ECA5 which shows synteny with HSA7.  A similar evaluation of the 
synteny between ECA19 and humans showed a large part of ECA19, including the 
region with which the ECA5 SNP cluster showed LD, corresponds to HSA3 (data 
not shown). 
HWE was examined as a guard against genotyping error; none of the SNPs identified 
in this part of the analysis deviated significantly from HWE (p<0.001), as calculated 
using Plink [105, 106] according to the exact test described by Wigginton et al. 
(2005) [204].  The average MAF of anomalous SNPs by chromosome can be found 
in Table 6-1.   
The application of genomic technologies to the horse 
Chapter 6 The identification of SNPs on the Equine SNP50 BeadChip with indeterminate 
positions  
118 
Table 6-1 MAF of SNPs identified as having rg
2







Mean SD Min Max 
5 20 0.288 0.122 0.096 0.495 
19 44 0.393 0.086 0.150 0.495 
10 63 0.182 0.101 0.073 0.359 
28 1 0.113 NA NA NA 
 
 
Figure 6-1 LD plot of ECA28: 0 – 1,342,640 with r²x10² values shown.  Anomalous SNP, BIEC2-
723147, is circled (plot produced in Haploview [203]).  SNPs 1, 3, 7, and 10 excluded during QC.  
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Figure 6-2 LD and synteny on ECA5 
a) LD plot of ECA5: 13,827,917 – 17,091,141 (plot produced in Haploview [203]); b) Map of ECA5 showing synteny between horse ECA5 and human HSA1, 3 
and 7 (http://www.ensembl.org/Equus_caballus).  Dashed lines indicate correspondence between the two diagrams.
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6.3.2 Within-chromosome discrepancies 
A total of 39 SNP pairs met the criteria for unusual within chromosome LD.  Most of 
the SNPs were on ECA5 (6), ECA7 (11) and ECA8 (6) (see Table 6-2 for full list).  
It should be noted that the SNPs identified in this analysis had a much lower than 
average MAF which may have led to biases in the estimation of rg
2
.  None of the 
SNPs identified deviated significantly from HWE, calculated as described above.  In 
the case of syntenic marker pairs, it is less straightforward to identify the limits of the 
discrepancies using Haploview [203].  However, the LD structure around anomalous 
SNPs was found to display potential irregularities.  As shown for ECA7 and ECA8 in 
Figure 6-3 and Figure 6-4, respectively, some of the areas identified by this analysis 
showed a banding pattern of LD.  In such cases, comparative analysis showed a 
complicated picture of chromosome synteny, exhibiting both intra- and inter-
chromosomal rearrangements when compared to the human genome (Figure 6-3 and 
Figure 6-4).  
  
The application of genomic technologies to the horse 
Chapter 6 The identification of SNPs on the Equine SNP50 BeadChip with indeterminate 
positions  
121 
Table 6-2 SNPs for which the maximum recorded LD value (in at least one direction) was 
rg
2















BIEC2-30677 1 72,451,788 0.02 0.04 BIEC2-25581 62,349,857 
BIEC2-475014 2 41,857,074 0.11 0.65 BIEC2-477849 51,877,913 
BIEC2-477849 2 51,877,913 0.08 0.15 BIEC2-474820 41,239,675 
BIEC2-487672 2 71,430,607 0.11 0.66 BIEC2-493166 82,177,609 
BIEC2-775088 3 27,995,999 0.06 0.79 BIEC2-779131 44,484,312 
BIEC2-779131 3 44,484,312 0.05 1.00 BIEC2-774953 27,229,795 
BIEC2-787064 3 64,658,125 0.11 0.17 BIEC2-781998 53,959,246 
BIEC2-891591 5 10,750,326 0.05 0.24 BIEC2-898063 22,107,371 
BIEC2-898063 5 22,107,371 0.06 0.00 BIEC2-891591 10,750,326 
BIEC2-906263 5 39,300,989 0.17 0.22 BIEC2-908762 51,065,448 
BIEC2-907143 5 41,918,001 0.09 0.72 BIEC2-909281 53,875,750 
BIEC2-907163 5 42,334,840 0.10 0.64 BIEC2-909281 53,875,750 
BIEC2-916364 5 69,429,005 0.15 0.29 BIEC2-910936 57,420,998 
BIEC2-996254 7 38,197,047 0.12 0.41 BIEC2-998369 48,314,947 
BIEC2-996263 7 38,199,984 0.33 0.40 BIEC2-1000225 53,386,780 
BIEC2-996515 7 39,533,116 0.16 1.00 BIEC2-1000179 53,064,035 
BIEC2-996542 7 39,651,243 0.30 0.27 BIEC2-998618 50,594,329 
BIEC2-996583 7 40,036,320 0.10 0.76 BIEC2-998755 51,944,102 
BIEC2-997395 7 47,105,730 0.08 0.70 BIEC2-1002897 57,211,137 
BIEC2-998395 7 48,651,819 0.45 0.42 BIEC2-996153 37,517,778 
BIEC2-998755 7 51,944,102 0.10 0.52 BIEC2-996583 40,036,320 
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BIEC2-1000179 7 53,064,035 0.34 0.17 BIEC2-996491 39,157,011 
BIEC2-1000243 7 53,507,061 0.03 0.65 BIEC2-996624 40,420,239 
BIEC2-1002897 7 57,211,137 0.07 0.83 BIEC2-997395 47,105,730 
BIEC2-1036317 8 21,474,716 0.02 1.00 BIEC2-1043377 33,536,248 
BIEC2-1037747 8 24,686,529 0.06 0.79 BIEC2-1046813 42,900,973 
BIEC2-1041132 8 29,729,387 0.05 0.77 BIEC2-1046803 42,896,634 
BIEC2-1045831 8 38,656,972 0.08 1.00 BIEC2-1039998 27,865,163 
BIEC2-1046803 8 42,896,634 0.03 0.05 BIEC2-1041132 29,729,387 
BIEC2-1047603 8 44,378,683 0.13 0.54 BIEC2-1040198 27,978,277 
BIEC2-1088412 9 37,902,127 0.02 0.36 BIEC2-1092490 48,511,213 
BIEC2-1092490 9 48,511,213 0.03 0.57 BIEC2-1088143 36,940,286 
BIEC2-211410 13 13,096,070 0.05 0.74 BIEC2-202330 543,297 
BIEC2-373784 17 21,903,878 0.01 1.00 BIEC2-375506 34,316,766 
BIEC2-375506 17 34,316,766 0.02 0.47 BIEC2-373784 21,903,878 
BIEC2-410605 18 34,575,897 0.03 0.58 BIEC2-408240 19,674,197 
BIEC2-449520 19 59,892,096 0.06 0.12 BIEC2-444554 49,441,028 
BIEC2-700515 27 3,763,777 0.03 1.00 BIEC2-707051 16,525,618 
BIEC2-706894 27 16,393,229 0.03 1.00 BIEC2-700515 3,763,777 
I
SNPs identified during filtering procedure 
II




Calculated using Plink [105, 106] according to Wigginton et al. (2005) [204]. 
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Figure 6-3 LD and synteny on ECA7. a) LD plot of ECA7: 32,554,745 – 57,862,186 (plot produced in Haploview [203]).  This region contains SNPs from 
ECA7 listed in Table 6-2; b) Map of ECA7 showing synteny between horse ECA7 and human HSA2, 10, 11 and 19 (http://www.ensembl.org/Equus_caballus).  
Dashed lines indicate correspondence between the two diagrams. 
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Figure 6-4 LD and synteny on ECA8. a) LD plot of ECA8: 21,048,394 – 44,982,527 (plot produced in Haploview, [203]).  This region contains SNPs from 
ECA8 listed in Table 6-2; b) Map of ECA8 showing synteny between horse ECA7 and human HSA12, 18 and 22 (http://www.ensembl.org/Equus_caballus).  
Dashed lines indicate correspondence between the two diagrams. 
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This work has demonstrated the use of LD analysis in the evaluation of sequence 
quality.  The evaluation of across chromosome LD identified both a single SNP and a 
group of SNPs likely to represent sequence errors.  Within-chromosome analyses 
revealed several SNPs which demonstrated higher LD with distant SNPs than with 
neighbouring SNPs.  Further interrogation of the chromosome regions containing 
these SNPs revealed both unusual LD structure and complex patterns of synteny.  
Whilst these secondary findings provide some validation for the method used, there 
remains ambiguity about the cause of the genome structure observed. 
In the case of non-syntenic SNPs, high LD between SNPs appears to be a good 
indication that there is an error in the genome assembly.  My results suggest that, 
whilst looking for SNPs mapped to the wrong chromosome, the threshold used to 
identify erroneous SNPs (in this case rg
2
>0.25), is not crucial.  Whilst the threshold 
used here did not pick up all the SNPs within the ambiguous region on ECA5, 
subsequent haplotype analysis helped to define the limits of the region (as illustrated 
in Figure 6-2).  Therefore, provided at least one SNP in the region returns an rg
2
 
value above the threshold, erroneous regions will be found.  Furthermore, 
maintaining a relatively high threshold offers an advantage in terms of computing 
time.  To see genuine LD across chromosomes is extremely unusual and, at the 
current time, there are only a few known (or suspected) causes of across 
chromosome LD [35].  Admixture or migration can cause spurious LD between 
unlinked markers but this quickly dissipates and in any case would be expected to 
affect multiple regions across the genome.  Epistasis between loci has also been 
shown to have the potential to maintain non-syntenic LD at levels that would 
otherwise not be seen under free recombination [205].  However, the pattern of non-
syntenic LD observed here does not seem to fit either of these scenarios. 
Further investigation based on the synteny map shown in Figure 6-2b shows that, 
whilst the majority of ECA5 aligns to HSA1, there are two small regions that do not, 
one aligning to ECA7 and the other to ECA3.  Interestingly, my analysis identified 
only the region aligning to ECA3 as being potentially erroneous.  Zoo-FISH analysis 
has shown that many of the meta/submetacentric chromosomes (1-13) do indeed 
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exhibit such breakages in synteny conservation as a result of interchromsomal re-
shuffling, including in some cases within-arm breakages [206].  Therefore, the 
apparent discrepancy in synteny shown cannot be considered confirmation of a 
sequencing error.  Even the fact that in the zoo-FISH analysis ECA5 showed whole 
chromosome conservation with HSA1 [206] cannot be considered conclusive since 
segments smaller than 5-7Mb are usually difficult to detect through cross-species 
chromosome painting [207].  However, in this instance, confirmation was possible 
through discussions with a principal member of the Horse Genome Project who 
confirmed that the region I had identified on ECA5, had indeed been the subject of 
an assembly error which resulted in a section of the centromeric portion of ECA19 
being incorrectly placed on ECA5 (C. M. Wade 2011, Pers. Comm.).  Therefore, the 
independent discovery of this error shows the potential utility of this approach.    
Being within the first 300kb of ECA28, the genomic region containing the single 
SNP identified on ECA28 as being potentially mapped to the wrong chromosome is 
at relatively high risk of being incorrectly assembled, with sequence coverage 
tending to be lower at the ends of chromosomes.  The scarcity of markers in this 
region makes confirmation of the finding and further evaluation of the extent of the 
error problematic.  The implication of this is that the potential discrepancy in the 
sequence will only be resolved with further sequencing.    
In the case of SNPs showing unusual LD patterns within a chromosome, it is much 
more challenging to differentiate between likely sequence error and simply unusual 
LD.  Suitable distance thresholds for the identification of erroneous SNPs are 
difficult to decide on but presumably should be based to some extent on expectation 
in order to identify unusual patterns of LD.  However, unusual LD could be 
considered an expectation in itself.  Whilst theoretically, LD decays with time and 
distance, such that   01 DrD
t
t  , where D0 is the extent of disequilibrium at some 
starting point and Dt is the extent of disequilibrium t generations later, this equation 
poorly represents the behaviour of LD over short distances [35] and it has been 
estimated from human data that, for relatively short distances (<5Mb), only 45% of 
variation in disequilibrium measures can be explained by physical distance [208].  
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Consequently, although a trend towards decreasing disequilibrium with increasing 
distance is observed (as shown in Chapters 3 and 4), significant variability exists as 
illustrated by the evaluation of LD in small regions [208, 209] and by looking at r
2
 
distributions produced from genome-wide data (Chapter 3, Figure 3-2).  Factors (in 
addition to mutation and recombination) which have been shown to contribute to the 
extent and distribution of disequilibrium include demographic factors and natural 
selection (see Ardlie et al. (2002) [35] for a full discussion).  In this instance, a 
relatively conservative distance threshold for unusually high LD of 10Mb was used; 
this allowed me to pick up the most extreme cases, whilst limiting the number of 
false positives (i.e. SNPs that are correctly positioned but demonstrate unusual 
patterns of LD) and ensuring a manageable number of SNPs for follow-up.  
Lowering the distance threshold would inevitably have led to more SNPs being 
identified, increasing the risk of finding false positives and leaving a long list of 
potential problem areas requiring further investigation.   
Unlike the non-syntenic case, visualisation of the problem area does not seem to help 
define its limits.  Furthermore, whilst both the banding patterns shown in the LD 
plots and the complex pattern of synteny (Figure 6-3 and Figure 6-4) for the areas of 
ECA7 and ECA8 identified in the syntenic analysis, support the finding of unusual 
LD, neither help us to resolve easily the source of the LD structure.  Therefore, 
whilst incorrect sequence assembly is one explanation, it is also possible that 
relatively recent intrachromosomal rearrangements, known to occur within species, 
could be responsible.  The correspondence between patterns of LD and synteny, as 
shown in Figure 6-3 and Figure 6-4 for ECA7 and ECA8 respectively, is in some 
cases as expected.  For example, in Figure 6-3, a block of high LD corresponds 
approximately with a block of the chromosome marked on the synteny map as 
corresponding to HSA19.  However, in other cases, more unexpected patterns can be 
seen, for example in the same figure, banding patterns show relatively high LD 
between SNPs in two non-adjacent regions that align to two different human 
chromosomes (HSA19 and HSA11).  Overall, the interpretation of my results based 
on synteny between horse and human chromosomes is dependent on the human 
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genome sequence being correct, but, this seems a fair assumption to make given the 
extent of the work that has been done in compiling this sequence.             
Given our inability to resolve the issue of causality, particularly in the case of 
unusual syntenic LD, how useful is this method in identifying misplaced SNPs?  My 
results have demonstrated that LD can be used to identify SNPs, and therefore 
regions of sequence, which have been assigned to the wrong chromosome during the 
assembly process.  These SNPs can then be excluded for analyses for which SNP 
order is important, e.g. homozygosity mapping.  In the case of GWAS or similar 
QTL mapping studies, such SNPs need not be excluded from the analysis since 
association statistics are not generally affected by SNP order.  However, it must be 
borne in mind that patterns of association observed in, for example, the commonly 
used Manhattan plot might be disrupted in areas containing incorrectly positioned 
markers.  Furthermore, should any of the incorrectly positioned SNPs be identified as 
associated with the phenotype, assurance would be needed that the search for 
candidate genes and other functional genome components was conducted in the 
relevant region.  In the long term, focussed re-sequencing of the regions concerned 
would presumably enable contigs to be confidently re-assigned to their correct 
position.   
The lack of clarity in the syntenic case limits the usefulness of this approach in 
identifying SNPs that should be excluded from future analysis.  Many of the SNPs 
identified as showing unusual patterns of LD had a low MAF and this result 
correlates with the findings of Khatkar et al. (2010) [201] who saw a dramatic 
decrease in the number of SNPs that could be positioned by LODE (their procedure 
for placing SNPs according to LD) when the MAF of SNP was <0.05.  The impact of 
these SNPs on most analyses will likely be limited, with nearly one third of the SNPs 
in Table 6-2 having MAF <0.05, a commonly used exclusion threshold.    However, 
remaining incorrectly positioned SNPs would still have the potential to disrupt 
analyses such as homozygosity mapping.  The impact of incorrectly positioned SNPs 
during tag SNP selection can be limited by imposing a constraint on distance, such 
that SNPs cannot be picked as tags for other SNPs if they are greater than a defined 
distance away, regardless of the LD shown.                
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An alternative to simply identifying erroneous SNPs for exclusion might be to 
attempt to re-position SNPs using LD.  However, in this case, the emphasis must be 
on the re-ordering of contigs and scaffolds, rather than the re-ordering of SNPs per 
se.  Whilst SNPs and other markers allow the visualisation of sequence error, simply 
re-positioning SNP loci in isolation using LD would not address the sequence errors 
within the assembly itself and would leave SNPs disassociated from surrounding 
sequence.  This represents an undesirable outcome when performing, for example, 
GWAS where regions surrounding associated SNPs are searched for candidate genes.  
For this reason, the re-positioning of SNPs according to LD, as suggested by 
Bohmanova et al. (2010) [202], would seem to have limited utility in the long term.  
Furthermore, patterns of LD are extremely variable, particularly over short distances, 
and therefore whilst it is possible to hypothesise the general location of SNPs using 
LD analyses such as those performed here, it seems unwise to attempt to definitively 
reposition them in this way.  For example, since BIEC2-723147 (currently mapped to 
ECA28) exhibited complete LD with two SNPs on ECA10 which were separated by 
more than 2Mb containing 37 SNPs, re-positioning this particular SNP next to the 
SNP with which it exhibits the highest LD was neither possible nor desirable.  It 
seems likely that only further molecular analysis will allow potential sequence errors 
to be completely resolved.           
The methods used in this study are a step towards identifying and resolving errors in 
the equine genome sequence.  The ability to prioritise specific regions of the genome 
for re-sequencing in this way may prove to be more important in species, such as the 
horse, for which resources are much more limited than in humans.  With next 
generation sequencing making possible the sequencing of longer reads, it is likely 
that errors associated with incorrect contig assembly will be reduced in the future.  In 
the meantime, this work serves as a reminder that the current version of the equine 
genome sequence remains a draft, and researchers should be aware that some SNPs 
on the Illumina Equine SNP50 BeadChip may be misplaced. 
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Chapter 7: A genome-wide association study of 
osteochondritis dissecans in the Thoroughbred 
7.1 Introduction 
Osteochondrosis (OC) is a disease of the locomotory system which affects the joints 
of many animals, most frequently being observed in pigs, horses and dogs.  
Osteochondrosis can be described as a focal disturbance of endochondral ossification 
[68] that occurs in young, growing individuals and as such has been classified as a 
developmental orthopaedic disease.  A more detailed description of OC can be found 
in 1.3.1.  Prevalence estimates for OC vary widely, ranging from 3% (stifle OC in 
Thoroughbreds [210]) to 70% (estimates for all joints in Dutch Warmbloods [69]).  
A large proportion of this variation is attributable to differences in the type and 
number of anatomical locations examined, differences in the specific manifestation 
of the disease considered and breed differences (see 1.3.4) [69, 77, 88, 211].  A 
recent prevalence estimate of 25% for the Thoroughbred [76] appears typical.  This 
relatively high disease prevalence, along with the likely contribution of OC to the 
predominance of lameness as a cause of wastage in young horses [212, 213], makes 
OC a high priority for study. 
Whilst there exists both experimental and anecdotal evidence of a genetic component 
to OC, the aetiopathogenesis of the disease is not fully understood [68].  The disease 
is considered multifactorial in origin with at least some evidence of both 
environmental factors, for example nutrition, and physiological factors, such as 
growth and body size, endocrine factors and conformation, which may themselves be 
mediated through genetics, playing a role in the condition [75, 76, 109].  Low to 
moderate estimates of heritability for OC across a range of breeds and disease 
manifestations [77, 80, 86-88] together with between breed differences in prevalence 
[76] indicate that genetic variability exists in disease susceptibility.  Typical values 
for OC scored as a single binary trait (all joints combined) are 0.10 to 0.20 [77, 86] 
but heritability estimates of up to 0.5 have been reported for individual joints [214]. 
The search for markers to explain the proposed genetic variance in susceptibility to 
OC began several years ago, with the intention both of enhancing our understanding 
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of the condition and of enabling marker assisted selection (MAS).  Early studies 
using primarily linkage based analyses (dependent on family data), to detect regions 
of the genome associated with OC in the horse have identified several putative 
quantitative trait loci (QTL) [97, 98].  As is typical for QTL discovered using this 
approach, their effects are generally large but their locations are imprecise.  Whilst 
several of these QTL have undergone further refinement, few if any have been 
validated in independent data sets.  Similar studies in pigs have revealed few [215] or 
no [216] QTL for OC.  These results illustrate the difficulty in identifying truly 
associated regions for complex traits using linkage analysis. 
The opportunity for QTL studies in horses has recently been advanced by the 
publication of the equine genome sequence [23] together with the release of the 
Illumina Equine SNP50 BeadChip, which has allowed the implementation of 
genome-wide association studies (GWAS).  In contrast to linkage analysis, GWAS 
rely on samples of individuals, which may be unrelated, genotyped at medium to 
high density.  It is expected that this approach will allow the identification of 
common variants which could not be found using the traditional linkage based 
approach [40].  I am aware of four GWAS for OC that have been carried out in three 
different horse breeds to date:  Lampe (2009) [99] and Komm (2010) [100] (using 
the same data), Teyssèdre et al. (2011) [101] and Lykkjen et al. (2010) [102].  The 
number of QTL identified per study ranges from four [102] to 18 [99] with the range 
likely at least partly attributable both to differences in significance thresholds used 
and to differing phenotype definitions.  Three putative correspondences between 
QTL have been described (see 1.3.5).   
This study demonstrates the use of clinical observations as a source of data for use in 
genomic studies and is the first QTL mapping study for OC to be conducted in the 
Thoroughbred.  A GWAS was performed on 348 samples using the Illumina Equine 
SNP50 BeadChip to identify loci associated with OCD in the Thoroughbred.  In 
addition, QTL for OC previously identified in a Hanoverian Warmblood (HWB) 
population were tested for their effect in the current data set. 
The application of genomic technologies to the horse 
Chapter 7 A genome-wide association study of osteochondritis dissecans in the Thoroughbred  132 
7.2 Materials and methods 
The data for this study comprised the OC samples that were sourced in the US 
(n=348 Thoroughbreds from the US), genotyped at the 50,707 SNPs that passed 
preliminary quality control (QC). 
7.2.1 Quality control 
Quality control for this study was carried out in GenABEL [217].  Firstly, samples 
were checked for sex discrepancies (marker-based prediction of sex versus sample 
label) and intermediate X-chromosomal inbreeding (0.2<F<0.8), with exclusions 
being made on the basis of suspected sampling or genotyping errors.  This process 
resulted in two exclusions due to sex discrepancy and 16 exclusions based on 
indeterminate sex as demonstrated by intermediate inbreeding, leaving 168 controls 
and 162 cases for further analysis.  Further, 30 SNPs were excluded on the basis that 
they were positioned on the X chromosome but were likely autosomal. 
For the GWAS (see below) the following thresholds were used for excluding data:  
minor allele frequency <0.05, >5% missing genotypes per SNP, >5% missing SNPs 
per sample and differential proportions of missing SNPs between cases and controls 
(p<0.05).  No exclusions were made on the basis of Hardy-Weinberg equilibrium 
(HWE).  
For construction of a kinship matrix (see below), a subset of markers meeting more 
stringent QC was chosen as recommended by Yang et al. (2011) [218] with 
exclusions made as follows:  minor allele frequency <0.10, >0.5% missing genotypes 
per SNP, >1% missing genotypes per sample and HWE (p<0.05). 
7.2.2 Mixed model analysis 
Binary case/control phenotypes were adjusted for fixed and random effects using the 
following linear mixed model in ASReml [219].  A single categorical fixed effect 
was fitted which represents the division of samples into contemporary groups 
relating to the three most common reasons for surgery, other than OC, listed in Table 
7-1 (angular limb deformities (ALD), fetlock chip(s) and sesamoid fracture(s)) and 
sex, resulting in 2
3
 x 2 = 16 classes in total, 11 of which contained observations in 
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the final analysis (see 2.4 and A.iii for further details).  A single random effect, 
animal, was fitted generating an individual animal model [220] in which the pedigree 
relationship matrix was replaced with a genomic kinship matrix in order to adjust for 
average allele sharing among sampled horses.  Autosomal markers remaining after 
QC were used to generate the kinship matrix as follows:  
  













, , where summation is across SNPs (k=1,N), xik  is a 
genotype of the i
th
 horse at the k
th
 SNP coded as 0, ½, 1 and pk is the frequency of the 
allele that is homozygous for the genotype coded as 1 [217].  On the diagonal, 
 iii ff  15.0, , where fi is the loss (or gain) of heterozygosity relative to the 
expectation.  The kinship matrix describes the average relatedness between 
individuals and therefore controls for genetic stratification likely to be present in the 
sample.  The transformation of the kinship matrix into a distance matrix followed by 
a multi-dimensional scaling (MDS) analysis [140, 221, 222], also allowed data to be 
inspected for the presence of outliers and substructure.  Multi-dimensional scaling 
plots based on the first two principal components were considered with respect to 
farm of origin (see 2.5), sex and contemporary group.  Following the implementation 
of the mixed model, a vector of approximately normally distributed (N(0,1)) residual 
errors replaced the binary (0,1) observation as the phenotype for testing in the 
GWAS.        
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Table 7-1 A description of conditions (other than OC) for which horses were treated.  For 
further information, see 2.4. 
 
Condition 
No. of affected 
Cases Controls Total 
Angular limb deformity (ALD) 38 90 128 
Fetlock chip(s) 36 71 107 
Other chip(s) 3 3 6 
Sesamoid fracture(s) 8 23 31 
Other – bone related 4 1 5 
Other – not bone related 7 3 10 
  
7.2.3 Genome-wide association study 
The GWAS was performed in GenABEL [217] using a score test for a Gaussian 
distributed trait and no covariates [223].  A genome-wide significance level was 
calculated by performing 10,000 permutations of the residual phenotypes against 
genotypes.  Permutations were carried out within sex, and the 5% significance level 
empirically determined.  Confirmation of the effects of SNPs found to be significant 
by this approach was carried out by fitting all such SNP genotypes (coded as 0, 1, 2) 
simultaneously as fixed effects in the original mixed model. 
7.2.4 Evaluation of ECA3 haplotype blocks 
A case/control haplotype association test (no covariates) with 10,000 permutations 
was performed in Haploview [203] for a 2Mb region containing a putative QTL 
identified in the single SNP GWAS described above.  Haplotypes (determined by the 
default algorithm based on confidence intervals [224]) were tested for association 
with OCD status using a chi-squared test, with each haplotype configuration 
observed being tested in turn, generating a single test statistic per haplotype.  This 
preliminary analysis was performed to supplement the single SNP GWAS after it had 
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been published.  Unfortunately, time limitations meant that the next step of the 
analysis, which would have been incorporating the fixed effect of contemporary 
group, was not completed.             
7.2.5 Testing previously published quantitative trait loci 
Single-nucleotide polymorphisms selected to represent OC QTL detected in other 
studies were also tested by fitting them simultaneously as fixed effects in the mixed 
model.  The QTL regions tested were based on GWAS results published in Lampe 
(2009) [99] and Komm (2010) [100].  These studies were performed on samples 
from HWB horses and it has been shown in a reference sample of more than 150,000 
horses that the Thoroughbred contributes nearly 35% of this breed’s genes [225].  
Whilst these studies examined a range of OC phenotypes, I tested only QTL relevant 
to OC or OCD with fetlock and hock cases combined, as here (see Table A-4 for a 
list of QTL).  Where SNP names or precise SNP locations were provided, the exact 
SNP was fitted in the mixed model with the exception of one case where the SNP 
was not typed in my sample, in this case the closest SNP was fitted in the mixed 
model (type A in Table A-4).  In cases where only an approximate location was 
given, i.e. to the nearest 0.1Mb, current GWAS results for the region 1Mb upstream 
and 1Mb downstream were examined and the SNP with the smallest p-value fitted in 
the mixed model (type B in Table A-4).  Finally, in cases where several SNPs within 
a region were listed as being significant, the same range was searched in the current 
GWAS analysis and the SNP with the smallest p-value fitted in the mixed model 
(type C and D in Table A-4).  In order to assess their ability to enhance the model, all 
SNPs representing QTL were fitted simultaneously in the mixed model alongside 
contemporary group, SNPs found to be significant in the current GWAS and the 
genomic kinship matrix. 
7.3 Results 
7.3.1 Mixed model analysis 
The genomic kinship matrix was calculated based on 30,554 autosomal SNPs that 
passed the stringent QC thresholds.  The distribution of kinships between individuals 
in the sample is shown in Figure 7-1.  Multidimensional scaling plots revealed no 
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obvious outliers or any genetic substructure relating to factors such as farm or 
contemporary group (data not shown).  The fitting of a genomic relationship matrix 
(calculated by doubling the kinship matrix) in the mixed model resulted in an 
extremely small estimated genetic variance component (<10
-6
) making it impossible 
to estimate trait heritability with any precision; estimates of random animal effects 
(estimated additive breeding values) were correspondingly small.  The residuals 
generated for testing in the association study were influenced primarily by 
contemporary group and their distribution can be seen in Figure 7-2.           
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Figure 7-1 Distribution of genomic kinship between pairs of horses 
 
Figure 7-2 Distribution of residuals from mixed model analysis  
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7.3.2 Genome-wide association study 
Following QC, 40,180 SNPs were tested for association; the mean minor allele 
frequency of remaining SNPs was 0.28 and the distribution of minor allele 
frequencies was approximately uniform.  Based on empirical genome-wide 
significance (p<2.91x10
-6
), a single SNP was found to be significantly associated 
with OCD as tested using residuals from the mixed model.  This was SNP BIEC2-
799865 located at 88,493,417bp on ECA3; this SNP has alleles C and T with a minor 
allele frequency (T) of 0.4 and conforms to a HWE genotype distribution (see Table 
7-2 for genotype frequencies).  Figure 7-3 shows a Manhattan plot of SNPs on 
ECA3.  A haplotype block analysis of the region containing BIEC2-799865 revealed 
somewhat erratic linkage disequilibrium (LD) structure surrounding the SNP making 
the definition of an associated QTL region problematical (Figure 7-4).  The apparent 
deviation from the expectation of decreasing LD with increasing distance between 
markers exhibited by BIEC2-799865 and its neighbours goes someway to explaining 
why this SNP stands apart from surrounding SNPs in Figure 7-3.  With SNPs 
exhibiting r² [105, 106] with BIEC2-799865 of greater than 0.10 at distances up to 
10Mb, I extended my search for other potentially associated SNPs within this range.  
A further four SNPs within 10Mb of BIEC2-799865 had p<0.001; two of these SNPs 
(BIEC2-799867 and BIEC2-799905) had r² of 0.45 – 0.55 with and were within 3 
SNPs of BIEC2-799865 (see Figure 7-4), with the remainder being >4Mb away and 
having r²<0.10.  All four SNPs were located to the right of BIEC2-799865. 
Fitting BIEC2-799865 as an additional covariate in the mixed model resulted in an 
estimated additive effect of -0.16 (±0.03), i.e. for every T allele an individual carries 
at the locus, that individual’s probability of OCD is decreased by 0.16.  This allows a 
crude estimate of the contribution of this SNP to the overall phenotypic variance to 
be made.  Under the assumption of no dominance or interaction effects and using 
  212 ppVA   [124] where p is allele frequency at the locus and α is the 
estimated SNP effect, BIEC2-799865 explains ~5% of the variance of OCD.  The 
effect of BIEC2-799865 remained significant even when contemporary group was 
removed from the mixed model.  Fitting the additional four SNPs with p<0.001 
alongside contemporary group and BIEC2-799865 resulted in both BIEC2-799865 
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and one of the more distant SNPs (BIEC2-802230), having regression coefficients 
significantly different from zero. 
7.3.3 Evaluation of ECA3 haplotype blocks 
The 2Mb region surrounding BIEC2-799865 (1Mb up and down) contained 4 
haplotype blocks as determined by the LD based algorithm of Gabriel et al. (2002) 
[224]; 24 of the 32 SNPs in the region were contained within one of these haplotype 
blocks (Figure 7-4).  The mean number of haplotypes per block (with a frequency 
>0.01) was 4.5 (range 3 to 7) and the mean number of SNPs per block was 6.0 (range 
4 to 10).  A single haplotype in the fourth haplotype block (CCGATTAACC) had 
p<0.10, suggesting a possible association with OCD status.   
7.3.4 Testing previously published quantitative trait loci 
For each of the 24 QTL regions listed in Table A-4, a representative SNP was added 
to the mixed model containing contemporary group, BIEC2-799865 and the random 
effect of animal so that all SNPs were analysed simultaneously.  This analysis 
resulted in only two of the 24 SNPs having a significant association with OCD.  
These SNPs were BIEC2-859811 on ECA4 (39,852,072bp), representing a QTL at 
39.26Mb (Table A-4, QTL no. 8) [100] and BIEC2-410967 on ECA18 (36,772,271), 
representing a QTL between 36,408,881bp and 38,738,316bp [99] (Table A-4, QTL 
no. 16).  BIEC2-799865 remained significant when fitted alongside the 24 QTL 
SNPs albeit with a slightly reduced size of effect (-0.11).       
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Table 7-2 Genotype frequencies of BIEC2-799865 and results of chi-square tests for association 
with OCD 
 Genotype 






C/C C/T T/T 
Controls 0.26 0.55 0.19 168  
Cases
II 
0.44 0.46 0.10 162 0.002 
Hock cases 0.42 0.46 0.12 89 0.034 
Stifle cases 0.48 0.44 0.08 50 0.008 
Fetlock cases 0.44 0.46 0.10 41 0.062 
I
The chi-square tests compare each case category with the controls. 
II
Note, the number of cases is not equal to the sum of the cases in each joint location because 
some horses were affected in multiple joint locations. 
 
Figure 7-3 A Manhattan plot showing association results for ECA3.  The black line represents 
the genome-wide significance level and the grey line represents the significance level used to 
identify surrounding SNPs with possible relevance.
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Figure 7-4 LD plot [203] of ECA3 region 1Mb either side of BIEC2-799865 (solid line, black circle).  SNPs within the UGDH gene are indicated by a white 
circle.  SNPs with a p<0.001 in the GWAS are indicated by a dashed circle.  Marked haplotype blocks calculated according to Gabriel et al. (2002) [224]. 
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7.4 Discussion 
This GWAS in the Thoroughbred revealed a single SNP, BIEC2-799865 on ECA3, 
to be associated with OCD at a genome-wide level of significance when tested using 
the residuals from a mixed model analysis.  Population genetics theory allows us to 
predict that, assuming the heritability for OCD is 0.15, this QTL accounts for ~34% 
of the genetic variation of the trait.  However, effect estimates based on primary 
GWAS data have been shown to be upwardly biased, often to a large degree [226] 
and so a majority of the genetic variance underlying OCD remains to be captured.  
Two neighbouring SNPs showed an association with OCD which approached 
significance (p<0.001); the relatively lower MAF of these SNPs (0.27 and 0.25) 
compared to that of BIEC2-799865 (0.4) may explain their failure to reach genome-
wide significance.  The lack of LD around BIEC2-799865, means that the much 
sought after and characteristic GWAS peak is not observed in this case. 
There are several reasons for considering haplotypes as well as individual SNPs 
when searching for variants associated with disease risk and Clark (2004) [227] 
discusses this in detail.  Most importantly, haplotypes represent more accurately the 
units of inheritance and testing haplotype associations is an efficient way of 
exploring interactions between SNPs [92].  For instance, in cases where an 
associated SNP appears on several haplotypes, one of which is strongly associated 
with disease, haplotype analysis will result in a more significant result.  Here, 
haplotype analysis was also intended to guide selection of a region for the 
investigation of candidate genes.  Whilst in this analysis BIEC2-799865 was found to 
lie between haplotype blocks, four blocks were identified within 1Mb of the SNP.  
One of the seven haplotypes observed in the fourth block (containing the two 
aforementioned neighbouring SNPs) was associated with OCD status at a suggestive 
level of significance (p<0.10), but, the single SNP association tests for BIEC2-
799865, BIEC2-799867 and BIEC2-799905 (under the same model) showed greater 
significance.  Whilst this could be an indication that, in this instance, there was little 
to be gained by considering haplotypes, it could also be due to the fact that 
contemporary group was not fitted in the haplotype model; this would need to be 
done to confirm this result.  Genotyping additional markers in the region may help to 
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resolve haplotype block structure in the immediate vicinity of BIEC2-799865 in the 
future.  Whilst the implication of these results on the validity of the association is not 
clear, it does impact on my ability to precisely define a corresponding QTL region 
for further evaluation.  For the purposes of candidate gene discovery I chose to 
examine the region 1Mb either side of the SNP.                    
The 2Mb window surrounding BIEC2-799865 contained 22 labelled genes, 21 of 
which are described as protein coding and one of which is labelled as a pseudo gene.  
Whilst according to the current annotation BIEC2-799865 lies between genes, 
LOC100064680 located at 88,494,283 - 88,511,285bp, contains (within an intron) 
BIEC2-799867; this SNP is adjacent to and most highly correlated with BIEC2-
799865 and falls within haplotype block 4.  This gene is described as being similar to 
basic kruppel like factor and studies in mice and C.elegans show orthologues to this 
gene, kruppel-like factor 3 (basic) (KLF3), to be involved in adipogenesis [228, 229].  
More generally, KLFs have been described as DNA binding transcriptional 
regulators that play diverse roles during differentiation and development [230].  
Whilst the likely function of KLF3 does not preclude its relevance, there is no 
evidence of a direct role for this gene in OC.  This was true of most of the genes 
located within the QTL region defined, with the exception of UDP-glucose 
dehydrogenase (UGDH). 
The UGDH gene (located at 87,818,121 – 87,843,937bp) appears to function in the 
regulation of glycosaminoglycan (GAG) synthesis in cells lining the articular 
cartilage surface [231].  These GAGs are involved in extra-cellular matrix integrity, 
playing a crucial role in chondrogenesis, homeostasis and compressive resilience 
[231].  A potential link between GAGs and OC has been demonstrated by the 
observation of differential levels of GAGs in osteochondritic lesions versus healthy 
cartilage [232, 233].  However, the direction of causality is not clear and several 
other studies have observed no significant difference [234, 235].  Two SNPs located 
within introns of UGDH were not significantly associated with OCD (0.05< p<0.10) 
and nor were any of the haplotypes in block 1 (Figure 7-4).  One of the SNPs did, 
however, show moderate LD (r²=0.1–0.2) with BIEC2-799865 and the two 
neighbouring SNPs mentioned above; as before, the relatively lower MAF of this 
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SNP (0.34) may have prevented it from appearing above the background in terms of 
significance.  The second SNP in UGDH had a MAF of 0.06 and therefore provides 
little information about either association or LD.  Whilst the distance of the UGDH 
gene from BIEC2-799865 and the relatively low LD in the region lead me to 
question its relevance, there are likely to be many untyped variants in this region, 
some of which could plausibly have stronger LD with BIEC2-799865.   
Four previous GWAS for OC in the horse have also identified QTL on ECA3 [99, 
100, 102, 236].  The closest to BIEC2-799865 was presented recently in a study 
carried out in French Trotters and is located at 100-110Mb [101].  The relatively 
close proximity of the two QTL represents some correspondence between studies.  
However, with average LD at this distance (~12Mb) being r²<0.02 (Chapter 3), it is 
also possible that these QTL represent two different underlying genetic variants.   
Adding SNPs to represent previously identified QTL to the model (which included 
BIEC2-799865) resulted in two out of 24 SNPs tested having regression coefficients 
significantly different from zero (p<0.05) and therefore showing the potential to 
enhance the fit of the model.  On ECA4, BIEC2-859811 (39,852,072bp) had a 
regression coefficient of -0.102 (±0.049).  Komm (2010) [100] identified six 
candidate genes located between 37.1Mb and 44.7Mb.  On ECA18, BIEC2-410967 
(36,772,271bp) had an estimated effect size of -0.085 (±0.042).  Lampe (2009) [99] 
identified three candidate genes in the vicinity of the QTL corresponding to this 
SNP.  These apparent validations should however be viewed with caution since 
adjustments to the mixed model, for example the removal of BIEC2-799865, lead to 
different QTL being significant and I was therefore unable to unambiguously 
confirm any of the previous QTL in the current dataset.  
There are several reasons for the poor correspondence between QTL studies of OC in 
the horse.  Firstly, the QTL which have been identified to date may be false positives 
[42].  Alternatively, subsequent studies may have been underpowered to detect them.  
In this case, such results may be due to, for example, differences in phenotypic 
definition or population ancestry.  Ideally, replication studies should involve 
precisely the same allele or haplotype, the same phenotype and the same genetic 
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model as the original signal [237].  In this study, by testing only the QTL regions 
associated with OC under the combined phenotype definition (hock and fetlock) used 
by Lampe (2009) [99] and Komm (2009) [100], the difference in phenotypic 
definition between the three studies was minimised.   
Another reason for the lack of correspondence may be breed differences.  Hamann et 
al. (2008) [225] estimated that 35% of the HWB genes came from Thoroughbred 
lines, but it is not known what the proportion was in the Komm (2010) [100] and 
Lampe (2009) [99] sample of 154 foals.  Assuming the same QTL are controlling the 
genetic predisposition to OC in both breeds, differences in allele and haplotype 
frequencies between breeds will impact on the proportion of variance the QTL 
explain and therefore on our ability to detect them.  Furthermore, with no 
standardised method either for reporting QTL, or for carrying out validation studies, 
the approach taken here to select SNPs for testing in the mixed model, was largely 
subjective and I may have missed more appropriate SNPs.   
Despite being one of the largest GWAS of OC in horses performed to date, the 
principal limitation of this study remains a lack of power.  This lack of power is 
evidenced by both the low number of genome-wide significant SNPs and the very 
small estimated genetic component.  Whilst disappointing, the inability to estimate 
heritability in this sample is perhaps not surprising given the relatively large standard 
errors which accompany some of the heritability estimates for OC to date [77, 86].  
Furthermore, my findings do not necessarily rule out a non-zero heritability, rather 
more data is needed to produce a reliable estimate.   
The explanation for the apparent low power of this study is likely to be multifaceted.  
Firstly, since power is directly related to sample size, the relatively small number of 
horses genotyped for this study will have limited the number of identifiable QTL, as 
shown by power calculations of, for example, Wang et al. (2005) [48].  Secondly, 
phenotypic definition can play an important role in determining the power of GWAS 
of complex diseases.  Optimal phenotypic definitions are those with strict inclusion 
criteria, with minimising genetic heterogeneity between cases being a useful way of 
increasing study power [42].  Unfortunately, OC represents a clinically complex 
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phenotype, affecting multiple joints and predilection sites within joints, as well as 
appearing in a variety of different forms.  Just as prevalence and heritability 
estimates for OC have been affected by this problem, so we can expect QTL 
mapping studies to be.  In this study, by considering exclusively those cases with 
fragments present (OCD), the genetic heterogeneity of the cases has been reduced 
and recommendations by van Grevenhof et al. (2009) [87] that flattened bone 
contours and fragments should be evaluated as statistically different disorders have 
been followed. 
Several studies to date have considered further subdivision of OC cases by joint 
affected, resulting in different QTL being identified for each subgroup [97, 98].  This 
is appealing given the apparent low correlation among the occurrence of lesions of 
OC in different body locations [87, 95, 238] and the corresponding idea that OC is in 
fact a localised disease [68].  However, subdividing cases in this way represents a 
significant loss of power.  Furthermore, testing several manifestations of the disease 
serves to exacerbate the already serious problem of multiple testing.  For this reason 
and from a practical selection perspective, expressing OC as a single trait is more 
appealing, and should enable the identification of QTL controlling more generalised 
factors.   
In this study, model complexity due to the presence of horses suffering from 
conditions other than OC in the cohort may have reduced the power of the 
association test.  The uneven representation of cases and controls across the 
contemporary groups describing the presence or absence of ALD, fetlock chips and 
sesamoid fractures in the samples, represented a potential cause of bias in the sample 
and therefore had to be fitted in the model.  In the event that none of these conditions 
are related to OC or have a hereditary component, the adjustment for contemporary 
group represents a loss of power through the reduction in the number of degrees of 
freedom of the model.  However, in the case where one or more of these diseases has 
a hereditary component (of which there is some evidence [86, 88]), the exclusion of 
contemporary group from the model would result in severe confounding.  Since the 
latter is by far the more serious case, I chose to fit contemporary group in the mixed 
model. 
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However, there is seemingly a trade-off to be made.  Whilst the use of clinical data in 
this case added complexity and potentially noise to the data, it also gave me 
increased confidence in the phenotypic classifications of OCD.  In this study, all of 
the cases underwent arthroscopy, the so-called ‘gold standard’ of diagnosis of 
cartilage defects [239] and so we can be confident of high specificity.  All of the 
controls had OC ruled out through a comprehensive radiographic survey of 
predilection sites and the evaluation of radiographs by a specialist in the field (LRB) 
significantly reduced the chance of OC going undiagnosed. 
In this GWAS, a single SNP associated with OCD in a sample of 330 Thoroughbreds 
was identified.  This association requires validation in an independent dataset in 
order to rule out the possibility that it represents a false positive association.  In the 
event that the SNP is validated, further fine-mapping and re-sequencing of the region 
will be needed in order to elucidate the causal mutation behind this association.  The 
likely issue of poor power to detect QTL in this study illustrates both the complexity 
of OC and the challenge faced by members of the equine genetics community in 
collecting and genotyping sufficiently large samples for effective GWAS to be 
carried out.  This complexity and the seemingly low heritability of OC suggest 
genome-wide evaluation might be a more efficacious approach to selection than 
MAS and this hypothesis is explored in the following chapter. 
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Chapter 8: The use of genome-wide evaluation 
in the prediction of risk for osteochondritis 
dissecans in the Thoroughbred 
8.1 Introduction 
The genetic improvement of complex traits in livestock has traditionally been 
achieved through the selection of animals for breeding based on the performance of 
the individual, its contemporaries and its relatives.  Through this approach, 
formalised in Best Linear Unbiased Prediction (BLUP) [220], huge gains have been 
made, particularly with respect to production traits such as milk volume per cow 
[240].  However, improvements in genotyping technology have paved the way for 
more informed breeding decisions based on the actual gene variants an animal is 
carrying rather than an expectation of what gene variants it is likely to be carrying.  
Initially, research was focused on identifying specific markers (or genes) which were 
associated with traits of interest and could then be used in marker (or gene) assisted 
selection (MAS/GAS).  Whilst this approach has often proved to be successful when 
applied to simple traits, such as monogenic diseases, its success in the arena of 
complex traits has been much more limited.  The principal reason for this limited 
success is that, in the case of complex phenotypes, there appear to be few genetic 
variants which explain a sufficiently large proportion of the total genetic variance of 
the trait to be useful for selection [92].         
The concept of genome-wide evaluation (GWE) was first introduced in the context 
of selection by Visscher & Haley (1999) [51].  In many ways, GWE represents a 
reversion to the black box approach of BLUP, focusing on the average effect of all 
gene variants, rather than attempting to identify individual gene variants of 
significance.  Meuwissen et al. (2001) [52] then showed that, with sufficiently dense 
markers and provided phenotypes had been available, it was possible to estimate an 
individual’s breeding value from its genotype alone and so the concept of genomic 
selection (GS) was borne.  New single-nucleotide polymorphism (SNP) genotyping 
technology has since delivered the required marker density in horses and other 
livestock species.  The methodology involves first simultaneously estimating all SNP 
effects in a training population for which both phenotype and genotype data are 
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available.  Essentially a multiple-linear regression problem, this step is described as a 
‘small n, large p’ problem, with the number of SNP effects to be estimated (p) 
always outnumbering (and in many cases considerably so) the number of 
observations from which estimations can be made (n).  The development of the 
optimal statistical solution to this problem has been the focus of many studies over 
the last ten years and yet remains largely open to debate.  Commonly used statistical 
models and approaches include multiple linear regression (typically with some kind 
of pre-selection of SNPs) [52], Bayesian procedures [52] and semi-parametric 
specifications [56, 62].  The second stage of the process involves the estimation of 
additive genetic values or genomic estimated breeding values (GEBV) in a test 
population (usually the selection candidates) for which only genotype information is 
available, through the application of the ‘SNP key’ developed in the training 
population. 
The accuracy of the GWE methodology is dependent on characteristics of the trait, 
such as heritability, properties of the genome, such as the extent of linkage 
disequilibrium (LD), and the coverage of the genome offered by the markers [61].  A 
key benefit of GS is that, whilst the accuracy of BLUP estimated breeding values is 
theoretically limited when based on individuals and ancestors, only being able to 
approach one with progeny or inbreeding, GEBV accuracy is not [241].  However, 
the advantages of GS over traditional approaches to selection extend beyond simply 
generating highly accurate breeding values.  The availability of GEBV from birth 
offers the potential for greatly reduced generation intervals, perhaps even 
velogenetics [242].  The implementation of GS also eliminates the need for 
phenotyping every generation, which is particularly useful in the case of traits which 
are difficult or expensive to measure.  Furthermore, in the case of sex specific traits, 
e.g. milk production, GEBV can be produced to equal accuracy for all animals. 
Whilst the benefits of GS have the potential to apply to all livestock populations, its 
implementation has been recognised as being particularly useful in the dairy cattle 
industry.  There are several factors that contribute to making implementation of GS a 
much more realistic risk-free prospect in this industry compared to in the more 
fragmented industries of the beef cattle and sheep sectors, these include: (1) the 
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structure of the industry, which consists of several large breeding companies who 
produce the elite breeding stock; (2) the domination of the industry by a single breed 
of small effective population size (Holstein); (3) the large proportion of costs and 
long generation intervals associated with traditional progeny testing schemes; and (4) 
the easy identification of cost savings for genotyping investments.  The equine 
industry, at least within the UK and notwithstanding the economic domination of the 
Thoroughbred, is more akin to the beef and sheep industries and therefore will likely 
suffer similar challenges in the implementation of GS.  These challenges include the 
need to produce GEBV across a large number of breeds (and crossbreds) and the 
coordination of the scheme across a number of disparate groups.   However, since 
little genetic information is currently on offer to breeders, even relatively low 
accuracy GEBV would represent considerable progress and, in principle, should 
increase genetic gain.     
In this study, the concept of GWE is applied to osteochondritis dissecans (OCD) 
expressed as a binary trait in the Thoroughbred.  The aim is to exploit the 
methodology in order to derive GEBV for the genetic risk of OCD in horses.  In 
addition, a trait was simulated by adding SNP effects to the available genotype data 
and then analysed in order to explore the power and other properties of the available 
data. 
8.2 Materials and methods 
8.2.1 Samples 
The data for this study comprised the OC samples that were sourced in the US 
(n=348 Thoroughbreds from the US), genotyped at the 50,707 SNPs that passed 
preliminary quality control (QC).  As in Chapter 7, horses were classified into 
contemporary groups relating to the three most common reasons for surgery, other 
than OC (angular limb deformities, fetlock chip(s) and sesamoid fracture(s)) and sex, 
resulting in 2
3
 x 2 = 16 classes in total, 11 of which contained observations in the 
final analysis (see 2.4 and A.iii for further details).  Contemporary group was 
subsequently fitted in models as a categorical fixed effect.   
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8.2.2 Quality control 
Samples were checked for sex discrepancies (marker-based prediction of sex versus 
sample label) and intermediate X-chromosomal inbreeding (0.2<F<0.8), with 
exclusions being made on the basis of suspected sampling or genotyping errors.  Two 
samples were excluded due to sex discrepancy and 16 based on indeterminate sex as 
demonstrated by intermediate inbreeding, leaving 168 controls and 162 cases for 
further analysis.  Further, 30 SNPs were excluded on the basis that they were 
positioned on the X chromosome but were likely autosomal. 
Only autosomal SNPs were used in the analyses.  To be eligible for selection as a 
QTL in the simulation, SNPs had to be polymorphic and genotyped in at least 95% 
of samples; there was no restriction on minor allele frequency (MAF).  Prior to the 
estimation of SNP effects (both for simulated and OCD phenotypes), the following 
thresholds were used for excluding SNPs:  MAF <0.05 and >5% missing genotypes 
per SNP.  No exclusions were made on the basis of Hardy-Weinberg equilibrium 
(HWE).  In the OCD dataset, additional exclusions were made on the basis of 
differential proportions of missing SNPs between cases and controls (p<0.05).  In the 
simulated dataset, SNPs which were assigned as QTL (see below) were also removed 
prior to genomic analysis.  Finally, pairwise LD between remaining SNPs was 
assessed (calculated using an EM algorithm as in Chapter 3) and in cases where r
2
=1, 
one of the pair excluded.  Following these exclusions, 56% of the original SNP set 
remained to be used in the genome-wide evaluation. 
8.2.3 Simulation of additive genetic merit and phenotypic 
performance 
A trait with a target heritability of 0.20, representing a typical OC estimate, was 
simulated
9
 using the genotypes from the sample described above.  The target number 
of QTL was 1,000 and was chosen by rounding up from the number of independent 
                                                 
 
9
 The simulation program used was adapted from a program written by Hans Daetwyler (then of The 
Roslin Institute, now of the Victorian Department of Primary Industries). 
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segments in the genome, such that there would be at least as many QTL as 
independent segments in the genome (see 8.4).  Each of the 48,387 SNPs were 
chosen as QTL in independent Bernoulli trials with a probability of 0.021 
(1,000/48,387), resulting in 984 QTL.  Each SNP had an equal chance of being 
selected, regardless of MAF, resulting in the distribution of MAF of the QTL 
following that of the SNP chip.  SNPs designated as QTL were not used in the 
subsequent estimation of GEBV.  True allele substitution effects ( i ) were sampled 
from N(0,1).  True genetic values for the 330 individuals were calculated as the sum 
of the average allele effects, calculated as   iip 1  for A1 and iip  for A2 (where 
ip  is the allele frequency of A1) across all QTL.  True genetic values were then 
scaled to approximate a N(0,0.2) distribution.  Residual effects for each animal were 
obtained by sampling from a N(0,0.8) distribution.  Finally, phenotypic records were 
simulated by adding residual effects to the simulated true genetic values.  The final 
genetic and residual (environmental) variances were 0.20 and 0.73, respectively, 
giving a heritability of 0.21 on the continuous (liability) scale.  Samples were then 
ordered according to their simulated phenotype.  The bottom 50% of the distribution 
(n=165) were labelled as controls and assigned a binary phenotype value of 1.  The 
top 50% of the distribution (n=165) were labelled as cases and assigned a binary 
phenotype value of 2.  This designation of samples as cases/controls led to a 
dichotomous trait with 50% prevalence and heritability on the observed scale of 0.13.  
8.2.4 Bayesian estimation of SNP effects 
The program described in this section was written by Ricardo Pong-Wong.  Marker 
effects were estimated using a BayesB type method similar to that described by 





i egXbμ1y iα , 
where y  is the vector of phenotypes; b  contains the fixed effect of contemporary 
group and X  is its incidence matrix (in OCD dataset only); i  is the allelic 
substitution effect for SNP i; ig  is the vector of genotypes (0, 1 or 2 for homozygote 
for the minor allele, heterozygote and homozygote for the major allele, respectively) 
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for SNP i and e  is the vector of residuals distributed  2,0 eN  .  Since not all SNPs 
are expected to affect the trait, the allelic substitution effect, i , for each SNP was 
sampled from a mixture distribution with probability π of having an effect on the trait 
and with probability (1-π) of not having an effect on the trait.  The SNP effects were 
then sampled from  2,0 snpN   such that the analysis might be referred to by some as a 
BayesC implementation [243].   
The implementation of the model was done using Gibbs sampling.  The parameter 
2
e  was estimated in the analysis using a scaled inverse chi-squared distribution 
with 2  degrees of freedom (df) and scale parameter 12  .  The parameter 2snp  
was estimated in the analysis using a scaled inverse chi-squared distribution with 
2  df and scale parameter 001.02  .  This represents a weak informative prior 
with a wide distribution.  Two analyses were performed.  In the first, π (the 
proportion of SNPs with an effect) was estimated during the analysis using a flat 
prior (BayesCπ).  In the second, π was assumed to be known (BayesC) such that for 
the simulated data, π was set to twice the number of simulated QTL divided by the 
average number of SNPs used in the Bayesian analysis (see 8.4), calculated as 
0.0693, and, in the case of the OCD data, π was set arbitrarily to 0.10.     
For each analysis, a Monte Carlo Markov chain (MCMC) was run.  The first 10,000 
cycles were discarded as burn-in.  This was followed by 30,000 realisations, with 50 
cycles between each consecutive realisation.  The posterior mean was used as the 
estimate for each parameter of interest.  GEBV were generated for every individual 
in the training and reference samples by the summation across all markers of the 
product of the mean estimated substitution effect of the marker and the genotype 
value (0, 1 or 2).  The estimated total genetic variance explained by the SNPs was 
calculated as the sum of the variance of the GEBV and the average predicted error 
variance. 
8.2.5 Genomic BLUP procedure 
Hayes et al. (2009) [244] state that the replacement of the average relationship 
matrix derived from pedigree by the realised (genomic) relationship matrix in BLUP 
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of breeding values is the equivalent to the GWE methodology where the effects of 
QTL contributing to variation in the trait are assumed to be normally distributed with 
constant variance.  Using the same SNP markers that were used for the Bayesian 
estimation of marker effects, marker derived relationships were calculated using a 
program written by Ricardo Pong-Wong.  Relationships were calculated as: 
  













, , where, summation is across SNPs (k=1, N), xik  
is a genotype of the i
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21 , and Oi is observed 
heterozygosity.  A single trait animal model was then fitted in ASReml [219] 
applying the model: eZuXbμ1y  , where y  is the vector of phenotypes; b  
contains the fixed effect of contemporary group (in the OCD dataset only) and X  is 
its incidence matrix; u  is the vector of animal effects and Z  is its incidence matrix 
and e  is the vector of residuals distributed  2,0 eN  .  The pedigree based numerator 
relationship matrix was replaced with the marker-based genomic relationship matrix 
in the model.  GEBV were generated for all individuals by solving the above linear 
mixed model equation using REML (restricted maximum likelihood).  This approach 
is referred to as GBLUP.       
8.2.6 Cross-validation procedure 
Cross-validation (CV) is a robust, non-parametric technique for model evaluation 
[245].  The method consists of splitting the data into a number of training or 
reference datasets and validation or test datasets.  Model parameters can then be 
estimated in the reference (training) datasets and used to predict observations in the 
test (validation) datasets.  A five-fold CV procedure was used to assess accuracy of 
predicted GEBV.  In the case of the simulated phenotype, cases and controls were 
randomly allocated to one of five subsets, such that each subset contained 33 cases 
and 33 controls.  In the case of the OCD phenotype, samples were randomly 
The application of genomic technologies to the horse 
Chapter 8 The use of genome-wide evaluation in the prediction of risk for osteochondritis 
dissecans in the Thoroughbred  
155 
allocated to one of five subsets in such a way that both the number of cases and 
controls, and the number of samples in each contemporary group were approximately 
equal in each subset.  Phenotypes from each subset in turn were masked (set to 
missing) and the remaining subsets used to predict parameters of the model in order 
to generate GEBV for all samples.   
8.2.7 Evaluation of the accuracy of genomic estimated 
breeding values   
The standard approach to assessing genomic evaluation models is to calculate the 
correlation between the true and estimated breeding values, denoted here as 
ggr ˆ , and 
referred to as the accuracy of prediction.  The value of ggr ˆ  was calculated directly for 
the simulated dataset.  However, the true breeding values for horses in the OCD 
dataset were unknown and therefore two alternative approaches were taken to assess 
the accuracy of the GEBV.  The fixed effect, contemporary group, was a nuisance 
factor (fitted only to avoid confounding and not for its predictive ability) and 
therefore its contribution to the estimated phenotypes had to be discounted.  For the 
first approach, this was achieved by obtaining a ‘corrected true phenotype’, 
calculated for each horse by subtracting the mean and fixed effect of contemporary 
group estimated in the model (either Bayesian or GBLUP) from its true phenotype.  
The corrected true phenotype therefore consisted of the genetic and residual 
components combined.  The correlation between this corrected true phenotype and 
the GEBV was then calculated to give a proxy measure for ggr ˆ , denoted here as ppr ˆ .  
This proxy measure of accuracy could then be compared to expected accuracies 
according to the equations of Daetwyler et al. (2008) [61] (see 8.4).      
The second approach taken to evaluate GEBV accuracy, involved the use of a 
permutation procedure to assess the significance of the contribution of the GEBV to 
phenotype prediction.  Initially, the correlation between the true phenotype and the 
predicted phenotype was calculated in each test set, this is denoted yyr ˆ  and is 
referred to as the predictive ability of the model.  Subsequently, GEBV were 
randomised amongst individuals of each test set and the correlation calculated again.  
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This was repeated 1,000 times in order to generate the null distribution of yyr ˆ  values, 
enabling the empirical determination of a 5% significance level in order to assess the 
contribution of the GEBV to the total predictive ability of the model.  yyr ˆ  was also 
calculated for the simulated dataset as a means of evaluating the impact of using 
proxies such as ppr ˆ  
and yyr ˆ  in place of the correlation between true and estimated 
additive genetic values ( ggr ˆ ) in the OCD dataset.   
The assessment statistics described above ( ggr ˆ , ppr ˆ and yyr ˆ ) were calculated for each 
CV test set in turn.  Test sets were then combined and the same assessment statistics 
calculated to give overall performance.  Assessment statistics were also calculated in 
reference sets for comparative purposes.  For the remainder of this chapter, ggr ˆ  will 
be referred to as the ‘accuracy of prediction’ and yyr ˆ , as the ‘predictive ability’ of the 
model.           
8.3 Results 
8.3.1 Osteochondritis dissecans trait results 
8.3.1.1 Bayesian estimation of SNP effects 
The mean predictive ability of the BayesCπ model ( yyr ˆ ) was 0.73±0.01 and 
0.60±0.02 in the reference and the test datasets, respectively.  Predictive abilities in 
the test sets ranged from 0.58 to 0.64 (Table 8-1) and a comparison of these 
calculated values with the distribution of yyr ˆ  calculated from the permutation of 
GEBV, showed the improvement in fit derived from the GEBV not to be significant 
(at the 5% level) in any of the test sets.  Figure 8-1 shows the distribution of yyr ˆ  that 
resulted from the permutation for Test Set 1.  The improvement was also not 
significant when the test sets were combined.  Similarly, when the results were 
assessed by ppr ˆ , none of the test sets exhibited a significant positive correlation 
between corrected true phenotype and GEBV.  Using BayesCπ, an average of 0.6% 
of all SNPs were fitted in the model.  A paired two-sample t-Test revealed that fixing 
the proportion of SNPs with an effect in the model to 10% did not significantly 
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improve the fit of the model (comparing yyr ˆ ) in the test sets (Table 8-2), but did 
increase the mean correlation between the observed and the estimated phenotypes in 
the reference sets (data not shown).  The mean estimated total genetic variance 
explained by the SNPs was 0.021±0.003 and 0.075±0.002, for the BayesCπ and 
BayesC models, respectively. 
8.3.1.2  Genomic BLUP Procedure 
The genomic BLUP estimate for the genetic variance component was fixed near the 
boundary in all CV sets, implying a very small genetic variance and resulting in 
GEBV in the range 10
-7
.  Therefore, estimated phenotypes were almost entirely 
determined by the fixed effect (contemporary group) and the permutation procedure 
showed no additional benefit could be gained by including GEBV (data not shown).  
When the results were assessed by ppr ˆ , none of the test sets exhibited a significant 
positive correlation between corrected true phenotype and GEBV.  The relative 
performance within each test set was similar to that seen in the Bayesian analysis 
(Figure 8-2). 
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Table 8-1 OCD: BayesCπ 
Test 
set 
Correlation between corrected 
true phenotypes and GEBV 
Correlation between predicted and 
observed phenotypes 
 
ppr ˆ  p-value yyr ˆ  5% sig. level 
1 0.15 0.23 0.593 0.596 
2 0.03 0.82 0.598 0.610 
3 0.03 0.80 0.592 0.606 
4 -0.01 0.91 0.639 0.656 
5 0.00 0.97 0.575 0.587 
Overall 0.04 0.50 0.599 0.603 
 
Table 8-2 OCD: BayesC (π=0.10) 
Test 
set 
Correlation between corrected 
true phenotypes and GEBV 
Correlation between predicted and 
observed phenotypes 
 
ppr ˆ  p-value yyr ˆ  5% sig. level 
1 0.18 0.14 0.604 0.609 
2 0.03 0.79 0.590 0.621 
3 -0.01 0.95 0.561 0.608 
4 0.00 0.97 0.617 0.659 
5 -0.03 0.84 0.549 0.584 
Overall 0.04 0.46 0.584 0.595 
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Figure 8-1 The distribution of correlations between predicted and true phenotypes ( yyr ˆ ) 
following the permutation of GEBV amongst individuals.  Data for Test Set 1 (BayesCπ).  The 




Figure 8-2 Correlation between corrected true phenotypes and genomic estimated breeding 
values ( ppr ˆ ) for BayesCπ and for GBLUP methods
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8.3.2 Simulated trait 
8.3.2.1 Bayesian estimation of SNP effects 
The mean predictive ability of the BayesCπ model ( yyr ˆ ) was 0.93±0.02 and 
0.16±0.07 in the reference and the test datasets, respectively.  The predictive ability 
in the test sets ranged from 0.059 to 0.26, but the correlation was significant only in 
test set 5 (Table 8-3).  A predictive ability, yyr ˆ , of 0.16 (p<0.005) was calculated 
when all test set data was combined.  When the accuracy of prediction was calculated 
as the correlation between true and estimated breeding values (
ggr ˆ ), three CV sets 
showed a significant positive correlation and when estimates were combined across 
all test sets, a significant positive correlation of 0.19 (p<0.005) was calculated.  On 
average, 2.4% of all SNPs were fitted in the BayesCπ model.  Fixing the proportion 
of SNPs with an effect in the model to 6.93% (BayesC) did not significantly improve 
the accuracy of the GEBV (based on results of a paired two-sample t-Test) (Table 
8-4) but did slightly increase the correlation between the true and the estimated 
phenotypes in the reference sets (data not shown).  The mean estimated genetic 
variance was 0.08±0.01 and 0.11±0.007, for the BayesCπ and BayesC models, 
respectively. 
8.3.2.2 Genomic BLUP 
The mean predictive ability of the GBLUP model ( yyr ˆ ) was 0.92±0.04 and 0.13±0.08 
in the reference and the test datasets, respectively.  The predictive ability in the test 
sets ranged from 0.023 to 0.24, but was not significant (p<0.05) in any of the 
individual test sets (Table 8-5).  A predictive ability, yyr ˆ , of 0.11 (p< 0.05) was 
calculated when all test set data was combined.  When the accuracy of prediction was 
calculated as the correlation between true and estimated breeding values ( ggr ˆ ), three 
of the CV sets showed a significant positive correlation and when estimates were 
combined across all test sets, a significant positive correlation of 0.16 (p<0.005) was 
calculated.  The mean heritability estimate on the observed scale was 0.29±0.12.  
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Table 8-3 Simulation: BayesCπ 
Test set Correlation between true and 
predicted phenotypes 
Correlation between true and 
predicted breeding values 
 
yyr ˆ  p-value
I
 
ggr ˆ  p-value
I
 
1 0.13 0.28 0.17 0.16 
2 0.18 0.15 0.26 0.03 
3 0.18 0.16 0.37 <0.01 
4 0.06 0.64 -0.11 0.36 
5 0.26 0.04 0.30 0.01 
Overall 0.16 <0.01 0.19 <0.01 
I
Significant results (p<0.05) shown in bold 
Table 8-4 Simulation: BayesC (π=0.693) 
Test set Correlation between true and 
predicted phenotypes 
Correlation between true and 
predicted breeding values 
 
yyr ˆ  p-value
I
 
ggr ˆ  p-value
I
 
1 0.19 0.12 0.19 0.12 
2 0.17 0.17 0.26 0.03 
3 0.17 0.16 0.36 <0.01 
4 0.06 0.63 -0.12 0.35 
5 0.24 0.05 0.30 0.01 
Overall 0.16 <0.01 0.20 <0.001 
I
Significant results (p<0.05) shown in bold 
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Table 8-5 Simulation: GBLUP 
Test 
set 
Correlation between true 
and predicted phenotypes 
Correlation between true 









yyr ˆ  p-value
II
 
ggr ˆ  p-value
II
  
1 0.09 0.50 0.17 0.17 0.17 (0.14) 
2 0.14 0.25 0.25 0.04 0.38 (0.18) 
3 0.16 0.20 0.36 <0.01 0.25 (0.17) 
4 0.02 0.86 -0.12 0.34 0.45 (0.17) 
5 0.24 0.06 0.29 0.02 0.22 (0.17) 
Overall 0.11 0.04 0.16 <0.01 n/a 
I
on the observed scale 
II
Significant results (p<0.05) shown in bold 
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8.4 Discussion 
Results from the OCD dataset suggest that the amount of genetic variance underlying 
OCD susceptibility that is tagged by the markers in this sample is extremely small.  
The combination of the low estimated genetic variance and the low number of SNPs 





 and estimated phenotypes that were dominated by the fixed effect 
(contemporary group).  Hence, the improvement of fit to the model provided by the 
GEBV was minimal and shown by permutation not to be significant in any of the CV 
sets.  The predictive ability of the model, as assessed by ppr ˆ , was also very low with 
no significant positive correlations observed in the test sets.  The results of the 
genomic BLUP analysis of the OCD dataset were generally in line with results from 
the Bayesian method.  The genetic component in the model was bounded which 
could be due to either a small genetic variance, or to data structure causing large 




.  Data was simulated in 
order to better understand the factors which may have led to this poor predictive 
ability. 
The parameters of the simulated dataset were chosen to be representative of a 
complex disease scenario similar to OCD where heritability is low and there are a 
large number of QTL affecting disease status, relative to the genome structure.  In 
order to make the best use of the available genotypes, disease prevalence was set to 
50% rather than the predicted 25% prevalence in Thoroughbreds of OCD [76].  The 
random nature of the simulation resulted in a realised heritability (on the liability 
scale) of 0.21, just over the target heritability of 0.20.  Of note, was the consistent 
over-estimation of heritability by the genomic BLUP procedure in all CV subsets.  
However, standard errors were large and three out of five estimates lay within a 
single standard error of the true observable heritability, 0.13.  Further checking of the 
heritability was carried out by fitting raw simulated phenotypes for all 330 animals as 
a continuous trait in the animal model.  Whilst the heritability was still 
overestimated, a log likelihood ratio test showed the estimate not to be significantly 
different from the simulated value of 0.21.  The reason for the consistent over-
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estimation of heritability is not clear, but may have to do with assumptions 
underlying the derivation of the genomic relationship matrix (see [59, 246, 247]). 
In all cases, regardless of the method, the correlation between the true and estimated 
phenotypes ( yyr ˆ ) for the simulated data were positive.  Predictive abilities ( yyr ˆ ) were 
higher than for the OCD dataset but were still relatively low and were not significant 
except in CV set five (using Bayesian analysis).  As expected, GEBV accuracies, 
calculated as the correlation between true and predicted breeding values ( ggr ˆ ), were 
greater than predictive ability ( yyr ˆ ) and correlations were significant in three out of 
five test sets.  When the five CV sets were combined, both predictive ability ( yyr ˆ ) 
and accuracy ( ggr ˆ ) were significantly different from zero.  The reason for the lack of 
significance in some of the individual CV sets may be a lack of power, caused by 
having only 66 samples per test set.  The accuracy based on the Bayesian analyses 
was significantly higher than that from the GBLUP analysis.   
The variation in accuracy across the CV sets was relatively high in both the OCD and 
simulated data sets, but showed similar trends across the methods, indicating 
systematic variation in groups.  This shows the importance of CV in the assessment 
of prediction performance.  Here, horses (aged nine to 12 months) were sampled over 
two years but essentially represent a single generation, so I did not have to consider 
the presence of ancestors within the different sets.  However, the chance sampling of 
half-sibs and other relatives within and between CV sets may have caused the 
relatively large variations in accuracy seen across them. 
Given the small sample sizes and apparently small amount of information coming 
from the data, the proportion of SNPs with an effect in the model (π) was fixed to 
reduce the number of parameters that needed to be estimated.  This method more 
closely resembles the original BayesB model of Meuwissen et al. (2001) [52].  
Fixing π=0.10 in the analysis of the OCD data, resulted in the correlation between 
corrected true phenotype and GEBV ( ppr ˆ ) in the reference sets increasing 
considerably, but the corresponding statistic in the test sets showing no improvement.  
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The estimated genetic variance also increased.  These findings suggest that the 
increased correlation observed in the reference sets was the result of over-fitting, that 
is, the result of marker effects explaining error, rather than any improvement in the 
estimation of the true effects.  Similar results were seen in the simulated data where 
the value of π=0.0693 was chosen under the assumption that two adjacent SNPs per 
QTL would be fitted in the model.  Clearly, this is a very simplistic view because the 
actual number of SNPs that it may be desirable to fit for every QTL so as to capture 
all its variance through LD, would be highly dependent on the degree of LD between 
each QTL and its surrounding SNPs.     
Deterministic formulae which predict the accuracy of predicted genetic risk using a 
genome-wide approach allow the comparison of these results to expectation [61].  
Two versions of the formula derived by Daetwyler et al. (2008) [61] are relevant 
here.  The first is for a dichotomous disease phenotype assuming a population 
sample.  This assumes that the proportion of samples with disease is the same as the 
prevalence of the disease in the population and is relevant to the simulation scenario.  
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Falconer & MacKay (1996) [124], assuming q here is equivalent to p.  Under both 
versions of the equation, it is assumed that all of the genetic variance is captured by 
the markers.     
Using these formulae, together with predictions of Ne for the US Thoroughbred 
population from Chapter Three, further conclusions may be drawn from the results.  
Assuming an Ne of 100 (and a corresponding Me of 939), predicted accuracies for the 
OCD dataset given heritabilities on the liability scale of 0.10 and 0.30, would be 
14.0ˆ ggr  
and 24.0ˆ ggr , respectively; clearly, this level of accuracy was not 
achieved.  In contrast, the predicted accuracy for the simulated scenario of 
19.0ˆ ggr  was realised when a Bayesian approach was used.  In the simulation, 
QTL SNP genotypes were removed prior to the genomic analysis to more closely 
resemble the likely situation in the OCD analysis.  The fact that the expected 
accuracy was still achieved suggests much of the genetic variance was captured by 
remaining markers through linkage, making inadequate genome coverage an unlikely 
explanation for the poor results of the OCD analysis.  Similarly, whilst there was 
some evidence in the simulation of poor power due to small sample size, with a 
significant correlation ( ggr ˆ ) only being observed in three out of five test sets, by 
combining test sets the power was sufficient to achieve strong significance (p<0.01) 
and so the small sample size may not fully account for the poor predictive ability in 
the OCD dataset.  Whilst the use of a proxy measure ( ppr ˆ ) for ggr ˆ  
in the OCD model 
would have lowered the expected correlation, the comparison of ggr ˆ  and yyr ˆ  in the 
simulated data showed only a small difference (0.03).  Therefore, it seems likely that 
specific properties of the OCD sample affected the accuracy with which GEBV 
could be predicted and some such properties are explored below. 
In order to negate any possible farm effect on the data, an approximately equal 
number of cases and controls were sampled from each farm (see Chapter 2).  
However, it is also likely that half sibs were clustered by farm as individual farms 
will tend to use the same stallion on several of its mares.  The result of this may have 
been the incidental matching of cases and controls for pedigree, adding structure to 
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the data that was subsequently unaccounted for.  The power of the analysis will also 
have been reduced by the fitting of the fixed effect, contemporary group.  Whilst this 
was necessary due to the uneven distribution of cases and controls amongst classes, 
the true power of the resulting analysis might be expected to more closely resemble 
that of a study with 144 samples, that is, twice the sum of the minimum out of the 
number of cases or controls for each class, rather than the actual sample size of 330.  
Furthermore, although horses were rigorously screened for OCD in this study, 
misclassification may also have contributed to a reduction in overall power.  The 
combination of these factors may go some way to explaining the difference in 
success between the OCD and the simulated trait analyses.    
Despite the disappointing results from the OCD dataset, the simulation results were 
promising.  By imposing QTL on existing genotypes, many real features of the 
genome are retained, along with their impact on the efficacy of the method.  A 
criticism of some early simulation studies might be that the low number of QTL 
simulated led to unrealistically high estimated accuracies of prediction that could not 
be achieved for highly complex traits.  Therefore, in this study, a relatively large 
number of QTL, relative to the genome structure, were simulated.  To see some 
predictive ability in the simulated data with such small sample sizes indicates that, 
whilst the OCD study may have been under-powered, the 50k SNP chip is sufficient 
to make such genome-wide methods efficacious in the horse.  With an increase in 
sample size and therefore a corresponding increase in accuracy, such an approach has 
the potential to be used to inform breeding decisions and this potential has been 
recognised by several authors to date.  Haberland et al. (2012) [249] showed by 
simulation that, given a young horse without phenotypic data (or progeny), the 
additional information from GEBVs with accuracies of 0.3, could increase the 
correlation between true and predicted breeding values from 0.27, achieved using 
sire and dam data only, to 0.39.  These results were based on a trait of low 
heritability (h
2
=0.15) intended to represent OC, but results were also shown for a 
more highly heritable trait.  Furthermore, Sitzenstock et al. (2010) [250] concluded 
from their simulation work, that the use of GEBV in horse breeding programmes 
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could increase profitability above that achieved with traditional selection strategies 
across a range of GEBV accuracies from 0.3 to 0.8. 
Whilst only Thoroughbred samples were used in this study predictions may need to 
be made across a wide range of breeds and crossbreds.  Work in other livestock 
species and using simulation has shown that across breed predictions can be much 
lower than within breed predictions [134, 251, 252].  Whilst this is also expected to 
be the case in horses, preliminary haplotype analyses have shown a large degree of 
haplotype sharing across breeds [23] which will aid across breed evaluations.  
Furthermore, many modern sport horse breeds comprise a large proportion of 
Thoroughbred genes, for example, the Hanoverian has a predicted 35% 
Thoroughbred genes [225] and this will aid transferability across breeds.  Further 
studies are warranted to evaluate the true potential of GS in horses but are currently 
not possible due to an insufficient number of well-phenotyped samples.  One 
possible approach to address this problem is low-density genotyping and this is 
explored in the next chapter. 
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Chapter 9: The utility of low-density genotyping 
in the Thoroughbred 
9.1 Introduction 
The introduction of high-throughput single-nucleotide polymorphism (SNP) chips 
which permit the analysis of large numbers of SNPs in parallel, has enabled large-
scale studies of human and livestock populations to be carried out.  The increased 
marker density has led to genome-wide association studies (GWAS) such as that 
carried out in Chapter 7, replacing linkage analyses as the dominant method in the 
hunt for genetic variants, due to their superior potential for informing us about 
complex as well as monogenic conditions.  In livestock, genomic selection (GS) has 
become a realistic alternative, or at least an adjunct, to the pedigree based selection 
methods of the last 40 years, helping to overcome the uncertainty due to the 
Mendelian sampling term [253].  A common feature of GWAS and other population 
scale analyses, is the requirement for large sample sizes which are needed to ensure 
sufficient power to detect what are hypothesised to be relatively small quantitative 
trait loci (QTL) effects.  As well as needing a substantial number of samples for the 
initial analysis, a second independent sample is required for the validation of any 
QTL identified.  Furthermore, any underlying data structure such as that caused by 
differing ancestries, e.g. different breeds, and the presence of environmental factors, 
has the potential to reduce power for a given sample size.  Whilst GS does not aim to 
identify QTL as such, the method is still reliant on large sample sizes in order to 
minimise the error in the estimation of the SNP effects which are then used to predict 
genomic estimated breeding values (GEBV) in the selection candidates.   
In the equine setting, the accumulation of large numbers of samples represents a 
significant challenge.  Since the introduction of the first equine SNP chip by Illumina 
in 2007, several GWAS of monogenic traits have been successful in identifying QTL 
and in several cases, causal mutations [66, 196, 254].  However, success in complex 
traits has been less convincing; some studies have reported QTL, but many of these 
QTL have been defined under ad hoc significance thresholds, as authors attempt to 
balance the risk of Type I and Type II errors.  The apparently low signal to noise 
ratio in such studies is an indication of low power caused, in part, by small sample 
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sizes.  Moreover, insufficient validation studies have been done to confirm whether 
or not these initial findings are true associations or false positives.  The 
discontinuation of the 50K SNP chip after only a few years production is evidence in 
itself that the numbers of horses being genotyped has been below that which was 
expected.  The reason for the typically small sample sizes is multifactorial but can be 
partly attributable to the cost of genotyping.  Whilst the cost of purchasing and 
running SNP chip analyses has undoubtedly fallen during the last few years, it is 
relative cost which is important.  In the equine industry, within the UK sport horse 
sector in particular, the potential to make significant returns from breeding superior 
animals is limited.  Therefore, the relative cost of genotyping remains high and the 
potential to genotype large numbers of samples is correspondingly low.  The 
integration of approaches such as GS into the equine industry will require genotyping 
to become more cost effective.        
One opportunity to lower genotyping costs comes in the form of low-density 
genotyping.  If a reference panel of individuals genotyped at high density is 
available, study samples (or selection candidates) may be genotyped for a subset of 
these loci on a low-density panel (LDP), and imputation carried out to fill in the 
‘missing’ SNP genotypes.  Provided the reference panel and study sample originate 
from a genetically similar population, population genetic models can be used to 
extrapolate allelic correlations measured in the former to predict unobserved 
genotypes in the latter [255].  The dependence of imputation accuracy on SNP 
density means that but there will always be a trade-off to be made between the cost 
of genotyping and the accuracy of imputation.  Other factors that affect the accuracy 
of imputation include levels of linkage disequilibrium (LD) in the population, the 
degree of similarity between the reference panel and the study sample and to some 
extent, the size of the reference population.  Efforts to develop improved imputation 
algorithms have resulted in a wide range of programs, most of which have evolved 
from programs written to infer haplotype phase from large-scale diplotype data sets, 
being available.  Commonly used programs include fastPHASE [256], MACH [257], 
IMPUTE [258] and BEAGLE [259] and their relative efficacies have been explored 
under various scenarios [259-263].  Whilst some of these imputation methodologies 
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may use linkage analysis to exploit known relationships between individuals, in 
many cases, knowledge of relationships is not required.  
Due to the reliance of the method on LD between LDP SNPs and remaining loci, 
SNP selection for LDPs also plays a role in determining the accuracy of imputation.  
As such, significant effort has been devoted to optimising LDP SNP selection and 
several algorithms have been developed along this vein.  Many programs utilise LD 
between pairs or groups of markers to select LDP SNPs in a so-called block-free 
approach, e.g. Tagger [264], LDSelect [265].  Another common approach is to use 
haplotype information in a block-based approach, e.g. Hapblock [266], whilst other 
more novel algorithms have also been developed such as the neighbourhood graph 
approach of Halldórsson et al. (2004) [267] or the multiple linear regression 
approach of He & Zelikovsky (2006) [268].  In situations where LDP SNPs are 
selected to predict haplotypes, they are commonly referred to as ‘tag SNPs’.  A 
useful review of many of the currently available software programs can be found in 
Halldórsson et al. (2004) [269]. 
In this study, I use genotypes from the Illumina Equine SNP50 BeadChip to 
investigate the accuracy of imputation which can be achieved in Thoroughbred 
horses, without pedigree information, and using a typical imputation program 
(BEAGLE).  Three methods of LDP SNP selection were tested across six LDP sizes 
in order to evaluate the impact of various SNP selection criteria including SNP 
informativeness and LD.  The effect of geographical substructure on the accuracy of 
imputation was also investigated. 
9.2 Materials and methods 
9.2.1 Genotypes 
The data for this study comprised all 1,201 available samples (n=853 Thoroughbreds 
from the UK and n=348 Thoroughbreds from the US), genotyped at the 50,707 SNPs 
that passed preliminary quality control (QC).  The UK dataset was used to evaluate 
three methods of LDP SNP selection across six LDP densities in a within-population 
analysis.  The US dataset was subsequently used to evaluate the impact on 
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imputation accuracy of geographical substructure between reference panels and study 
samples in a between-population analysis (at a single LDP density).   
Samples in the UK dataset were randomly assigned to one of the following three 
subsets:  Set A containing 200 samples that were used to select LDP SNPs; Set B 
containing 490 samples that were used as the reference panel; Set C containing the 
remaining 163 samples that were used as the test panel (representing the study 
sample).  Two analyses were performed using the US dataset.  In the first analysis, 
Set B was used as the reference panel for imputation and the entire US dataset used 
as the test panel.  In the second analysis, samples in the US dataset were randomly 
assigned to one of two subsets: Set D containing 261 samples that were used as the 
reference panel; Set E containing 87 samples that were used as the test panel.  A 
graphical representation of this data flow can be seen in Figure 9-1. 
Quality control was applied in Set A in order to generate a list of SNPs to be used in 
the subsequent stages.  SNPs that were genotyped in less than 95% of the set and 
those with a minor allele frequency (MAF) of less than 0.01 were excluded.  In the 
within-population analysis, four Equus caballus (ECA) chromosomes were analysed: 
ECA1, ECA10, ECA20 and ECA26; these chromosomes were chosen to represent 
the shortest (ECA26), longest (ECA1), and median length (ECA20) chromosomes 
(as measured in cM according to Swinburne et al. (2006) [22]) and to include two 
chromosomes with centromeres (ECA1 and ECA10) and two acrocentric 
chromosomes (ECA20 and ECA26).  In the between-population analysis ECA1 and 
ECA26 were analysed. 
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Figure 9-1 Data flow for analysis 
9.2.2 Low-density panel SNP selection 
The three methods used to select LDP SNPs are detailed below.  The methods were 
tested at six different densities representing genome-wide panels with 384, 768, 1K, 
2K, 3K and 6K SNPs.  The equivalent densities, expressed in terms of Ne SNP per 
Morgan [270], were 0.09, 0.18, 0.24, 0.48, 0.72 and 1.44Ne/Morgan (assuming 
Ne=150 and total genome length is 27.72 Morgans).  The number of LDP SNPs 
selected per chromosome was proportional to the length, in base pairs, of the 
chromosome for all methods.   
Method 1: Equidistant (Mb) selection (bpEQ) 
Low-density panel SNPs were selected so that they approached equidistant spacing, 
by base pairs, along the chromosome.  This was achieved by dividing the total length 
(Mb) of the chromosome into equally sized segments, the number of segments being 
equal to one less than the number of desired LDP SNPs for the given density.  The 
closest SNP to each segment boundary was then chosen to be a SNP in the LDP, 
irrespective of MAF.       
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Method 2: Equidistant (Mb) optimised for MAF (bpMAF) 
The program described in this section was written and run by Andreas Kranis (of 
Aviagen Ltd.).  Low-density panel SNPs were selected so that they approached 
equidistant spacing, by base pairs, along the chromosome and had a high MAF.  The 
following paragraph was written in part by Andreas Kranis to describe his program. 
In order to meet both objectives, SNP selection was performed using a custom 
python program employing a genetic algorithm.  The cost function to be minimized 
included two components.  The first one aimed to drive the MAF of selected SNPs 
towards 0.5 by employing a penalty equal to (           )
 
 (1).  The second 
component ensured the equal spacing.  An ideal distance was calculated as:   
         
      
 and then, the spacing between consecutive SNPs i and i+1 in the LDP was 
forced to approach d using the function: ((       )   )
  
(2), where S is the base 
pair position of the SNP. By combining (1) and (2), the selected set of nchr SNPs was 
derived by iteratively minimizing this function over all SNPs: 
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In order to ensure good coverage on the telomeres, where recombination events are 
more frequent and hence accuracy of imputation is expected to be lower, the first and 
last SNPs in the chromosome qualified in the LDP. 
Method 3: Equidistant (LDU) optimised for MAF (lduMAF) 
Low-density panel SNPs were selected according to the same algorithm as used in 
Method 2, but with SNP location given, not as a base pair position, but in linkage 
disequilibrium units (LDU).  The LDMAP program 
(http://cedar.genetics.soton.ac.uk/pub/PROGRAMS/LDMAP) described and 
developed by Maniatis et al. (2002) [271] was used to construct an LD map for each 
chromosome in turn using the diplotypes of samples in Set A.  First, LDMAP 
computes the absolute Dʹ-statistic [272] between all pairs of markers.  For map 
construction, each of the chromosomes was divided into several overlapping 
segments with no more than 250 SNPs per segment and an overlap of 50 SNPs.  The 
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number of segments per chromosome ranged from four (ECA26) to 15 (ECA1).  For 
each segment, LDMAP fits the Malecot model to Dʹ vs. inter-marker distance (d) 
data in kilobases.  This quantifies the average rate of decline of LD for the segment 
which is a useful starting value for computing the interval-specific estimates used in 
LD map construction.   
The Malecot model predicts the decline of association with distance as 
    LMeLd d   1 , with    DEd  , and where L is the residual association 
at large distances, M is the proportion of the youngest haplotype (assumed to be the 
rarest haplotype) that is monophyletic (descended from one source), and ε is the rate 
of exponential decline of  d  with distance d.  For LD map construction, the 
LDMAP program estimates the ε and M parameters in the Malecot model for each 
interval (between adjacent SNPs) in the map, using data from marker pairs that 
include that interval in sliding windows.  Here, three rounds of iteration were 
performed.  In the first round, the ε parameter was estimated with M set equal to 0.5.  
In the second round, both ε and M were estimated, with the starting values taken 
from the first round.  The third round ensured convergence.  The third Malecot 
model parameter L was kept constant at a value predicted according to Morton et al. 
(2001) [273] and generated by the program internally.  Any larger interval that 
includes the one being estimated contains some information about ε unless the 
markers in the pair are at such a large distance that they contain no more useful 
information about LD.  Here, the maximum distance between any pair was set to 
10Mb.  The length of the ith interval is εidi LDUs, where εi is the Malecot decay rate 
parameter specific to that interval and di is the length of the interval on the physical 
map in kilobases.  A chromosome has a total of i iid  LDUs [271].  Once all 
SNPs in all segments have been mapped, the fit of the completed LD map is checked 
in a final round of iterations and parameter estimates.  In cases where SNPs were 
allocated the same position in the LD map, a small addition was made to subsequent 
locus positions (10
-6
) before entry of the SNP locations to the LDP SNP selection 
algorithm in order that SNP order (according to the physical map) was maintained.  
Linkage disequilibrium maps are shown in Figure 9-2 and Figure 9-3. 
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Figure 9-2 LD maps 
a) ECA1; b) ECA10 
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Figure 9-3 LD maps 
a) ECA20; b) ECA26 
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9.2.3 Imputation 
The program BEAGLE [274] was used to impute from low to high density markers.  
This program is based on a Hidden Markov model (HMM) in which the observed 
data are the observed unphased genotypes (which may include errors and missing 
data) and the hidden state represents the haplotype phase and the true genotypes 
[275].  In the model, the observed haplotypes are clustered at each marker position, 
based on the similarity of the haplotypes in the local vicinity [275].  The default 
parameters of the program were used throughout and the most likely genotype taken 
to be the imputed genotype.  Input files consisted of the reference panel genotype 
data (Set B/Set D) with a corresponding list of all SNPs contained in the high density 
panel after QC and the test panel genotype data in which all genotypes except those 
selected to be LDP SNPs were set to missing (Set C/Set E/Set D + E).  For reference 
purposes, missing genotypes were also imputed by random assignment of alleles to 
missing loci, assuming that the probability of a particular allele was equal to its 
observed frequency in the reference panel (Set B/Set D).         
The accuracy of imputation in the test panel was assessed in several ways.  Measures 
of accuracy were made both at the sample level and at the marker level.  Firstly, the 
proportion of correctly imputed genotypes was calculated as the number of correctly 
imputed genotypes divided by the total number of imputed genotypes.  Secondly, the 
correlation between the imputed and the true genotypes (coded as 0, 1, 2) was 
calculated.  In the case of monomorphic SNPs, loci were excluded from the 
correlation calculation.  These measures were made for the three different LDP SNP 
selection methods, six different LDP densities and four chromosomes.   
9.3 Results 
9.3.1 Within population assessment 
The accuracy of imputation from low to high density panels increased as the number 
of SNPs in the low density panel increased, as shown in Table 9-1 for ECA1 and in 
Figure 9-4 and Figure 9-5 for all chromosomes.  The increase was greatest at the 
lower densities, with the increase in accuracy from 1K to 6K being relatively less.  A 
large range in the proportion of genotypes correctly imputed was observed between 
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animals, particularly when the number of LDP SNPs was at its lowest when the 
range was typically around 0.4.  Whilst the difference in accuracy across the three 
LDP SNP selection methods was small or indistinguishable, selection methods 2 and 
3 did appear to reduce the variation in imputation accuracy across SNPs, particularly 
at lower SNP densities.     
The random imputation of genotypes based on allele frequencies in the reference 
panel demonstrates the minimum imputation accuracy that can be expected.  Figure 
9-6 shows the strong dependency of the accuracy of imputation on MAF when 
random imputation is used; the results follow closely the expectation, calculated as 
4224 4 qqpp   [92].  The relationship between MAF and imputation accuracy is 
less strong when BEAGLE is used to impute but becomes increasingly strong as the 
SNP density of the LDP decreases. 
In order to explore possible causes of heterogeneity in SNP imputation accuracy, 
imputation accuracy was plotted on SNP position (bp) (Figure 9-7).  In addition, 
average pairwise LD (calculated as in Chapter 6) was calculated in 1Mb sliding 
windows (0.5Mb overlap) and plotted alongside imputation accuracy.  Hypothesised 
centromere positions are also marked on the plots; these are regions that share some 
similarity with centromeric satellite sequences.  ECA1 centromere position is 
hypothesised to be at 66Mb or 89Mb; ECA10 centromere position is hypothesised to 
be at 28.2Mb although there is a second region, ranging from 81Mb to 83Mb, that 
also contains some centromeric satellite-like sequences; ECA 20 and ECA26 are not 
centromeric but regions identified here may, if the similarity with centromeric 
satellite sequences is real, represent locations harbouring centromeres in the past (C. 
M. Wade 2012, Pers. Comm.).  Plots show considerable variation in imputation 
accuracy across the chromosome which is often correlated with levels of LD.  The 
variation is particularly marked in the case of ECA10, where the high LD around the 
proposed centromere position led to a peak in imputation accuracy.  Using Method 3 
(lduMAF) to select LDP SNPs reduces the variation in accuracy across the 
chromosome, leading to a more consistent level of accuracy and a reduction in its 
correlation with LD levels.  This corresponds with the decreased variance of Method 
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3 shown in Figure 9-4 and Figure 9-5.  In general, the decrease in accuracy seen with 
Method 3 in regions of high LD was greater than the corresponding increase in low 
LD areas.  This explains the inability of this method improve mean accuracies above 
those achieved using Method 2 (bpMAF).     
 
Table 9-1 Mean (min., max.) proportion of correctly imputed genotypes by sample (ECA1) 
No. of SNPs
I
 bpEQ bpMAF lduMAF 
384 0.66 (0.52,0.93) 0.67 (0.55,0.94) 0.69 (0.55,0.92) 
768 0.76 (0.59,0.94) 0.77 (0.62,0.95) 0.78 (0.59,0.96) 
1K 0.79 (0.61,0.94) 0.84 (0.66,0.97) 0.83 (0.64,0.98) 
2K 0.90 (0.70,0.99) 0.91 (0.71,0.99) 0.89 (0.68,0.99) 
3K 0.94 (0.70,0.99) 0.95 (0.73,1.00) 0.92 (0.67,0.99) 
6K 0.97 (0.79,1.00) 0.98 (0.78,1.00) 0.95 (0.75,1.00) 
I
Total number of SNPs that would be on a genome-wide LDP of equivalent density 
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Figure 9-6 Proportion of correctly imputed genotypes plotted on the MAF of the SNPs (calculated 
in the reference panel) for ECA1 (bpEQ) 
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Figure 9-7 Proportion of correctly imputed genotypes and mean LD, presented as Lowess curves as calculated in R [140] [276-278], and plotted on SNP 
position (1K panel).  Key: Green – bpEQ; blue – bpMAF; red – lduMAF; black – mean r
2
 calculated in sliding windows of 1Mb (0.5Mb overlap); yellow – 
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An alternative measure of imputation accuracy, the correlation between true and 
predicted genotypes, was also calculated.  Accuracy rates were generally lower when 
expressed as correlations with considerable variation being observed across animals 
and SNPs (Table 9-2).  A comparison of the two accuracy measures (proportion 
correctly imputed and correlation between true and predicted genotypes) showed 
some correspondence but also MAF dependent variation in the relationship (Figure 
9-8a).  The adjustment of the proportion of correctly imputed genotypes by the 






 [263], where accuracy is the proportion of correctly 
imputed genotypes achieved and random accuracy is the expected accuracy that 
would be achieved using random imputation according to the aforementioned 
equation, 
4224 4 qqpp  .  This statistic adjusts for the fact that SNPs with low 
MAF are likely to be imputed to high accuracy by chance alone.  Plotting the 
adjusted statistic against the correlation between true and imputed genotypes shows a 
much stronger relationship between the two measures than when the raw accuracy 
was used.  Furthermore, the relationship is almost independent of MAF, although 
SNPs with lower MAF tend to illustrate more variation in both imputation accuracy 
and correlation (Figure 9-8b).     
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 bpEQ bpMAF lduMAF 
384 0.46 (0.14,0.89) 0.49 (0.20,0.91) 0.53 (0.22,0.89) 
768 0.64 (0.36,0.93) 0.66 (0.38,0.93) 0.69 (0.37,0.94) 
1K 0.70 (0.41,0.93) 0.78 (0.51,0.96) 0.75 (0.47,0.98) 
2K 0.86 (0.53,0.99) 0.88 (0.62,0.98) 0.85 (0.52,0.99) 
3K 0.92 (0.59,0.99) 0.94 (0.60,1.00) 0.88 (0.48,0.99) 
6K 0.97 (0.73,1.00) 0.97 (0.71,1.00) 0.93 (0.61,1.00) 
I
Total number of SNPs that would be on a genome-wide LDP of equivalent density  
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Figure 9-8 Correlation between true and imputed genotypes plotted on: a) proportion of 
correctly imputed genotypes; b) proportion of correctly imputed genotypes, scaled by random 
expectation.  Black – SNPs with MAF ≥ 0.40; blue – SNPs with 0.30 ≤ MAF < 0.40; green – SNPs 
with 0.20 ≤ MAF < 0.30; yellow – SNPs with 0.10 ≤ MAF < 0.20; red – SNPs with MAF < 0.10.  
Data for ECA1 and 1K panel.   
a 
b 
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9.3.2 Between-population assessment 
When Set B was used as the reference panel for imputation in the US dataset there 
was very little change in the mean proportion of correctly imputed genotypes relative 
to the within-population results (Table 9-3).  Using random imputation, no change in 
accuracy was observed for ECA1, whilst a small but consistent decrease in the mean 
of 0.01 was seen for ECA26.  This small difference is presumably due to the high 
correlation in MAF between the two populations which was calculated to be 0.91 for 
ECA1 and 0.90 for ECA26.  Using BEAGLE to impute gave a similar pattern of 
results with no change for ECA1 and a slight decrease in accuracy for ECA26. 
When Set D and E were used as reference and test sets, a slight increase in 
imputation accuracy was seen compared with the UK within-population results 
across both imputation methods and for all three LDP SNP sets (Table 9-3).  This 
increase is likely due to higher average genomic relationship of horses in the US 
dataset compared to the UK dataset; when average genomic relationships were 
calculated for all samples using SNPs on ECA1 (as in Chapter 8), the mean 
relationship between horses in the US dataset was 0.022, compare to 0.003 in the UK 
dataset.   There appeared to be no relative improvement of the bpEQ LDP SNP set 
over the more population specific LDP SNP sets (bpMAF and lduMAF), with the 
relative ranking of LDP SNP sets remaining unchanged when compared to the 
within-population assessment of the UK dataset. 
9.3.3 Relative Cost 
Of interest is the cost of genotyping horses for the LDPs relative to both the cost of 
genotyping at high-density and the loss of accuracy incurred.  In the following, it is 
assumed that a reference population of horses, of comparable genetic background, 
have already been genotyped at high density (either 50K or 70K).  Estimated 
genotyping costs were provided by Illumina for 3,072 to 6K SNPs based on their 
iSelect Infinium Assay and by Neogen for 384 to 2K SNPs, with 1K and 2K panel 
prices based on a custom chip construction.  A minimum order size of 1,152 samples 
applies to all custom panels from both companies.  Neogen are also the current 
providers of the 74K SNP chip which costs £115 per sample.  The 50K chip is no 
longer available so the 74K chip is used to represent the high-density genotyping 
The application of genomic technologies to the horse 
Chapter 9 The utility of low-density genotyping in the Thoroughbred 189 
option although it is possible that imputation accuracies up to 74K would be slightly 
different to those observed here.  Figure 9-9 shows the cost of the different sized 
chips plotted against the average imputation accuracy (expressed as the correlation 
between the imputed and the true genotypes).  In this plot, the most advantageous 
place to be would be the bottom right-hand corner, as here you benefit from both low 
cost and high accuracy.  It is assumed that 100% accuracy is achieved by genotyping 
horses for all SNPs on the high-density panel, although the realised accuracy would 
be slightly less than this due to genotyping errors.           
 
 
Figure 9-9 The cost of genotyping relative to the maximum (high-density) and plotted against 
average accuracy, expressed as the average correlation between imputed and true genotypes 
across the four chromosomes (bpMAF) 
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Table 9-3 Mean (standard error across SNPs/samples) proportion of correctly imputed 
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9.4 Discussion 
In this study, the efficacy of imputation from low to high density in a sample of 
Thoroughbred horses was investigated.  Using equidistant LDP SNPs (bpEQ), the 
mean proportion of correctly imputed genotypes ranged from 0.59 at the minimum 
LDP SNP density of 0.09Ne/Morgan, to 0.97 at a density of 1.44Ne/Morgan.  The 
relative increase in accuracy was greater between 0.09 and 0.48Ne/Morgan, than 
between 0.48 and 1.44 Ne/Morgan.  By calculating equivalent Ne/Morgan marker 
densities in other studies, my results can be compared to those conducted in other 
species.  Using a 2K low-density panel in Border Leicester sheep, equivalent to a 
SNP density of 0.23Ne/Morgan (assuming Ne=242 [279] and a total genome length of 
36.3 Morgans [280]), Hayes et al. (2011) [263] achieved an imputation accuracy of 
approximately 0.73.  Results here using the 1K bpMAF SNP panel (0.24Ne/Morgan) 
thus compare favourably, with accuracies ranging from 0.74 to 0.84 across 
chromosomes.  Equivalent results from a study of Jersey cattle were in the range 0.7 
to 0.8 [262].   
By comparing results here to those of other studies which have gone on to examine 
the impact of imputation accuracy on subsequent use of the imputed genotypes, it 
can be determined whether the imputation accuracies here are likely to be high 
enough for implementation in the future.  Daetwyler et al. (2011) [263] observed that 
the accuracy of GEBV achieved for a sparse subset of markers, as a percentage of 
that achieved for the dense accuracy, was in all cases greater than the proportion of 
correctly imputed genotypes.  Specifically, when 87.8% of missing genotypes were 
correctly imputed, 95% of the dense genomic evaluation accuracy was achieved.  
Furthermore, the imputation accuracy achieved here for the 3K panel (≥0.90), was 
very similar to that reported by Weigel et al. (2010) [281] (0.912) with a 2,942 SNP 
panel, despite the actual SNP density likely being lower in the Thoroughbred 
(0.72Ne/Morgan compared to 0.93Ne/Morgan in the Jersey cow, assuming Ne=100 
[92] and total genome length of 31.6 Morgans [282]).  Weigel et al. (2010) [281] 
demonstrated GEBV accuracies for daughter pregnancy rate (DPR) of 0.642 when 
imputation (from 2,942 SNPs) was used compared to 0.674 when all SNPs were 
genotyped (42,552 genotypes).  Given these results, it seems likely that a 2K to 3K 
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LDP would enable sufficiently high imputation accuracies to be useful in the 
Thoroughbred.  The accuracy of imputation and therefore the predictive ability is 
likely to be slightly greater in the Thoroughbred than in other horse breeds because 
of the higher LD (and smaller effective population size) [23].      
When correlation was used to assess imputation accuracy, the relative rank of the 
different methods remained unchanged.  When compared across SNPs, the two 
measures of accuracy were correlated (Figure 9-8) but there was a strong bias in the 
proportion of correctly imputed genotypes due to MAF of the SNPs.  Adjusting the 
proportion of correctly imputed genotypes by the expected accuracy using random 
imputation significantly reduced the bias, whilst emphasising the greater variation in 
imputation accuracies seen for SNPs with low MAF.  Correlation therefore provides 
a MAF independent assessment of imputation accuracy, a property which makes it a 
preferable measure of accuracy to the proportion correctly imputed (a similar 
conclusion was also reached by Hickey et al. (2012) [283] in a study published after 
this work was done).  However, accuracy expressed as the proportion of correctly 
imputed genotypes is more easily compared to other studies and so is also presented 
here. 
There was considerable variation in imputation success both across SNPs and across 
samples.  The range in imputation accuracies was greatest for the lowest density SNP 
panels.  For example, at a LDP SNP density of 0.09Ne/Morgan, some SNPs were 
imputed correctly in all samples, whilst others were correct in only 30% of samples 
(based on ECA1 bpMAF results).  Increasing the density of the LDP led to an 
increase in the minimum accuracy so that by 1.44Ne/Morgan, the minimum was 
around 80%.  A similar pattern was seen in the variation across samples, albeit with a 
slightly smaller range of less than 50%, even at the lowest LDP SNP density.  As 
expected, using random imputation, there was a direct and predictable relationship 
between the MAF of the SNPs and the accuracy with which they were imputed.  This 
relationship was much less strong when using BEAGLE to impute, except at the 
lowest LDP SNP densities when presumably the amount of additional information 
available from LD was low. 
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A major source of the variation in SNP imputation accuracy was the extent of LD, 
with variation being seen both between and within chromosomes.  There was a 
tendency for imputation accuracies to be higher for the longer chromosomes (ECA1 
and ECA10) and this coincides both with the higher average LD of these 
chromosomes demonstrated in Chapter 3 and results of Weigel et al. (2010) [262].  
Within chromosomes, SNPs located within regions of high LD were typically 
imputed more accurately than those in regions of low LD.  The strength of this 
relationship varied across the four chromosomes being most obvious for ECA10 and 
least convincing for ECA1.  In the case of ECA10, the region of highest LD (and 
imputation accuracy) also coincided with the hypothesised position of the centromere 
on this chromosome.  However, this relationship was not seen on ECA1, which 
suggests that the processes underlying the LD may be important.   
Given the relationship between MAF and SNP imputation accuracy, one hypothesis 
is that, by preferentially selecting LDP SNPs to be more informative, that is, to have 
a high MAF, whilst at the same time ensuring relatively consistent coverage across 
the chromosome, imputation accuracies could be improved.  The increase in 
accuracy achieved by using a stochastic algorithm to do this (bpMAF) was small but 
consistent, ranging from 1.6% to 4.4% for the 2K panel.  The biggest increase was 
seen in the range of SNP panel densities from 768 to 3K and for ECA20 and ECA26.  
This corresponds with results of Hayes et al. (2011) [263] who also saw little benefit 
in using MAF to select SNPs for LDPs of 5K or more.  Using bpMAF LDP SNPs 
also resulted in a decrease in the across SNP variation in imputation accuracy 
compared to the bpEQ method.   
Given the relationship between LD and SNP imputation accuracy, a further 
hypothesis is that by taking account of LD during the LDP SNP selection process, 
the across SNP variation in imputation accuracy could be reduced.  The use of LD in 
the selection of LDP SNPs is not new, and several algorithms exist that use either 
pairwise or multimarker LD statistics to help select the most informative LDP SNP 
set [264, 265].  However, in this case, a more natural extension to the approach being 
used (bpMAF) was simply to adapt the input so that SNP locations were made 
relative to the amount of LD in the region.  In fact, the stochastic algorithm used here 
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was initially designed to be used with cM locations, in which case patterns of LD 
related to recombination rate would naturally be incorporated.  However, in the case 
of the Illumina Equine SNP50 BeadChip, all marker locations are given in base pairs 
and whilst some markers may have corresponding positions on the equine linkage 
map [22] to re-position all SNPs in this way would be unfeasible.  As an alternative, 
LD map distance was used, which has been shown to have a close relationship with 
linkage maps [284] and recombination rates, at least to the extent that recombination 
hot spots can be identified [285]. 
Using lduMAF LDP SNPs did result in a decrease in the across SNP variation in 
imputation accuracy as hypothesised, particularly at the lower SNP densities.  Figure 
9-7 shows that by using this approach, the relationship between LD and imputation 
accuracy across chromosomes was indeed broken down.  The change in mean 
imputation relative to results using bpMAF was small and inconsistent, with an 
increase in accuracy seen for ECA26 and a decrease for ECA1.  The results shown in 
Figure 9-7 suggest that when using lduMAF LDP SNPs, whilst there is an increase in 
imputation accuracy where LD is low (due to a greater concentration of SNPs), the 
decrease in accuracy where LD is high is relatively greater, leading to a tendency for 
the mean imputation accuracy to be reduced.  It may be possible to increase the 
overall mean imputation accuracy achieved with the lduMAF SNP set by inserting an 
additional SNP selection criterion into the algorithm such that the LD between the 
selected SNPs is reduced (B. Kinghorn 2012, Pers. Comm.).  In contrast to the other 
chromosomes, using lduMAF LDP SNPs on ECA26 led to an increase in imputation 
accuracy across the entire latter half of the chromosome (for the 1K panel), which 
suggests some dependence on LD at the level of the chromosome.  Further benefit 
may therefore be seen if this approach was applied at a genome-wide level such that 
the number of LDP SNPs per chromosome was proportional to the total LD map 
distance of the chromosome, rather than the base pair length as in the current 
implementation.      
The fact that by using lduMAF the across SNP variation in accuracy can be reduced, 
but the mean accuracy of imputation not reliably increased, leads to the question of 
which properties are most important when assessing efficacy of imputation.  
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Specifically, are higher mean accuracies actually advantageous, even though some 
SNPs and some individuals may actually be poorly imputed?  Or are lower mean 
accuracies preferable if a greater proportion of SNPs (or individuals) are imputed at a 
given threshold?  Furthermore, should the focus be on the distribution of accuracies 
across SNPs or across samples?  The answer to these questions almost certainly lies 
in the intended use of the imputed genotypes and there does not seem to be any 
methodology for assessing imputation performance in the context of its application at 
this time.  Given the likely dependence on use of the imputed genotypes, a solution 
might be derived in the form of a loss function, whereby, a strategy is selected that is 
consistent with the actual loss experienced, in the context of a particular problem, for 
example, a GWAS.  Alternatively, the success of imputation might be measured 
according to some utility function, such that when plotted against, for example, 
chromosome position as in Figure 9-7, the area under the curve becomes informative 
with respect to the optimum scenario.  The development of such a method to assess 
imputation success in the context of its application would allow a more quantitative 
comparison of the different SNP sets used in this study, in particular the relative 
usefulness of the novel lduMAF approach and might also help to evaluate the relative 
cost of a missing genotype, as compared to a wrong genotype.  At the current time, 
the uncertainty in imputed genotypes is generally dealt with either by setting a 
minimum threshold on the confidence with which a genotype is assigned or by using 
a genotype probability in place of the most likely genotype [92].  However, these 
approaches do not take into account the variance associated with the estimates.  
Meanwhile, several approaches have been proposed to take into account the 
uncertainty of imputations when performing GWAS and tend to be based on 
Bayesian frameworks [258, 286-290].  Utilising these with simulated data might be 
the next step to resolve the issue of whether uniform accuracy is more desirable than 
a high mean, at least for GWAS.               
The transferability of LDPs both across breeds and across countries within breeds is 
an important consideration when designing a LDP.  Here data from a cohort of US 
Thoroughbreds was used to evaluate the impact of geographical origin on the 
efficacy of imputation.  A 2K panel density was used to assess the between-
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population efficacy since at this density, the within-population accuracy was always 
greater than 0.8.  Whilst comparisons involved both reference sets and test sets of 
differing sizes, my work (data not shown) and that of others [263, 281] has shown 
reference set size not to have a major impact on imputation accuracy across the range 
used here.  Using a UK reference set to impute genotypes in a US test set had no 
impact on the proportion of correctly imputed genotypes for ECA1, regardless of the 
SNP selection strategy.  A slight decrease in accuracy was observed for ECA26, but 
accuracies remained above 0.8. 
When the UK reference set was replaced with a US reference panel for predicting the 
US data, imputation accuracies increased above those seen both in the first between-
population assessment and in the within-population assessment of UK horses, despite 
the bpMAF and lduMAF LDP SNP sets being tailored to the UK dataset.  This 
increase is presumably due to the higher average relationships in the US dataset 
which has been shown to improve imputation accuracy [283].  Whilst this difference 
in sample properties between the US and the UK samples does not allow the direct 
comparison of the corresponding within-population results, the fact that there was no 
difference in the relative increase between the bpEQ LDPs (not population 
dependent) and the bpMAF and lduMAF LDPs (selected using the UK dataset), 
suggests that the LDP SNP sets are equally appropriate for both populations.  This 
implies that similar LD patterns exist in both populations.  This in turn indicates that 
either, the genetic differentiation between the UK and US populations is small, or, 
that similar LD structure exists due to a common recombinatorial background.  The 
high correlation between MAF across the two populations lends some credence to 
the former argument, whilst the relationship between LD and the centromere position 
in ECA10 suggests the latter is also relevant.  The small difference in accuracy 
observed here correspond to results of Weigel et al. (2010) [262] who found that 
subdividing their population of Jersey cattle by country of registration, allele 
frequency similarity or by sire family, did not improve imputation accuracy.  Whilst 
there appears to still be an advantage to using the bpMAF or lduMAF LDP SNP sets 
in a population of the same breed but different geographical origin, whether this will 
still be true when looking across breeds remains to be seen.  The frequent sharing of 
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major haplotypes among diverse horse populations [23] suggests some accuracy 
should be maintained; further indications may be sought from across breed 
comparisons of allele frequencies.  Furthermore, with allele frequencies and patterns 
of LD constantly changing over time, LDPs based on these properties may become 
less effective as generations progress.  
The loss in accuracy that occurs as a result of using lower density SNP panels must 
also be considered alongside the cost savings that would be achieved and this is 
demonstrated in Figure 9-9.  The fact that some SNPs will require more than one 
beadtype on the chip has not been accounted for, although preliminary analysis 
suggests there are no A/T or C/G SNPs on the chromosomes analysed in this study 
and so the impact of this is expected to be minimal.  There is no difference in cost 
between genotyping 768 and 2K SNPs, or between genotyping 3,072 and 6K SNPs 
and therefore, the logical choice is between a 384, a 2K and a 6K SNP panel; these 
options offer 42%, 84% and 96% of the accuracy for 17%, 29% and 40% of the cost, 
respectively.  Whilst the increase in cost is almost linear across this range, increasing 
by $20 (USD) from 384 to 2K and another $20 from 2K to 6K, the increase in 
accuracy is more than three times greater from 384 to 2K than from 2K to 6K, 
suggesting that a 2K SNP panel represents better value for money.  However, certain 
uses may demand certain accuracies, in which case cost may be less important.  
The results of this study show that it is possible to impute genotypes from low to 
high density in the Thoroughbred with reasonable to high accuracy.  The haplotype 
phasing and imputation program used here (BEAGLE) has been shown to perform 
similarly to other available software [261, 263, 275] and therefore the results are 
thought to be representative.    An investigation of the source of variation in 
imputation accuracy revealed dependence both on MAF of the SNPs being imputed 
and on the underlying LD structure.  Confirmation of some of these results has since 
become available in a publication which explored similar dependencies when 
imputation was carried out in maize [283].  Whilst equidistant LDP SNPs work well, 
optimising LDP SNP selection to increase their MAF was advantageous, even when 
LDPs were subsequently used in a population of different geographical origin.  By 
using LD map distance in place of base pair position, the variation in imputation 
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accuracy across SNPs was reduced.  Whilst a 1K panel was generally sufficient to 
ensure more than 80% of genotypes were correctly imputed, inference from other 
studies suggests that a 2-3K panel would ensure the subsequent loss in accuracy in, 
for example, GS analyses was minimal.  Furthermore, the relationship between 
accuracy and genotyping costs for the different LDPs, suggest a 2K SNP panel 
would represent good value for money.  More work is needed to evaluate the impact 
of between breed differences on imputation accuracy.  As well as enabling use of 
low-density SNP panels as a low cost alternative to high-density genotyping, 
imputation provides a means by which datasets from different genotyping platforms 
can be combined, something which will be necessary as researchers start to use the 
recently developed equine 70K SNP chip. 
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Chapter 10: General discussion 
This chapter provides a general overview of the contents of this thesis and is 
presented in four parts.  Part 1 is a brief summary of the main contributions of the 
thesis.  Parts 2 and 3 comprise of a précis of the results contextualised within the 
limitations of the methods used.  The final section considers the future for the 
application of genomic technologies to the horse.        
10.1 Summary 
This thesis represents one of the first explorations of the use of high-density SNP 
genotyping technology in the horse.  The potential of the SNP chip to be used to 
investigate quantitative traits, in particular complex diseases, has been investigated 
both from a theoretical perspective and empirically, using osteochondrosis (OC) in 
Thoroughbreds as a case in point.  An assessment of Thoroughbred genome coverage 
offered by the 50K SNP chip, based on a comprehensive analysis of linkage 
disequilibrium (LD), revealed good average coverage.  However, this work also 
showed considerable variability both in LD and in the distribution of SNPs across the 
genome.  Whilst this is to be expected, especially given that the 50K chip was the 
first high-density genotyping chip developed for the horse, researchers should be 
aware that some areas of the genome are not well captured.  My efforts to use LD to 
explore the demographic history of the Thoroughbred population suggested that 
some information about a population’s history can be gleaned in this way.  However, 
a subsequent critique of the method identified a number of limitations relating to the 
application of the theoretically derived models to data from real populations.  This 
work highlights the need for researchers to be aware of the assumptions underlying 
such models and to interpret the results of such analyses accordingly.  Linkage 
disequilibrium was also used to examine the quality of the sequence assembly itself.  
As well as providing molecular geneticists with a potential approach for targeting 
regions of the genome for re-sequencing in the future, this work served as a reminder 
of the preliminary nature of the current assembly. 
The conclusion from the series of LD analyses performed was that the SNP chip 
should, in theory, be a useful tool for studying the genetic background of complex 
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diseases such as OC.  However, the empirical evidence from this study suggests that 
major challenges remain in the application of new genomic approaches to the horse.  
At the outset of this study, considerable effort had to be invested in deriving a dataset 
suitable for genomic analysis.  The issues faced during this process demonstrate a 
clear need for the development and implementation of standard collection 
methodologies for use by equine clinicians and researchers.  The results of both the 
genome-wide association study (GWAS) and the genome-wide evaluation (GWE) of 
OCD conducted as part of this study were disappointing given the theoretical 
potential of the SNP chip to capture genetic variation in the population of 
Thoroughbred horses used.  A significant conclusion from this work is therefore that 
large, well-phenotyped cohorts of horses will be essential if the true potential of 
genomic technologies are to be realised in the horse.  One recommendation to both 
equine researchers and the equine industry more generally, is to focus their efforts on 
sample collection.      
10.2 Linkage disequilibrium and effective population 
size: Theory and practice 
Linkage disequilibrium has a long history as a parameter of interest to population 
geneticists, as evidenced by the date range of the references given in Chapters 2 to 5.  
At the outset of this thesis, the extent and decline of LD in the Thoroughbred had not 
been comprehensively examined, but was of considerable interest because of its 
relevance in determining how well genetic variation would be captured by the 50K 
SNP chip.  Whilst the use of r
2
 to measure LD has been criticised in the past for 
reasons discussed in Chapter 5, it remains the most widely used statistic to quantify 
LD using high-density genotype data.  This is due to both its relative ease of 
calculation and its relevance to GWAS such that, to achieve approximately the same 
power at the marker locus as would be achieved by genotyping the susceptibility 
locus, the sample size must be increased by a factor of    ⁄  [291].  Therefore, in 
Chapter 3, r
2
 was calculated in order to determine the likely efficacy of such 
methodologies as GWAS.  The analysis revealed high average LD at short distances 
which declined fairly slowly, reaching baseline levels at around 50Mb.  In terms of 
genome coverage, this high LD points towards a good level of coverage on average.  
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However, there is expected to be considerable variability in coverage due to both an 
uneven distribution of markers across the genome and variable recombination rates.  
Whilst this high average LD is an advantage with respect to power to detect QTL 
associated with traits, it may make the identification of causal variants by fine-
mapping more difficult.  This issue has already been raised by Orr et al. (2010) [292] 
who, despite genotyping additional markers, were unable to further refine a 2Mb 
region identified in a GWAS for dwarfism in Friesian horses.  Whilst this problem 
may be overcome to some extent by exploiting across breed recombination, the high 
rate of haplotype sharing across breeds [23] may hinder progress by this route.   
Whilst this characterisation of LD in the Thoroughbred has given some indication of 
how well GWAS and the plethora of other methodologies that are reliant on LD 
between markers and causal variants can be expected to perform, there are many 
more factors that play a role.  The genomic architecture of the trait is another 
important factor in determining which, if any, causal variants will be identified.  
Several studies have looked at the impact of the allele frequency of variants and the 
strength of their phenotypic effects on power of detection, that is, on the ability to 
reject the null hypothesis of no association whilst controlling for the type I error rate 
[37, 42, 48].  In general, if causal alleles are rare (minor allele frequency <0.1) and 
effect sizes small (odds ratio <1.3), then they will not be detected, with realistic 
sample sizes (below 10,000) [48].  As well as having a direct impact on GWAS 
power, the allele frequency of variants is also important in the context of LD.  In 
order for the r
2
 between a causal variant and a marker variant to be high, the 
frequencies of the coupled loci must be similar.  If, as has been suggested by some, 
disease causing alleles occur at low frequencies in the population, our power to 
detect them using relatively common SNPs will necessarily be low.  So, whilst 
calculating summary statistics of r
2
 as in Chapter 3 has provided some useful 
information, it is only a piece of the puzzle. 
As well as being used directly as an indication of the genome coverage achieved 
using the 50K SNP chip, the extent and decline of LD was used here to infer the 
effective population size (Ne) of the two Thoroughbred populations from which 
samples were collected.  Initially, this analysis simply represented a means to an end.  
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In order to estimate the predictive accuracy of GWE in the Thoroughbred, using 
deterministic equations derived by Daetwyler et al. (2008) [61], an estimate of Ne 
was required.  Because no pedigree was available for the sampled horses, alternative 
marker-based methods were explored.  Whilst there were several options available 
for estimating Ne using marker data, some assumed multi-allelic markers whilst 
others needed two or more samples to be collected from the population over a period 
of time.  The most appropriate method, given the data available for this study, 
seemed to be that used by Tenesa et al. (2007) [139] in which the theoretical 
relationship between expected r
2
, the distance between markers and the Ne of the 
population was used.  This approach was thus implemented in Chapter 3 and two 
estimates of Ne calculated for each sample.  The first, was a single estimate assuming 
constant Ne, and the second, a series of estimates going back in time, under the 
assumption of linear change in Ne [138].  The results from this analysis largely 
coincided with expectations based on pedigree analyses by other authors, the 
demographic history of the Thoroughbred and the origins of the samples.  The small 
estimated Ne of the population, led to relatively high predicted accuracies for GWE 
of between 0.15 and 0.30 for trait heritabilities typical of complex diseases and for 
reference sample sizes similar to those available for this study.    
Despite obtaining Ne estimates which were largely in agreement with expectations, a 
review of literature around the method used revealed considerable variation in the 
way in which the method had been applied in different studies in the past.  Evidently, 
there was some confusion over exactly how the model should be implemented, for 
example, whether adjustments were necessary to account for sample size and 
mutation.  This apparent disagreement surrounding the optimal model, combined 
with the failure of empirical datasets to conform to the theoretical assumptions under 
which the models had been derived, led to some doubt over the accuracy of the 
estimates calculated using this approach.  Therefore, the application of this method 
progressed from being a means to an end to being the focus of a new investigation.  
This investigation (Chapter 4) served as a reminder of the limitations that must apply 
when theoretically derived formulae are applied to real world data.  An alternative 
approach to estimating Ne from marker data that exploited linkage information in a 
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different way (the CLE method used in Chapter 5), though useful in certain 
circumstances, was found to have its own limitations.  Such methods will likely 
continue to be refined with time and new alternative approaches developed to replace 
them as more is understood about what influences genome structure.           
10.3 Genetic control of osteochondrosis  
At the outset of this study, no GWAS for OC in the horse had been published.  
However, prior to the publication of the work in Chapter 7, three such studies had 
made it to press.  This demonstrates both the current relevance of OC to the equine 
industry and the perceived benefits in tackling the disease using genomics over 
traditional pedigree-based selection methods.  However, given the results to date and 
the wider context discussed below, it seems likely that there is a long way to go 
before QTL identified in GWAS will be making any contribution to a reduction in 
OC.  At the present time, despite many QTL having been identified, including one in 
this thesis (Chapter 7), no validated markers for OC have been published.  
Furthermore, the attempted validation of QTL in Chapter 7 resulted in at best the 
tentative confirmation of two regions.  In some sense, it is not a surprise that these 
studies have essentially failed to produce a marketable product.  More than ten years 
ago, the limited potential for MAS to be useful in livestock breeding for complex 
traits was recognised and people started looking for alternative approaches, namely 
GWE [51, 52].  Those involved in the research of complex disease in humans are 
also increasingly turning towards GWE as it has become evident that few genetic 
variants exist that have a sufficiently large effect on the phenotype to be clinically 
relevant.  Therefore, whilst GWAS of complex disease continue to be carried out, the 
main motivation must be to improve knowledge of the underlying pathogenesis of 
the condition which in turn can contribute to developing better treatments and 
management strategies, rather than to identify markers for the implementation of 
MAS.  Meanwhile, the future for selection to reduce the incidence of complex 
disease appears to be focused on GWE. 
The potential for GWE to be used in the breeding of horses has already been 
recognised [249, 250].  Interestingly, in the only published application of GS to the 
horse to date, Ricard et al. (2012) [293] suggest GS has little advantage over 
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traditional BLUP-based selection when applied to showjumping.  However, it could 
be argued that, if similar GEBV accuracies (0.37-0.51) could be achieved with 
respect to OC, significant progress could be made in reducing disease incidence.  
Unfortunately, given predicted accuracies (from Chapter 3) in the range of 0.11 to 
0.21, the results of the GWE performed in this thesis (Chapter 8) were disappointing, 
with neither of the models used producing GEBV with any predictive value for the 
phenotype.  However, GEBV generated for a simulated phenotype achieved 
predicted accuracies, suggesting the failure to achieve expected accuracies with the 
true data may well be due to characteristics of the disease and/or the sample or 
incorrect assumptions with respect to these properties, rather than problems with the 
expectations.  For example, power may have been reduced due to factors such as 
population substructure and misclassification.  It is likely that, because of the issues 
surrounding OC definition discussed in 1.3.4, OC studies will have less power than 
might be predicted when assuming a perfect sample.  Greater sample sizes will 
therefore be needed to provide a proof of principle for GWE applied to complex 
disease in horses.     
The results in Chapters 7 and 8 will have been influenced to some extent by the type 
of analysis performed, with both approaches making certain assumptions about the 
underlying genetic model of disease.  The major driver of association analyses is the 
common disease common variant (CDCV) model, with analyses being designed to 
distinguish genetic variants which are shared by a large number of affected 
individuals.  If, however, this assumption is false and complex disease occurs as a 
result of an accumulation of much rarer variants, GWAS will have little power to 
detect them [40].  Not surprisingly, this has been put forward as one of the potential 
explanations for the disappointing results of GWAS to date and the problem of the 
so-called ‘missing heritability’ (see 1.2).  In contrast, GWE might be better placed to 
exploit these variants but would still require large sample sizes to accurately estimate 
their effects.  In reality, it seems likely that neither of these theories truly represent 
the highly complex nature of the true genetic architecture of complex traits. 
The methods underlying both the GWAS and the GWE performed in this study are 
biased towards capturing additive genetic variation and such models tend to be 
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adopted because of their superior power.  For example, in GWAS a test of allele 
counts can be done with a single degree of freedom whilst a test of three genotypes 
means an additional degree of freedom.  However, it should be recognised that, if the 
genotype risks are not additive, for example in cases of dominance or epistasis, 
assuming an additive model represents a loss of power [294, 295].  In GWAS, a 
possible alternative to fitting an exclusively additive model is to take the maximum 
test statistic from tests designed to detect additive, dominant and recessive models of 
inheritance [296, 297].  Whilst this strategy is a manageable prospect, the study of 
epistatic effects in association studies is much more daunting due to the large number 
of tests that have to be performed.  However, the computational burden of such 
analyses is being rapidly eroded through the use of novel data processing techniques 
[298] and researchers should soon be able to quantify the contribution of epistasis to 
genetic variation more easily.  In the case of GWE, the use of alternative semi-
parametric or non-parametric approaches to GEBV prediction has been advocated to 
overcome problems relating to the assumption of additive inheritance.  De los 
Campos et al. (2009) [299] state that a Reproducing Kernel Hilbert Spaces (RKHS) 
methodology can be used under any genetic model, whilst Gonzalez-Recio (2008) 
[53] advocate RKHS and kernel regression methods to account for non-additive 
genetic effects, including dominance and epistasis.  More recently, Gianola et al. 
(2011) [300] have explored the possible application of Bayesian neural networks in 
capturing the non-linear relationships between predictors.  Also of interest when 
dealing with binary outcome traits such as the OC phenotype used in Chapters 7 and 
8, is the machine learning classification procedure of Long et al. (2007) [54].  This 
methodology involves a two-step feature selection procedure such that the most 
informative SNPs are first selected and then fed into a so-called ‘wrapper’ step, 
which uses a naïve Bayesian classifier to build the predictive model [54].  These 
approaches represent a potential alternative to parametric methods for use in cases 
where the mode of inheritance is not thought to be additive but, initial results suggest 
that the improvement in the accuracy of GEBV that can be achieved is relatively 
modest [92]. 
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10.4 The future for genomics in the horse 
The story told in this thesis parallels developments in the field of equine research as 
we have entered the so-called genomics era.  As outlined in Chapter 1, fantastic 
progress has been made with regard to equine genetics and genomics over the last 
twenty years, with the efforts of a relatively small number of individuals pushing 
equine genetics up the research agenda worldwide.  However, it seems likely that 
harder times are already upon us, with the funding available for equine research in 
the current economic climate being severely limited.  The emphasis is now as much 
on exploiting current resources so that they can be maintained as it is on striving to 
develop new research tools.  During the course of this study, Illumina ceased 
production of the 50K SNP chip due to lack of demand.  Whilst Geneseek, now a 
Neogen company, took on the project of developing a new 70K chip, the future of 
this product may now also be under threat.  Furthermore, the identification of 
potential sequence errors in Chapter 6 and the lack of information available on the 
equine specific function of many genes, demonstrates the importance of work being 
carried out to refine and annotate the draft genome sequence.  So, the question 
becomes, how do we ensure genomics in the horse remains a viable proposition in 
the future?   
For tangible benefits to be seen by the horse industry from using genomic 
methodologies such as those demonstrated in Chapters 7 and 8, greater sample sizes 
are needed across a wide range of relevant breeds both for preliminary analysis and 
for subsequent validation work.  Factors that are currently inhibiting the large scale 
collection of well-phenotyped samples include: cost, logistics, suspicion in the 
industry and a lack of agreement about disease phenotypes amongst practitioners.  
Whilst these factors are also relevant to other species, they are often exaggerated in 
the case of the horse.  The cost of producing and maintaining horses is much greater 
than in most other livestock and it would be extremely costly to establish 
experimental populations of horses to study complex diseases.  Therefore, 
researchers generally have to work with existing populations of horses and this is a 
huge logistical task and typically involves visiting a large number of yards and 
veterinary clinics to collect samples.  Researchers are then dependent on the good 
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will of horse owners whose permission is required to collect samples.  Whilst many 
owners are willing to contribute to genetic studies, others are wary of the impact of 
such research on the value of their animals.  How then can larger sample sizes be 
secured for future studies?   
The genotyping of some samples at lower density and the use of imputation to fill in 
the ‘missing’ genotypes, could be a strategy that benefits the equine industry at both 
the research level and the implementation stage.  Provided a reference population of 
several hundred horses has been genotyped at high density (either for the 50K or the 
70K SNP chip), new samples need only be genotyped for several thousand SNPs 
which can be done at lower cost, thereby increasing the number of horses that can be 
genotyped for a given budget.  The validity of this approach in the Thoroughbred has 
been demonstrated in Chapter 9 but a significant question that remains is how 
accurately imputation will be when applied across breeds.  In particular, the potential 
for this approach to be applied to the UK sport horse is not clear given the likely 
genetic heterogeneity of this population.  This represents an important piece of 
outstanding research that should be prioritised in future.   
There is a great need for a more cost-effective approach to the study of disease and 
performance traits in the horse.  A large proportion of the time and cost involved in 
setting up a project from scratch is invested in sample collection.  This aspect of the 
project also represents the biggest risk in terms of project failure and can therefore 
make funding providers wary of supporting projects which are reliant on collecting 
large numbers of samples.  Where projects are funded, the conclusion of the project 
typically sees the samples which were collected relegated to the back of a freezer.  
Whilst some researchers may intend to use samples again, the reality of the situation 
is that poor record keeping and a lack of standardised procedures frequently prohibits 
their further use.  Furthermore, under the current system, a series of barriers make 
subsequent sharing of samples difficult.  Taking OC as an example, whilst more than 
1,000 horses with a confirmed presence or absence of OC have been genotyped for 
the 50K SNP chip (based on GWAS published to date), a meta-analysis of this data 
represents a challenging prospect at both a practical and a political level.  Samples 
have been collected according to different criteria relating to the presence of 
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radiographic findings as specified by the project veterinarian(s).  Therefore, unless 
full and complete records exist for each horse that was sampled, for example, 
radiographs and surgery reports, it would be impossible for the same phenotypic 
criteria to be applied retrospectively to all cases.  It was this concern that motivated 
the collection of additional details about OC lesions in the cases for this study (2.4).  
Furthermore, all the factors that are relevant at a single project level, for example, 
issues of population substructure and environmental factors, still apply.  Politically, 
there are issues relating to funding and intellectual property (IP) that make 
retrospective collaborations difficult to set up.  Funding providers need to agree that 
data can be shared and complex legal documents need to be drafted to ensure that, in 
the event the results are of value in a patentable sense, the rights to the commercial 
exploitation of the IP have been clearly established. 
An alternative to combining samples in a meta-analysis is to collect samples in a 
cooperative way in the first instance, for example, through the establishment of a 
biobank.  A biobank is an organised collection of biological samples and associated 
data from large numbers of people or animals.  Samples and data can be made 
available to researchers to use in genetic and epidemiological studies of complex 
traits and diseases.   The potential of this approach was recognised in the field of 
biomedical research some time ago, with the first official collaborative biobanks set 
up at the beginning of the century and several biobanks now containing samples and 
data from tens of thousands of people.  Whilst banks of animal samples exist, they 
tend to be on a small scale and set up on an ad hoc basis.  A nationwide or 
international scale equine biobank could enable the collection of the large numbers 
of samples required for genomic analyses to be carried out more efficiently.  
Furthermore, if samples were banked prospectively, researchers would be able to 
present much less risky research proposals to funders in the future.  However, the 
success of this approach is dependent on a wide range of factors relating both to the 
equine industry and to the research community.  These factors will be investigated in 
a feasibility study, commissioned by the British Equestrian Federation, to determine 
whether a UK equine biobank would enable the horse industry to better exploit new 
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genomic technologies in the future.  Some materials which have been produced for 
this project can be found in Appendix B. 
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Appendix A: Supplementary documents 
A.i Details of Meta-Analysis 
In the meta-analysis there are k chromosomes and for each chromosome a parameter 
μ is estimated.  The value of μ may vary between chromosomes so that the i
th
 
chromosome true value is μi, and this is estimated as i̂ , with sampling error 
  2ˆvar iii s  .  Let    ivar
2
 be the variance between chromosome 
parameter estimates, where μ is now the mean value over chromosomes.  Each 
estimate i̂  is then an independent estimate of μ with sampling error 
22
is .  The 
best estimate of μ is then  
i
iiw  ˆˆ , where  















iwes  .  This requires an estimate of 
2  to use in the weighting.  
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iiw ww  ˆ  and 
2 ii sw  {note that w  is also an estimate 
of μ but using sub-optimum weighting iw , not 

iw .  Since    














, equating the observed wQ  with its expectation 




























22 1,0maxˆ  
The maximisation step provides an estimate of 
2  with lower mean square error 
should 0ˆ 2 w .  This value is then used to calculate 

iw , ̂  and  ̂..es  as described 
above. 
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A.ii Details of simulation validation 
The expected number of segregating sites was calculated according to the formula 
kk maS  , where Sk is the expected number of segregating sites, uNe4 , u is the 
mutation rate, m is the number of nucleotides in the sequence (assuming 1Mb≈1cM) 
and ak is Watterson’s correction factor for k sampled alleles (2n) [170].  In this case, 
ak was calculated as   kln , where γ is Euler-Mascheroni’s constant which 





1 ka ) 
and the natural logarithm (  kln ) which has been suggested as providing a suitable 
approximation to ak.  
Table A-1 Comparison of observed and expected number of segregating sites 
Sample size 
(n) 
Expected no. of 
segregating sites (Sk) 
Mean observed no. of 
segregating sites 
(across 30 replicates) 
Percentage 
difference 
50 4144 4150.8 0.164 
100 4696 4718.2 0.471 
200 5256 5324.8 1.301 
400 5808 5990.1 3.087 
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Appendix A A-3 
The expected heterozygosity  HE of the sample was calculated as follows10. 





































































HE .  If Ne=200, then the minimum 
frequency is 1/400 and maximum frequency is 399/400, and the best continuous 
approximation has 399 intervals going from p0 = 1/800 to p1 = 799/800 so 
      149.0799ln
800798
HE . 
Table A-2 Observed heterozygosity 
Sample size (n) 





weighted by total no. of 
sites 
50 0.1903 2,369,691.7 
100 0.1679 4,753,081.1 
200 0.1491 9,527,191.8 
400 0.1327 19,077,270.5 
 Overall Mean: 0.1438 
I 
Calculated assuming HWE (H = 2pq) 
  
                                                 
 
10
 Derivation by John Woolliams (The Roslin Institute). 
The application of genomic technologies to the horse 
Appendix A A-4 
A.iii Description of contemporary groups 
Table A-3 The distribution of samples across contemporary groups 











Controls Cases Total 
1 Af 0 0 0 F 3 40 43 
2 Am 0 0 0 M 4 57 61 
3 Bf 1 0 0 F 52 12 64 
4 Bm 1 0 0 M 21 13 34 
5 Cf 0 1 0 F 28 10 38 
6 Cm 0 1 0 M 28 15 43 
7 Df 0 0 1 F 8 4 12 
8 Dm 0 0 1 M 13 1 14 
9 Ef 1 1 0 F 7 6 13 
10 Em 1 1 0 M 3 3 6 
11 Ff 1 0 1 F 1 1 2 
12 Fm 1 0 1 M 0 0 0 
13 Gf 0 1 1 F 0 0 0 
14 Gm 0 1 1 M 0 0 0 
15 Hf 1 1 1 F 0 0 0 
16 Hm 1 1 1 M 0 0 0 
     TOTAL: 168 162 330 
I
ALD = angular limb deformity 
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A.iv Quantitative trait loci 
Table A-4 Details of QTL regions from Lampe (2009) [99] and Komm (2010) [100] tested 
QTL 
no. 
Chr From (bp) To (bp) QTL type
I
 Reference 
1 1 43,130,411 44,675,827 C Lampe (2009), ch. 8 
2 2 17,546,278  A Komm (2010), ch. 5 
3 3 64,213,851 64,632,362 C Lampe (2009), ch. 8 
4 3 69,400,000 71,400,000 B Komm (2010), ch. 5 





 Komm (2010), ch. 4 
7 4 15,993,651  A
†
 Komm (2010), ch. 4 
8 4 38,260,000 40,260,000 B Komm (2010), ch. 5 
9 4 41,202,168 41,365,096 C Lampe (2009), ch. 8 
10 5 57,960,000 59,960,000 B Komm (2010), ch. 5 
11 7 16,020,000 18,020,000 B Komm (2010), ch. 5 
12 14 57,700,667 57,826,754 C Lampe (2009), ch. 8 
13 16 39,044,608  A Komm (2010), ch. 5 
14 16 79,400,000 81,400,000 B Komm (2010), ch. 5 
15 16 82,398,594 82,803,587 C Lampe (2009), ch. 8 
16 18 36,408,881 38,738,316 C Lampe (2009), ch. 8 
17 18 79,364,656 80,836,383 D Lampe (2009), ch. 7 
18 19 620,000 2,620,000 B Komm (2010), ch. 5 
19 20 13,220,000 15,220,000 B Komm (2010), ch. 5 
20 22 2,790,000 4,790,000 B Komm (2010), ch. 5 
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QTL 
no. 
Chr From (bp) To (bp) QTL type
I
 Reference 
21 26 26,610,000 28,610,000 B Komm (2010), ch. 5 
22 29 7,670,000 9,670,000 B Komm (2010), ch. 5 
23 30 12,182,691 12,239,797 C Lampe (2009), ch. 8 
24 X 55,573,885 55,574,350 C Lampe (2009), ch.8 
I
A – a specific SNP locus which lies within a QTL previously identified in linkage analyses and 
was subsequently found to be associated with OCD and/or OC in a GWAS; A
†
 - a specific SNP 
locus found to be associated with OC or OCD in a QTL refinement study; B – a region which 
represents a 2Mb window surrounding the approximate location of a significant QTL identified 
in a GWAS; C – a region which contained ≥3 significant SNP(s) in a GWAS; D – a region which 
contained a significant SNP haplotype found within a QTL previously identified in linkage 
analyses.      
II
BIEC2-893170 at position 13,101,957 was not typed in my sample.  Therefore BIEC2-849331 at 
position 13,126,529 was tested in the mixed model.   




Appendix B: Equine biobank documents 
B.i Project brief  
 
Background 
During my PhD, there have been several discussions between myself, my supervisors 
(Prof. John Woolliams of RI and Sarah Blott of AHT) and representatives of the BEF 
(Jan Rogers, Graham Suggett and Jenny Hall) about the lack of sample availability 
for future genomic work in the horse.  There is potential for genomic technologies to 
be used to increase the rate of genetic improvement in the UK sport horse population 
both with respect to disease reduction and performance improvement.  A significant 
barrier to the implementation of such marker assisted breeding programs is a lack of 
DNA samples with associated data for use in research studies.  Since the 
development of the Illumina Equine SNP50 BeadChip, groups from across the world 
have embarked on projects to elucidate the genetic component of various traits from 
coat colour to racing speed.  Studies published to date nearly all share one thing in 
common – a lack of power to detect all but the largest genetic effects due to small 
sample size.  Therefore, if the UK equine industry is to make use of the current and 
future genomic technologies, a strategy is needed to collect well-characterised DNA 
samples.  This project is concerned with whether a national equine biobank could be 
part of such a strategy. 
 
Scope, Objectives and Deliverables 
This project has two main components: 
1. An overview of biobank methodology.  Objectives: 
 Produce a report that: describes the principal considerations in setting 
up a biobank and discusses the advantages and disadvantages of 
different biobank methodologies.  
2. A survey of opinion within the equine industry.  Objectives: 
 Undertake interviews with sample cross-section of industry 
representatives  




 Document the opinions of a range of industry representatives on the 
establishment of a national biobank 
 Document the opinions of the general horse owning public on the 
establishment of a national biobank 
Further objectives are then: 
 To consider different biobank methodologies in the context of the equine 
industry. 
 To produce a list of stakeholders within the equine industry and their 
particular interests/needs with respect to a national equine biobank.  
 To provide guidance to the BEF on the next steps with respect to the 
establishment of a national equine biobank. 
 To produce a list of experts that could offer advice and/or assistance to the 
BEF on the topic of an equine biobank in the future. 
This project will not: 
 Provide a full stakeholder analysis 
 Provide a costing for the establishment of a national equine biobank 
 Provide a plan for the execution of a national equine biobank  
 
Funding 
Reasonable expenses will be provided by the BEF to cover costs including:  travel to 
conduct interviews, printing costs.  
 
Success Criteria 
This project will be considered a success if: 
 A report is compiled that improves the BEF’s knowledge regarding the 
feasibility of setting up a national equine biobank, enabling them to make a 
decision regarding the future progression of this idea.   
 A list of experts in the field is provided to the BEF. 
 
  




Work/Task Breakdown Structure 
1. An overview of biobank methodology: 
 Literature review of biobank methodology including different 
workflows, sample collection options, etc. 
 Investigation of biobank services offered by companies, e.g. 
processing and storage of samples, software packages to manage 
biobank collections 
 A superficial look at the cost of establishing a biobank 
2. A survey of opinion within the equine industry: 
 Online survey open to all horse owners and riders 
 Interviews with industry representatives both to gather opinions and to 
compile a list of experts in the field that could be consulted in future   
3. Presentation of results: 
 Written report in the style of a government white paper discussing 
biobank methodology in the context of the horse industry 
 Short report with key conclusions and recommendations   
 
Milestones 








 January 2012 






 March 2012 
Contact made with majority of 






 April 2012 
Relevant information about 
biobanking methodology 
collected, interviews completed, 





 July 2012 








 August 2012 Final report submitted 100% 
  





By the end of the project, it should be clearer whether a national equine biobank is a 
feasible solution to the current problem of a lack of well-characterised DNA samples 
for use in genomic studies of disease and performance in the horse. 
Resources, Skills and Costs  
The majority of the work will be undertaken by me (Laura Corbin), with the 
proportion of my time being spent on the project as indicated in the milestones 
section above.  The main expenditure will be travelling costs. 
Project Impacts and Dependencies 
Whilst carrying out this project the remainder of my time (as indicated under 
milestones) will be spent writing up my thesis.  Timings may need to be adjusted to 
ensure both this project and my thesis are completed on time. 
  




B.ii Online survey questions 
1. Select one or more of the following to best describe your involvement within the horse 
industry. 
 I am a hobby/amateur rider 
 I am a professional rider 
 I am a breeder 
 I own and/or manage a commercial yard 
 I am a groom and/or instructor 
 I am studying/have studied a further education or higher education course in horses 
 I am an equine professional/paraprofessional (please use space below to specify, e.g. 
veterinarian,dentist) 
 Other, please specify 
 
2. Do you compete in any of the following disciplines? Please select all that apply. 
 No, I don't compete 
 Show Jumping 
 Dressage 
 Eventing 








 Other, please specify 
 
3. Are you a member of any of the following equine organisations? Please select all that apply. 
 No, I am not a member of any equine societies/organisations 
 British Horse Society 
 British Show Jumping 
 British Dressage 
 British Eventing 
 Endurance GB 
 British Equestrian Vaulting 
 British Reining 
 British Horse Driving Trials Association 
 Thoroughbred Breeders Association 
 Other, please specify 
 




 More than 5 
 
5. Is/are your horse/s registered with a breed society or studbook, either in the UK or overseas? 
 No 
 Yes 
 If yes, please specify 
  




6. Has/have your horse/s ever been tested for a genetic disease? 
 No 
 Don't know 
 Yes 
 If yes, please provide further details below 
 
7. Biobanks have traditionally been associated with biomedical research. They are collections of 
biological materials (such as blood and/or tissues) and personal data (medical records, lifestyle 
data) from large numbers of people.  Using such biobanks, researchers can identify the genetic 
and environmental factors associated with the risk of certain diseases. This information can help 
to improve prevention, diagnosis and treatment. Critics, however, raise questions about the 
privacy and confidentiality of biobanks and have concerns over commercial interests and 
regulation. As scientists unravel the genetic code of many animals, including the horse, 
veterinary researchers are creating collections of animal biological samples with associated data 
for use in similar genetic studies. Data in this setting may include diagnostic test results, 
treatment received, etc.   
 
Suppose you were asked to vote for or against the creation of an equine biobank in the UK, what 
issues would you like to know more about before voting? Rank the following from the issue you 
would be most interested in knowing more about (1) to the issue you would be least interested in 
knowing more about (5). 
Rank the following items using numbers from 1 to 5. 
 What the potential benefits would be What the possible risks would be  
 Who would fund the biobank  
 How the biobank would be managed and by 
 whom 
 How the biobank would be regulated and by whom 
 




9. Other than for the purposes of this survey, have you ever....? 
 Talked about biobanks with anyone 
 Searched for information about biobanks 
 Talked specifically about an equine biobank with anyone 
 Searched for information specifically about equine biobanks 
 
10. Below is a list of areas in which an equine biobank could be used. Indicate how important 
you think each of them are. 
 Conservation 
 Genetic research of disease 
 Genetic research of performance traits 
 Breeding – to reduce disease by using marker assisted selection 
 Breeding – to improve performance by using marker assisted selection 
  




11. In order to understand the causes of disease, researchers need as much information as 
possible about the horses in the biobank. Would you be concerned or reluctant about the 
collection of any of the following types of data about and materials from your horse/s? 
 Blood samples (left over from essential veterinary procedures) 
 Blood samples (taken solely for the purpose of the biobank) 
 Surplus tissue collected during essential veterinary procedures 
 Hair (with roots attached) 
 Buccal (cheek) swab 
 Nasal swab 
 Veterinary records 
 Performance records, e.g. British Showjumping points 
 Lifestyle information, e.g. time spent at grass, feeding regime 
 Pedigree  
 
12. Assuming that you had agreed for a sample to be collected from your horse/s, where and by 
whom should the sample to be taken? Indicate whether you would participate in the following 
collection schemes. 
 Collection at a competition or other event that you were already taking your horse/s to. 
 Collection at a nearby venue which you would take your horse/s to, specifically for a sample 
to be taken. 
 Collection by yourself (only applies to hair, buccal (cheek) swabs and nasal swabs). 
 Collection by your vet during a routine visit. 
 Collection by your vet following the admission of your horse/s for treatment. 
 
13. The more information associated with a sample in the biobank, the more valuable that 
sample will be to researchers. Therefore, the ability to obtain follow-up data would be an 
important aspect of a biobank. For each of the following statements regarding methods of 
obtaining follow-up information relevant to your horse’s sample, indicate whether you agree or 
disagree. 
 I would be willing to provide regular updates (e.g. every six months) about my horse/s via an 
online profile 
 I would be willing to provide updates about my horse/s when asked to do so 
 I would be happy for my horse's performance records to be accessed by researchers, as 
required, without my permission 
 I would be happy for my horse's veterinary records to be accessed by researchers, as 
required, without my permission 
 I would be happy for my horse's performance records to be accessed by researchers, as 
required, provided that my permission was sought first 
 I would be happy for my horse's veterinary records to be accessed by researchers, as 
required, provided that my permission was sought first 
 I would prefer for my horse's sample and associated data to be made anonymous following 
collection and therefore would not be willing for any further data to be collected 
 
14. Biobanks are expensive to maintain. Therefore, owners may be asked to pay a small fee to 
have their horse’s sample and data collected. For each of the following statements regarding 
payment for biobank services, indicate whether you agree or disagree. 
 I would be happy to pay a small fee 
 I would be happy to pay a small fee but I would expect something in return 
 I do not think horse owners should have to pay, the people who use the samples and 
information should pay 
 I do not think horse owners should have to pay, equine organisations should pay 
 I do not think horse owners should have to pay, the government should pay 
 I do not think horse owners should have to pay, but I do not know who else should pay 
  




15. If a UK equine biobank was created, how concerned would you be about the following? 
 Confidentiality of biological samples 
 Confidentiality of data 
 Potential effects of genetic test results on insurance premiums 
 Potential effects of genetic test results on sale values 
 Potential effects of genetic test results on breeding values 
 
16. Do you think that the UK should have an equine biobank? Please use the box below if you 
have any additional 
comments. 
 Yes, definitely 
 Yes, probably 
 No, probably not 
 No, definitely not 
 Don't know 
 Additional Comments 
 
17. If a UK equine biobank were created, would you be willing to provide samples from and 
information about your 
horse/s? Please use the box below if you have any additional comments. 
 Yes, definitely 
 Yes, probably 
 No, probably not 
 No, never 
 Don't know 
 Additional Comments 
 
18. Why would/might you not be willing to provide samples from and information about you 
horse/s to a biobank? 
 
19. Please use the space below to add any further comments that you feel are relevant to the 
topic of an equine 
biobank. 
 
20. Please indicate below how much of the online supplementary information you read before 
completing this questionnaire. 
 Survey Welcome Greeting (on the BEF website) 
 Project Information (on The Roslin Institute website) 
 What is a biobank? (on The Roslin Institute website) 
 What could an equine biobank be used for? (on The Roslin Institute website)
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